Clinical Trials

• C-PHONE Study
  ClinicalTrials.gov Identifier: NCT00211601 - Active, not recruiting
  Chemotherapy Induced Nausea and Vomiting
  
• C-Reactive Protein (CRP) in Obese Diabetic Women
  ClinicalTrials.gov Identifier: NCT00262548 - Completed
  Diabetes Mellitus, Type 2
  
• C-Reactive Protein (CRP)-Guided Management Algorithm for Adults with Acute Cough
  ClinicalTrials.gov Identifier: NCT00221351 - Active, not recruiting
  Cough
  
• C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
  ClinicalTrials.gov Identifier: NCT00179868 - Recruiting
  Cancer; Leukemia
  
• C-Spine Movement - Shikani Optical Scope vs Macintosh Laryngoscope for Patients With Cervical Spine Injury
  ClinicalTrials.gov Identifier: NCT00310999 - Completed
  Wounds and Injuries
  
• C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00402545 - Recruiting
  Head and Neck Neoplasms
  
• C.A.T.C.H.-I.T.Competent Adulthood Transition with Cognitive, Humanistic and Interpersonal Teaching
  ClinicalTrials.gov Identifier: NCT00152529 - Terminated
  Depression
  
• C1 Esterase Inhibitor (Human) for the Treatment and Prevention of Acute Hereditary Angioedema (HAE) Attacks
  ClinicalTrials.gov Identifier: NCT00289211 - Completed
  Hereditary Angioedema
  
• C1 Esterase Inhibitor in HAE (Extension Study)
  ClinicalTrials.gov Identifier: NCT00292981 - Active, not recruiting
  Hereditary Angioedema
  
• C2P - Phase III (With Venues)
  ClinicalTrials.gov Identifier: NCT00271908 - Recruiting
  HIV
  
• C2P – Phase III:MPowerment and Community Promise
  ClinicalTrials.gov Identifier: NCT00381784 - Recruiting
  HIV Infections
  
• C2P Mobilization Intervention (Pilot)
  ClinicalTrials.gov Identifier: NCT00393575 - Recruiting
  HIV Infections
  
• CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00058032 - Active, not recruiting
  ovarian epithelial cancer
  
• CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen
  ClinicalTrials.gov Identifier: NCT00305838 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• CA-125 in Screening Patients at High Risk for Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00080639 - Active, not recruiting
  ovarian epithelial cancer
  
• Cabergoline Reduces OHSS
  ClinicalTrials.gov Identifier: NCT00440258 - Completed
  Ovarian Hyperstimulation Syndrome
  
• CABG Off or On Pump Revascularization Study
  ClinicalTrials.gov Identifier: NCT00463294 - Recruiting
  Coronary Artery Bypass
  
• CABG Without the Use of CPB
  ClinicalTrials.gov Identifier: NCT00202332 - Active, not recruiting
  Coronary Artery Bypass
  
• CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00227344 - Recruiting
  Atrial Fibrillation
  
• Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00579371 - Enrolling by invitation
  Islets of Langerhans Transplantation; Diabetes Mellitus, Type 1
  
• Caduet in an Untreated Subject Population.
  ClinicalTrials.gov Identifier: NCT00332761 - Completed
  Hypertension; Dyslipidemia
  
• Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors
  ClinicalTrials.gov Identifier: NCT00407537 - Recruiting
  Hypertension
  
• Caelyx Adjuvant in Elderly Breast Cancer
  ClinicalTrials.gov Identifier: NCT00284336 - Completed
  Breast Cancer; Elderly
  
• Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years
  ClinicalTrials.gov Identifier: NCT00563953 - Recruiting
  Breast Cancer
  
• Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00170573 - Active, not recruiting
  Ovarian Cancer
  
• Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
  ClinicalTrials.gov Identifier: NCT00189553 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer
  
• Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00258960 - Recruiting
  Breast Cancer
  
• Caesarean and Corticotherapy
  ClinicalTrials.gov Identifier: NCT00446953 - Recruiting
  Neonatal Distress
  
• CAFE Comparison of Atypicals in First Episode
  ClinicalTrials.gov Identifier: NCT00034892 - Completed
  Schizophrenia; Psychotic Disorders; Mental Health; Mental Disorders
  
• CAFE Study - Cancer Patient Fracture Evaluation
  ClinicalTrials.gov Identifier: NCT00211237 - Recruiting
  Cancer; Spinal Fractures
  
• Cafeteria-Based Study of Weight Gain Prevention
  ClinicalTrials.gov Identifier: NCT00142662 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Caffeine and Intermittent Claudication
  ClinicalTrials.gov Identifier: NCT00388128 - Recruiting
  Intermittent Claudication
  
• Caffeine for Apnea of Prematurity (CAP)
  ClinicalTrials.gov Identifier: NCT00182312 - Active, not recruiting
  Apnea of Prematurity
  
• Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00459420 - Recruiting
  Parkinson's Disease; Excessive Daytime Somnolence
  
• Caffeine in the Prevention of Post-Operative Nausea and Vomiting
  ClinicalTrials.gov Identifier: NCT00130026 - Completed
  POSTOP NAUSEA VOMITING
  
• Caffeinol Hypothermia Protocol
  ClinicalTrials.gov Identifier: NCT00299416 - Recruiting
  Acute Ischemic Stroke
  
• CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00330746 - Active, not recruiting
  Advanced Non-Small Cell Lung Cancer
  
• Calcifidol Therapy in Men with Cancer
  ClinicalTrials.gov Identifier: NCT00018538 - Completed
  Prostate Cancer
  
• Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00305396 - Completed
  Kidney Transplantation
  
• Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
  ClinicalTrials.gov Identifier: NCT00541814 - Recruiting
  Chronic Allograft Nephropathy
  
• Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk
  ClinicalTrials.gov Identifier: NCT00138970 - Completed
  Renal transplant recipients
  
• Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
  ClinicalTrials.gov Identifier: NCT00358839 - Completed
  Familial Hemiplegic Migraine
  
• Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00017576 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
  ClinicalTrials.gov Identifier: NCT00084864 - Recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00030069 - Recruiting
  Myelodysplastic Syndromes
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00524589 - Recruiting
  Prostate Cancer
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00238199 - Active, not recruiting
  Pancreatic Cancer
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00301067 - Suspended
  Intraocular Melanoma; Melanoma (Skin)
  
• Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004928 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Calcitriol in Preventing Prostate Cancer in Patients with Prostatic Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00118066 - Recruiting
  Prostate Cancer; Precancerous Condition
  
• Calcitriol in the Treatment of IgA Nephropathy
  ClinicalTrials.gov Identifier: NCT00319761 - Active, not recruiting
  IGA Nephropathy
  
• Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004043 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance
  ClinicalTrials.gov Identifier: NCT00482157 - Not yet recruiting
  Prostatic Neoplasms
  
• Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00008086 - Active, not recruiting
  Brain Tumor; Genetic Condition; Solid Tumor
  
• Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00009802 - Completed
  unspecified adult solid tumor, protocol specific
  
• Calcitriol, Cisplatin, and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00470431 - Recruiting
  Lung Cancer
  
• Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00238225 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Calcitriol, Ketoconazole, and Hydrocortisone in Treating Patients With Advanced or Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00536991 - Recruiting
  Prostate Cancer
  
• Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00182741 - Active, not recruiting
  Prostate Cancer
  
• Calcium Absorption and Retention From Marine Products
  ClinicalTrials.gov Identifier: NCT00393289 - Active, not recruiting
  Calcium Metabolism
  
• Calcium and Bone Mass in Young Females
  ClinicalTrials.gov Identifier: NCT00000402 - Completed
  Osteoporosis
  
• Calcium and Vitamin D Malnutrition in Elderly Women
  ClinicalTrials.gov Identifier: NCT00352170 - Active, not recruiting
  Osteoporosis; Secondary Hyperparathyroidism
  
• Calcium and Vitamin D Supplementation Decreases Incidence of Stress Fractures in Female Navy Recruits
  ClinicalTrials.gov Identifier: NCT00476346 - Completed
  Stress Fracture
  
• Calcium Channel Splice Variant Expression in Cardiovascular Disease and Aging
  ClinicalTrials.gov Identifier: NCT00251615 - Recruiting
  Atherosclerosis
  
• Calcium Current in Human Heart Cells
  ClinicalTrials.gov Identifier: NCT00243776 - Recruiting
  Congenital Heart Disease; Tetralogy of Fallot
  
• Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density
  ClinicalTrials.gov Identifier: NCT00205036 - Recruiting
  Healthy
  
• Calcium for Pre-Eclampsia Prevention (CPEP)
  ClinicalTrials.gov Identifier: NCT00000534 - Completed
  Cardiovascular Diseases; Eclampsia; Heart Diseases; HELLP Syndrome; Hypertension; Pre-Eclampsia; Pregnancy Toxemias; Vascular Diseases
  
• Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00316914 - Active, not recruiting
  Colorectal Cancer; Neurotoxicity
  
• Calcium Intake, Metabolism, and Gestational Blood Pressure
  ClinicalTrials.gov Identifier: NCT00005206 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)
  ClinicalTrials.gov Identifier: NCT00386672 - Active, not recruiting
  Obesity; Overweight
  
• Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00000429 - Completed
  Juvenile Rheumatoid Arthritis
  
• Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00043069 - Active, not recruiting
  Osteoporosis; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Calcium, Probiotics and Acute Diarrheal Disease Among Indonesian Children Aged 1-6 Years in Low Socio-Economic Urban Area of East Jakarta
  ClinicalTrials.gov Identifier: NCT00512824 - Recruiting
  Healthy; Diarrhea
  
• Calcium, Vitamin D, and Colon Cancer Risk Biomarkers
  ClinicalTrials.gov Identifier: NCT00208793 - Active, not recruiting
  Colonic Polyps; Adenomatous Polyps
  
• Calcium/Vitamin D, Biomarkers,& Colon Polyp Prevention
  ClinicalTrials.gov Identifier: NCT00399607 - Recruiting
  Adenomatous Colon Polyps
  
• CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
  ClinicalTrials.gov Identifier: NCT00099151 - Completed
  Aging; Cardiovascular Disease; Diabetes Mellitus
  
• CALERIE (Tufts) - Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy
  ClinicalTrials.gov Identifier: NCT00099099 - Completed
  Aging
  
• CALERIE (Washington University): Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy
  ClinicalTrials.gov Identifier: NCT00099138 - Completed
  Aging
  
• CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy
  ClinicalTrials.gov Identifier: NCT00427193 - Recruiting
  Aging
  
• Calibration of Non-Invasive Non-Ionizing Imaging Techniques to Study Vasculature of Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00546091 - Recruiting
  Healthy Volunteers Only
  
• Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods
  ClinicalTrials.gov Identifier: NCT00339443 - Active, not recruiting
  Calibration
  
• California WISEWOMAN Project
  ClinicalTrials.gov Identifier: NCT00153400 - Not yet recruiting
  CVD risk
  
• CALM-AD
  ClinicalTrials.gov Identifier: NCT00142324 - Active, not recruiting
  Alzheimer''s Disease
  
• Cambridge Anti-Myopia Trial: Accommodation Training and Aberration Control in Myopia Development
  ClinicalTrials.gov Identifier: NCT00317551 - Completed
  Myopia
  
• Caminemos! Trial to Increase Walking Among Sedentary Older Latinos
  ClinicalTrials.gov Identifier: NCT00183014 - Recruiting
  Aging; Sedentary Lifestyle
  
• Campath in Chronic GVHD
  ClinicalTrials.gov Identifier: NCT00495755 - Recruiting
  Chronic Graft-vs.-Host Disease
  
• Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation
  ClinicalTrials.gov Identifier: NCT00579592 - Active, not recruiting
  Acute Rejection; Renal Transplantation
  
• Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
  ClinicalTrials.gov Identifier: NCT00038883 - Terminated
  Leukemia, Lymphocytic, Chronic; Leukemia, Lymphocytic, Acute; Lymphoma, Low-Grade; Lymphoma, T-Cell; Lymphoma, B-Cell
  
• Campath-1H and EPOCH to Treat non-Hodgkin's T- and NK-Cell Lymphomas
  ClinicalTrials.gov Identifier: NCT00069238 - Recruiting
  Lymphoma
  
• Campath-1H for Treating Adult T-Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00061048 - Recruiting
  Acute T-Cell Leukemia-Lymphoma
  
• Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00214201 - Active, not recruiting
  Primary Renal Transplant
  
• Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00167661 - Recruiting
  Renal Transplantation
  
• Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
  ClinicalTrials.gov Identifier: NCT00071396 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto
  ClinicalTrials.gov Identifier: NCT00251888 - Completed
  Cervix Cancer.
  
• Campus Health Intervention Projects UBC Site
  ClinicalTrials.gov Identifier: NCT00278733 - Completed
  High Risk Drinking
  
• Campylobacter Jejuni Challenge Model Development: Dose Ranging Study
  ClinicalTrials.gov Identifier: NCT00434798 - Recruiting
  Campylobacter Infections
  
• Can a Modified Fat Diet With Low Glycaemic Load Improve Insulin Sensitivity and Inflammatory Mediators in Overweight People With Chronic Heart Failure?
  ClinicalTrials.gov Identifier: NCT00163904 - Recruiting
  Heart Failure
  
• Can a Novel Treatment Using "Mandometer®" Technology Improve Weight Loss in a Childhood Obesity Clinic?
  ClinicalTrials.gov Identifier: NCT00407420 - Completed
  Childhood Obesity
  
• Can a Physical Activity Skill Development and Parent-Centered Dietary Intervention Help Combat Child Obesity?
  ClinicalTrials.gov Identifier: NCT00107692 - Active, not recruiting
  Obesity
  
• Can a Very High Result From a Screening Test for Celiac Disease Be Used to Diagnose Celiac Disease?
  ClinicalTrials.gov Identifier: NCT00175760 - Recruiting
  Celiac Disease
  
• Can Acupuncture Be Used as Preparation for Induction of Labour
  ClinicalTrials.gov Identifier: NCT00245752 - Recruiting
  Pregnancy Overdue - Week 41+6
  
• Can Additional Drug Therapy Accelerate Response Time to Antidepressants
  ClinicalTrials.gov Identifier: NCT00221494 - Active, not recruiting
  Depression
  
• Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? a Multi-Center Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00120978 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?
  ClinicalTrials.gov Identifier: NCT00261625 - Not yet recruiting
  End-Stage Renal Disease; Peritoneal Dialysis; Osteoporosis
  
• Can Aprotinin Reduce Pancreatitis After Scoliosis Surgery
  ClinicalTrials.gov Identifier: NCT00357851 - Recruiting
  Pancreatitis
  
• Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?
  ClinicalTrials.gov Identifier: NCT00468494 - Recruiting
  General Anesthesia; Hyperglycemia
  
• Can CSM Monitor Depth of Anaesthesia Just as Good as BIS?
  ClinicalTrials.gov Identifier: NCT00251810 - Active, not recruiting
  General Anaesthesia
  
• Can CT Enteroclysis Predict the Outcome of Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00572780 - Active, not recruiting
  Crohn's Disease
  
• Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?
  ClinicalTrials.gov Identifier: NCT00431925 - Not yet recruiting
  Oral Mucositis; Xerostomia; Weight Loss; Head and Neck Cancer
  
• Can Education for South Asians with Asthma and Their Clinicians Reduce Unscheduled Care? A Randomised Trial
  ClinicalTrials.gov Identifier: NCT00214669 - Recruiting
  Asthma
  
• Can Erythopoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?
  ClinicalTrials.gov Identifier: NCT00265486 - Recruiting
  Healthy
  
• Can Group Visits Improve Outcomes of Veterans With Diabetes
  ClinicalTrials.gov Identifier: NCT00286741 - Recruiting
  Diabetes; Hypertension
  
• Can Immune Parameters Predict Acute and Chronic Rejection in Lung Recipients?
  ClinicalTrials.gov Identifier: NCT00340951 - Completed
  Lung Transplantation
  
• Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
  ClinicalTrials.gov Identifier: NCT00172302 - Not yet recruiting
  Kidney Failure, Chronic
  
• Can MRSA Screening Reduce ICU Infections?
  ClinicalTrials.gov Identifier: NCT00428259 - Not yet recruiting
  Cross Infection
  
• Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?
  ClinicalTrials.gov Identifier: NCT00164970 - Recruiting
  Dementia
  
• Can parathyroid hormone injections reverse glucocorticoid-induced osteoporosis
  ClinicalTrials.gov Identifier: NCT00004993 - Completed
  Osteoporosis
  
• Can Parental Activation Over the Internet Improve Pediatric Preventive Care?
  ClinicalTrials.gov Identifier: NCT00101855 - Active, not recruiting
  well child preventive care
  
• Can Quantitative Ultrasound Be Used for the Evaluation of Bone Health in Adolescents and Adults with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00221572 - Recruiting
  Cystic Fibrosis
  
• Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?
  ClinicalTrials.gov Identifier: NCT00279552 - Completed
  Vitamin B12 Deficiency
  
• Can Resistance Enhance Selection of Treatment? (CREST)
  ClinicalTrials.gov Identifier: NCT00262717 - Completed
  HIV Infection
  
• Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?
  ClinicalTrials.gov Identifier: NCT00214708 - Active, not recruiting
  Tuberculosis
  
• Can Structured Education Promote Physical Activity in Those Identified With an Increased Risk of Developing Diabetes
  ClinicalTrials.gov Identifier: NCT00566319 - Active, not recruiting
  Prediabetic State
  
• Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?
  ClinicalTrials.gov Identifier: NCT00215631 - Terminated
  Prostate Cancer; Erectile Dysfunction
  
• Can Targeted Elimination of B-Cell Depletion Therapy and/or Combination Therapy on SLE
  ClinicalTrials.gov Identifier: NCT00556192 - Recruiting
  Systemic Lupus Erythematosus
  
• Can Thought Field Therapy (TFT) Be Helpful for Patients With an Anxiety Disorder?
  ClinicalTrials.gov Identifier: NCT00202709 - Completed
  Agoraphobia; Social Phobia
  
• Can Ultrasound be Used to Verify CVC Position and to Exclude Pneumothorax?
  ClinicalTrials.gov Identifier: NCT00388375 - Recruiting
  Catheterization, Central Venous
  
• Can Vignettes Be Used to Improve Practice & Outcome
  ClinicalTrials.gov Identifier: NCT00122148 - Terminated
  
  
• Can We Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation
  ClinicalTrials.gov Identifier: NCT00129701 - Completed
  Asthma; COPD; Sleep Apnea Syndromes; Interstitial Lung Disease; Bronchiectasis
  
• Canactfast: Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
  ClinicalTrials.gov Identifier: NCT00150371 - Completed
  Hypercholesterolemia (D006937)
  
• Canadian Aesthetic Experience With Sculptra Therapy
  ClinicalTrials.gov Identifier: NCT00447551 - Active, not recruiting
  Skin Aging
  
• Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis.
  ClinicalTrials.gov Identifier: NCT00332332 - Recruiting
  Psoriasis
  
• Canadian C-Spine Rule Study
  ClinicalTrials.gov Identifier: NCT00290875 - Recruiting
  Cspine Injury
  
• Canadian Fabry Disease Initiative (CFDI) Enzyme Replacement Therapy (ERT) Study
  ClinicalTrials.gov Identifier: NCT00455104 - Recruiting
  Fabry Disease
  
• Canadian Orthopaedic Foot and Ankle Society Surgical Treatment of Ankle Arthritis Outcome Study
  ClinicalTrials.gov Identifier: NCT00552136 - Recruiting
  Ankle Arthritis
  
• Canadian Pegvisomant Compassionate Study In Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00151437 - Completed
  Acromegaly
  
• Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)
  ClinicalTrials.gov Identifier: NCT00182546 - Terminated
  Suspected Pulmonary Embolism; Deep Venous Thrombosis
  
• Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
  ClinicalTrials.gov Identifier: NCT00233532 - Active, not recruiting
  Hypertension
  
• Canadian Trial of Dietary Carbohydrates in Diabetes
  ClinicalTrials.gov Identifier: NCT00223574 - Completed
  Type 2 Diabetes
  
• Canalith Repositioning Procedure for BPPV in Primary Care
  ClinicalTrials.gov Identifier: NCT00182273 - Completed
  Benign Paroxysmal Positional Vertigo
  
• CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)
  ClinicalTrials.gov Identifier: NCT00219973 - Recruiting
  Cancer; Venous Thromboembolism
  
• Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )
  ClinicalTrials.gov Identifier: NCT00236002 - Terminated
  Osteoporosis
  
• Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting
  ClinicalTrials.gov Identifier: NCT00322647 - Completed
  Cancer
  
• Cancer Detection in Pancreatic Cysts
  ClinicalTrials.gov Identifier: NCT00222898 - Completed
  Pancreatic Cyst; Pancreatic Pseudocyst; Pancreatic Neoplasm
  
• Cancer Dietary Objectives Study
  ClinicalTrials.gov Identifier: NCT00561977 - Recruiting
  Cancer; Heart Disease
  
• Cancer Genetics CD-ROM for Hispanics
  ClinicalTrials.gov Identifier: NCT00525980 - Recruiting
  Breast Cancer
  
• Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-Antigen-Positive Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00455572 - Recruiting
  Tumor-Antigen-Positive Non-Small-Cell Lung Cancer
  
• Cancer in Inherited Bone Marrow Failure Syndromes
  ClinicalTrials.gov Identifier: NCT00027274 - Recruiting
  Fanconi's Anemia; Anemia, Diamond-Blackfan; Dyskeratosis Congenital; Thrombocytopenia; Neutropenia
  
• Cancer of the Pancreas Screening Study (CAPS 3)
  ClinicalTrials.gov Identifier: NCT00438906 - Recruiting
  Pancreatic Neoplasm; Peutz-Jeghers Syndrome
  
• Cancer Pain
  ClinicalTrials.gov Identifier: NCT00046709 - Terminated
  Neoplasms
  
• Cancer Patients' Medication Knowledge in the Emergency Center
  ClinicalTrials.gov Identifier: NCT00385476 - Recruiting
  Advanced Cancer
  
• Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial
  ClinicalTrials.gov Identifier: NCT00509444 - Recruiting
  Breast Cancer; Colon Cancer; Rectum Cancer; Cervix Cancer; Prostate Cancer; Lung Cancer
  
• Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities
  ClinicalTrials.gov Identifier: NCT00453661 - Recruiting
  Breast Cancer; Cervical Cancer; Prostate Cancer; Colorectal Cancer; Lung Cancer
  
• Cancer Related Fatigue in Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00261534 - Active, not recruiting
  Cancer; Fatigue
  
• Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
  ClinicalTrials.gov Identifier: NCT00046189 - Recruiting
  Xeroderma Pigmentosum
  
• Cancer Risk in Individuals Who Have a Xeroderma Pigmentosum Gene Alteration Compared With Those Who Don't
  ClinicalTrials.gov Identifier: NCT00049621 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Cancer Risk in X-Ray Technologists: Second Survey
  ClinicalTrials.gov Identifier: NCT00410475 - Active, not recruiting
  Neoplasm
  
• Cancer Treatment Followed by Surgery for Early Stage Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00313690 - Recruiting
  Lung Cancer
  
• Cancer Vaccine for Lymphoma following Chemotherapy
  ClinicalTrials.gov Identifier: NCT00001945 - No longer recruiting
  B Cell Lymphoma; Follicular Lymphoma
  
• Cancer Vaccine Study for Unresectable Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00409188 - Recruiting
  Non-Small Cell Lung Cancer
  
• Cancer-Preventing Qualities of Broccoli Sprouts Tea
  ClinicalTrials.gov Identifier: NCT00090350 - No longer recruiting
  Hepatocellular Carcinoma
  
• Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00125463 - Active, not recruiting
  Hypertension; Cardiovascular Diseases
  
• Candesartan Effectiveness Study in Pro-BNP
  ClinicalTrials.gov Identifier: NCT00348686 - Active, not recruiting
  Hypertension; Left Ventricular Hypertrophy
  
• Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
  ClinicalTrials.gov Identifier: NCT00139386 - Recruiting
  Hypertension; Coronary Artery Disease; Coronary Angioplasty
  
• Candesartan in the Prevention of Relapsing Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00130975 - Completed
  Atrial Fibrillation
  
• Candidate HIV Vaccine
  ClinicalTrials.gov Identifier: NCT00089531 - Active, not recruiting
  HIV Infections
  
• CANDIS - Targeted Treatment for Cannabis Disorders
  ClinicalTrials.gov Identifier: NCT00252980 - Active, not recruiting
  Cannabis Use Disorder
  
• Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
  ClinicalTrials.gov Identifier: NCT00385138 - Recruiting
  Atherosclerosis
  
• Cannabinoids in Bipolar Affective Disorder
  ClinicalTrials.gov Identifier: NCT00397605 - Recruiting
  Bipolar Affective Disorder
  
• Cannabis Cigarettes Used for Doping: THC Urine Detection
  ClinicalTrials.gov Identifier: NCT00534716 - Recruiting
  Healthy
  
• Cannabis for Spasticity in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00260741 - Terminated
  Multiple Sclerosis
  
• CAP
  ClinicalTrials.gov Identifier: NCT00172172 - Active, not recruiting
  Osteoporosis
  
• Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00254137 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Capadenoson in Angina Pectoris
  ClinicalTrials.gov Identifier: NCT00518921 - Not yet recruiting
  Chronic Stable Angina
  
• Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-Line Therapy in HER2/Neu-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00496366 - Recruiting
  Breast Cancer; Metastatic Breast Cancer; Advanced Breast Cancer; HER2/Neu-Positive Breast Cancer
  
• Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma
  ClinicalTrials.gov Identifier: NCT00216424 - Terminated
  Colorectal Cancer
  
• Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00216086 - Recruiting
  Rectal Cancer
  
• Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00291486 - Active, not recruiting
  Colorectal Neoplasms
  
• Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00257348 - Completed
  Cervical Cancer
  
• Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00258284 - Active, not recruiting
  Prostate Cancer
  
• Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00290693 - Recruiting
  Pancreatic Cancer
  
• Capecitabine and Gemcitabine in Patients with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00159445 - Recruiting
  Colorectal Cancer; Colon Cancer
  
• Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00042965 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00022698 - Completed
  Colon Cancer; Rectal Cancer
  
• Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater
  ClinicalTrials.gov Identifier: NCT00354887 - Active, not recruiting
  Gastrointestinal Cancer
  
• Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00104689 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004187 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00101075 - Active, not recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00354224 - Recruiting
  Gastric Cancer
  
• Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00216021 - Completed
  Metastatic Breast Cancer
  
• Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00427713 - Recruiting
  Colorectal Cancer
  
• Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00227734 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00397761 - Recruiting
  Breast Cancer
  
• Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00031876 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer
  ClinicalTrials.gov Identifier: NCT00227656 - Completed
  Brain and Central Nervous System Tumors; Breast Cancer
  
• Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00176735 - Terminated
  Pancreatic Cancer
  
• Capecitabine and Radiation Therapy in Treating Patients with Locally Advanced Cervical Cancer Or Other Pelvic Cancer
  ClinicalTrials.gov Identifier: NCT00118300 - Completed
  Endocrine Cancer; female reproductive cancer
  
• Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery
  ClinicalTrials.gov Identifier: NCT00562718 - Recruiting
  Breast Cancer
  
• Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00357253 - Recruiting
  Brain and Central Nervous System Tumors
  
• Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00165217 - Completed
  Colorectal Adenocarcinoma
  
• Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00077363 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
  ClinicalTrials.gov Identifier: NCT00003902 - Active, not recruiting
  stage IV breast cancer
  
• Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00347438 - Recruiting
  Breast Cancer
  
• Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene
  ClinicalTrials.gov Identifier: NCT00303927 - Recruiting
  Pancreatic Cancer
  
• Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00270491 - Recruiting
  Breast Cancer; Metastatic Disease
  
• Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00010023 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer
  
• Capecitabine Compared With Fluorouracil Plus Leucovorin in Treating Patients Who Have Undergone Surgery for Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00009737 - Active, not recruiting
  stage III colon cancer
  
• Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00049660 - Active, not recruiting
  stage IV breast cancer
  
• Capecitabine in Combination with Oxaliplatin (XELOX) vs. Fluorouracil/Leucovorin as Adjuvant Therapy for Patients who have Undergone Surgery for Colon Carcinoma
  ClinicalTrials.gov Identifier: NCT00069121 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine in Treating Older Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00049335 - Active, not recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Capecitabine in Treating Patients Who Have Undergone Previous Surgery, Radiation Therapy, and/or Chemotherapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00258310 - Active, not recruiting
  Head and Neck Cancer
  
• Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095641 - Not yet recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00016926 - Completed
  stage III cervical cancer; recurrent cervical cancer; stage IVB cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma
  
• Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer
  ClinicalTrials.gov Identifier: NCT00095901 - Active, not recruiting
  recurrent squamous cell carcinoma of the nasopharynx; stage IV squamous cell carcinoma of the nasopharynx; ...
  
• Capecitabine in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00004183 - Active, not recruiting
  recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; sarcomatous mesothelioma; ...
  
• Capecitabine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00274768 - Recruiting
  Breast Cancer
  
• Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00006023 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00039442 - Active, not recruiting
  recurrent cervical cancer; cervical adenocarcinoma; cervical adenosquamous cell carcinoma
  
• Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004012 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00026442 - Active, not recruiting
  stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Capecitabine in Treating Women With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00006812 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Capecitabine in Women with Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00148720 - Active, not recruiting
  Invasive Breast Carcinoma; Primary Invasive Breast Cancer; stage I breast cancer; Stage II Breast Cancer; Stage III Breast Cancer
  
• Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00215501 - Active, not recruiting
  Solid Tumor
  
• Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00363584 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
  
• Capecitabine Plus GTI-2040 in Treating Patients With Advanced or Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00084331 - Recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
  ClinicalTrials.gov Identifier: NCT00561522 - Recruiting
  Recurrence; Metastasis; Hepatocellular Carcinoma; Surgery
  
• Capecitabine vs. S-1 in Elderly AGC: Randomized Phase II Trial
  ClinicalTrials.gov Identifier: NCT00278863 - Completed
  Gastric Cancer
  
• Capecitabine(Xeloda) With Or Without Lapatinib(GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00078572 - Active, not recruiting
  Advanced Breast Cancer; Metastatic breast cancer
  
• Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00114179 - Active, not recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer; stage II pancreatic cancer
  
• Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00201734 - Recruiting
  Tumors; Unknown Primary Tumors; Adenocarcinoma
  
• Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00290615 - Recruiting
  Colorectal Cancer
  
• Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
  ClinicalTrials.gov Identifier: NCT00320749 - Recruiting
  Pancreatic Cancer
  
• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00486356 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00496587 - Recruiting
  Renal Cell Carcinoma
  
• Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00544063 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00216073 - Terminated
  Metastatic Breast Cancer
  
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients Who Are Undergoing Surgery for Liver Metastases Due to Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00118105 - Completed
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer; liver metastases
  
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00416494 - Active, not recruiting
  Colorectal Cancer
  
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Previously Untreated, Unresectable Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00450346 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00087334 - Active, not recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00114231 - Recruiting
  adenocarcinoma of the rectum; stage I rectal cancer
  
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
  ClinicalTrials.gov Identifier: NCT00093379 - Recruiting
  stage II anal cancer; stage IIIA anal cancer; stage IIIB anal cancer; squamous cell carcinoma of the anus
  
• Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients with Biliary Tract and Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00142480 - Recruiting
  Biliary tract adenocarcinoma; Gallbladder adenocarcinoma
  
• Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006108 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00093808 - Recruiting
  recurrent breast cancer; stage IV breast cancer; Male Breast Cancer
  
• Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00353457 - Recruiting
  Rectal Cancer
  
• Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotnib Followed of Capecitabine
  ClinicalTrials.gov Identifier: NCT00440167 - Recruiting
  Advanced; Pancreatic Cancer
  
• Capillary and Venous Blood Count Parameters
  ClinicalTrials.gov Identifier: NCT00390988 - Completed
  Hematological Diseases; Healthy Volunteers; Adult
  
• CAPITAL: Carotid Artery Plaque Intravascular Ultrasound Evaluation
  ClinicalTrials.gov Identifier: NCT00271076 - Completed
  Carotid Artery Disease
  
• CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
  ClinicalTrials.gov Identifier: NCT00526643 - Not yet recruiting
  Advanced Non-Small Cell Lung Cancer
  
• Capravirine (AG1549) in Combination with Viracept and Two NRTIs in HIV infected Patients Who Failed an Initial NNRTI Containing Regimen
  ClinicalTrials.gov Identifier: NCT00051844 - Completed
  Human Immunodeficiency Virus
  
• Capravirine to Treat Children with HIV Infection
  ClinicalTrials.gov Identifier: NCT00006519 - Completed
  HIV Infection
  
• Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003610 - Completed
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Capsaicin to Control Pain Following Third Molar Extraction
  ClinicalTrials.gov Identifier: NCT00008476 - Completed
  Facial Pain
  
• Capsaicin to Control Pain Following Third Molar Extraction
  ClinicalTrials.gov Identifier: NCT00088686 - Completed
  Healthy; Tooth Extraction
  
• Capsaicin-Evoked Pain in Patients With CRPS
  ClinicalTrials.gov Identifier: NCT00468390 - Recruiting
  CRPS (Complex Regional Pain Syndromes)
  
• Capsule Endoscopic Miss Rates Determined by Back-to-Back Capsule Endoscopy
  ClinicalTrials.gov Identifier: NCT00530231 - Recruiting
  Capsule Endoscopy
  
• Capsule Endoscopy in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00333957 - Recruiting
  Cystic Fibrosis
  
• Capsule Endoscopy in Obscure GI Bleeding
  ClinicalTrials.gov Identifier: NCT00203619 - Active, not recruiting
  Obscure Gastrointestinal Bleeding
  
• Capsule Endoscopy or Mesenteric Angiogram in Patients with Overt GIB of Obscure Origin
  ClinicalTrials.gov Identifier: NCT00153686 - Recruiting
  Gastrointestinal Hemorrhage
  
• Capsule Endoscopy vs. Push Enteroscopy in Occult Gastrointestinal Bleeding OGIB
  ClinicalTrials.gov Identifier: NCT00224627 - Completed
  Occult Gastrointestinal Bleeding
  
• CAPTAIN:CNV Assessment by Pattern Electroretinography
  ClinicalTrials.gov Identifier: NCT00500344 - Recruiting
  Age-Related Macular Degeneration
  
• Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00004230 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
  ClinicalTrials.gov Identifier: NCT00077064 - Active, not recruiting
  limited stage small cell lung cancer; Non-small cell lung cancer; Pulmonary Complications; Radiation Fibrosis
  
• CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse
  ClinicalTrials.gov Identifier: NCT00275769 - Completed
  Arrhythmia; Bradycardia
  
• CAPTURE 2 Post-Marketing Registry
  ClinicalTrials.gov Identifier: NCT00302237 - Recruiting
  Carotid Artery Disease
  
• Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
  ClinicalTrials.gov Identifier: NCT00351676 - Completed
  Heart Failure, Congestive; Pulmonary Disease, Chronic Obstructive; Pneumonia; Diabetes Mellitus, Type 2; Coronary Arteriosclerosis
  
• Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
  ClinicalTrials.gov Identifier: NCT00357864 - Completed
  Headache
  
• Carbachols Headacheinducing Effect and Changes in Cerebral Blood Flow in Migraine Patients
  ClinicalTrials.gov Identifier: NCT00564408 - Recruiting
  Headache
  
• Carbamazepine Extended-Release for the Treatment of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00203567 - Recruiting
  Bipolar Depression
  
• Carbamazepine Treatment for Cocaine Dependence - 5
  ClinicalTrials.gov Identifier: NCT00000191 - Completed
  Cocaine-Related Disorders
  
• Carbamazepine Treatment of Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00000242 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Carbetocin Versus Syntometrine for the Third Stage of Labour
  ClinicalTrials.gov Identifier: NCT00499005 - Recruiting
  Postpartum Haemorrhage
  
• Carbon Monoxide to Prevent Lung Inflammation
  ClinicalTrials.gov Identifier: NCT00094406 - Recruiting
  
  
• Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00392938 - Recruiting
  Metastatic Cancer; Prostate Cancer
  
• Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00456859 - Completed
  Kidney Failure, Chronic
  
• Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00404235 - Recruiting
  Melanoma (Skin)
  
• Carboplatin and Docetaxel After Surgery in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00280735 - Active, not recruiting
  Lung Cancer
  
• Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00061919 - Active, not recruiting
  extensive stage small cell lung cancer; limited stage small cell lung cancer
  
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00070486 - Active, not recruiting
  stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; large cell lung cancer; ...
  
• Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00470249 - Recruiting
  Breast Cancer
  
• Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-Small Cell Lung Cancer.
  ClinicalTrials.gov Identifier: NCT00400803 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024284 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific
  
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00553462 - Not yet recruiting
  Lung Cancer
  
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00520000 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
  ClinicalTrials.gov Identifier: NCT00322881 - Recruiting
  Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer; Mesodermal Tumors
  
• Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005059 - Completed
  stage IV non-small cell lung cancer; recurrent non-small cell lung cancer; psychosocial effects/treatment
  
• Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00003206 - Completed
  recurrent nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00565851 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00483782 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00262847 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin and Paclitaxel With or Without Cediranib in Treating Women With Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00544973 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00052468 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00017407 - Completed
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00110019 - Recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00481078 - Recruiting
  Lung Cancer
  
• Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00230542 - Recruiting
  Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer
  
• Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases
  ClinicalTrials.gov Identifier: NCT00362817 - Recruiting
  Brain Tumor
  
• Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003747 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Carboplatin Combined with Paclitaxel in Treating Patients With Advanced Thymoma
  ClinicalTrials.gov Identifier: NCT00010257 - Recruiting
  invasive thymoma and thymic carcinoma; recurrent thymoma and thymic carcinoma
  
• Carboplatin in Patients With Progressive Gliomas
  ClinicalTrials.gov Identifier: NCT00002749 - Active, not recruiting
  recurrent childhood brain stem glioma; recurrent childhood visual pathway glioma; recurrent childhood cerebral astrocytoma; ...
  
• Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00098878 - Recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00321633 - Recruiting
  Breast Cancer; Hereditary Breast/Ovarian Cancer (brca1, brca2)
  
• Carboplatin plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00097214 - Completed
  Non-small cell lung cancer
  
• Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
  ClinicalTrials.gov Identifier: NCT00085358 - Recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00010036 - Active, not recruiting
  adult glioblastoma multiforme
  
• Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00003998 - Active, not recruiting
  stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
  
• Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003644 - Active, not recruiting
  ovarian epithelial cancer
  
• Carboplatin Plus Taxotere in Anaplastic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00514540 - Recruiting
  Prostate Cancer
  
• Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003255 - Completed
  secondary acute myeloid leukemia; recurrent adult acute myeloid leukemia
  
• Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma
  ClinicalTrials.gov Identifier: NCT00003015 - Active, not recruiting
  untreated childhood visual pathway glioma; low-grade childhood cerebral astrocytoma; untreated childhood cerebellar astrocytoma; ...
  
• Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00002794 - Active, not recruiting
  intraocular retinoblastoma
  
• Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004096 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Carboplatin Taxol Avastin in OVCA
  ClinicalTrials.gov Identifier: NCT00129727 - Recruiting
  Ovarian Cancer
  
• Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00551733 - Recruiting
  Lung Cancer
  
• Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
  ClinicalTrials.gov Identifier: NCT00006453 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00043082 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00004876 - Recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00114153 - Completed
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the lip and oral cavity; ...
  
• Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00075387 - Recruiting
  adult anaplastic astrocytoma; adult anaplastic ependymoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; ...
  
• Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00258362 - Active, not recruiting
  Endometrial Cancer
  
• Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00002943 - Completed
  adult solid tumor; extragonadal germ cell tumor; ovarian germ cell tumor; Testicular Cancer
  
• Carboplatin, Gemcitabine, and Thalidomide in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00281827 - Recruiting
  Lung Cancer
  
• Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00449020 - Completed
  Lung Cancer
  
• Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00088556 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00255762 - Active, not recruiting
  Recurrent Melanoma; Stage IV Melanoma
  
• Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
  ClinicalTrials.gov Identifier: NCT00352300 - Recruiting
  Fallopian Tube Cancer; Infection; Neutropenia; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003387 - Active, not recruiting
  Squamous Cell Lung Cancer; stage III non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer
  
• Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004859 - Active, not recruiting
  Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; large cell lung cancer; Non-small cell lung cancer; ...
  
• Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00331422 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00526890 - Recruiting
  Lung Cancer
  
• Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00234052 - Recruiting
  Lung Cancer
  
• Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00006263 - Active, not recruiting
  adult brain stem glioma; adult glioblastoma multiforme; high-grade childhood cerebral astrocytoma; adult anaplastic astrocytoma; ...
  
• Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00077207 - Active, not recruiting
  untreated childhood cerebellar astrocytoma; untreated childhood visual pathway and hypothalamic glioma; childhood spinal cord tumors; ...
  
• Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00003249 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas
  ClinicalTrials.gov Identifier: NCT00019019 - Completed
  Brain and Central Nervous System Tumors; Breast Cancer; Kidney Cancer; Lung Cancer; Lymphoma; Melanoma (Skin); Ovarian Cancer; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005045 - Completed
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00006486 - Completed
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00019461 - Completed
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003869 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Carboxyamidotriazole Plus Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00004146 - Active, not recruiting
  adult glioblastoma multiforme
  
• Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
  ClinicalTrials.gov Identifier: NCT00018967 - Completed
  Neurotoxicity; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Carcinoembryonic Antigen-Loaded Dendritic Cells in Advanced Colorectal Cancer Patients
  ClinicalTrials.gov Identifier: NCT00228189 - Recruiting
  Colorectal Cancer; Liver Metastases
  
• Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00450281 - Recruiting
  Lung Cancer
  
• Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling
  ClinicalTrials.gov Identifier: NCT00384540 - Recruiting
  Allograft Vasculopathy
  
• Cardiac and Renal Disease Study (CARDS)
  ClinicalTrials.gov Identifier: NCT00049907 - Completed
  Coronary Disease; Cardiovascular Diseases; Cerebrovascular Accident; Heart Failure; Heart Diseases; Peripheral Vascular Diseases; Diabetes Mellitus; ...
  
• Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
  ClinicalTrials.gov Identifier: NCT00461240 - Not yet recruiting
  Acromegaly; Growth Hormone Deficiency
  
• Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
  ClinicalTrials.gov Identifier: NCT00000464 - Completed
  Arrhythmia; Cardiovascular Diseases; Heart Arrest; Heart Diseases; Myocardial Infarction; Ventricular Fibrillation
  
• Cardiac Arrest Recovery EEG Study
  ClinicalTrials.gov Identifier: NCT00483873 - Not yet recruiting
  Cardiac Arrest; Arrhythmia
  
• Cardiac Arrhythmia Pilot Study (CAPS)
  ClinicalTrials.gov Identifier: NCT00000504 - Completed
  Arrhythmia; Cardiovascular Diseases; Heart Diseases; Ventricular Arrhythmia
  
• Cardiac Arrhythmia Suppression Trial (CAST)
  ClinicalTrials.gov Identifier: NCT00000526 - Completed
  Cardiovascular Diseases; Coronary Disease; Death, Sudden, Cardiac; Heart Arrest; Heart Diseases; Myocardial Infarction; Myocardial Ischemia; ...
  
• Cardiac Arrhythmias and the Perception of Symptoms
  ClinicalTrials.gov Identifier: NCT00005688 - Completed
  Cardiovascular Diseases; Heart Diseases; Arrhythmia
  
• Cardiac Autonomic Control in Children of HIV Positive Mothers
  ClinicalTrials.gov Identifier: NCT00005353 - Completed
  Acquired Immunodeficiency Syndrome; Arrhythmia; Heart Diseases; HIV Infections
  
• Cardiac Autonomic Functions During Head-Out Immersion and During Head Down Tilt
  ClinicalTrials.gov Identifier: NCT00515645 - Not yet recruiting
  Healthy
  
• Cardiac Autonomic Reactivity and Behavioral Response to Pain in Full-Term Neonates
  ClinicalTrials.gov Identifier: NCT00396838 - Recruiting
  Pain
  
• Cardiac Computarized Tomography in Infective Endocarditis
  ClinicalTrials.gov Identifier: NCT00550823 - Not yet recruiting
  Infective Endocarditis
  
• Cardiac Computed Tomography In the Management of Patients With indeterminAte or inConclusive Stress Tests
  ClinicalTrials.gov Identifier: NCT00541203 - Recruiting
  Coronary Disease
  
• Cardiac Disease and the Electrocardiogram in SCI Patients
  ClinicalTrials.gov Identifier: NCT00013325 - Completed
  Spinal Cord Injury
  
• Cardiac Dysfunction in Obstructive Sleep Apnea Patients: Prevalence of and Effect of nCPAP
  ClinicalTrials.gov Identifier: NCT00503945 - Completed
  Sleep Apnea
  
• Cardiac Elastography
  ClinicalTrials.gov Identifier: NCT00205387 - Recruiting
  Normal volunteers; Patients with known underlying heart disease
  
• Cardiac Function After CPAP Therapy in Patients With Chronic Heart Failure and Sleep Apnea. A Multicenter Study
  ClinicalTrials.gov Identifier: NCT00404807 - Terminated
  Sleep Apnea; Heart Failure; Cardiovascular Diseases
  
• Cardiac Function in Patients with Hereditary Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00068159 - Active, not recruiting
  Hemochromatosis
  
• Cardiac Function Under Stress for Early Detection of the Right Ventricular Insufficiency After Repair of Tetralogy of Fallot
  ClinicalTrials.gov Identifier: NCT00564993 - Recruiting
  Tetralogy of Fallot
  
• Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
  ClinicalTrials.gov Identifier: NCT00252187 - Recruiting
  Congestive Heart Failure; Cardiomyopathy
  
• Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation
  ClinicalTrials.gov Identifier: NCT00578968 - Recruiting
  COPD
  
• Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Doxorubicin
  ClinicalTrials.gov Identifier: NCT00577798 - Recruiting
  Cardiac Toxicity; Chemotherapeutic Agent Toxicity; Lymphoma
  
• Cardiac MR of Subclinical CVD: Impact of Age
  ClinicalTrials.gov Identifier: NCT00041418 - Active, not recruiting
  Atherosclerosis; Heart Diseases; Cardiovascular Diseases; Hypertrophy, Left Ventricular
  
• Cardiac MRI Normal Reference Control Group Testing
  ClinicalTrials.gov Identifier: NCT00573339 - Recruiting
  
  
• Cardiac Rehabilitation for the Treatment of Refractory Angina
  ClinicalTrials.gov Identifier: NCT00411359 - Recruiting
  Angina Pectoris; Coronary Disease
  
• Cardiac Rehabilitation for TIA Patients
  ClinicalTrials.gov Identifier: NCT00536562 - Not yet recruiting
  TIA (Transient Ischemic Attack)
  
• Cardiac Resynchronisation Therapy in Combination With Overdrive Pacing in the Treatment of Central Sleep Apnea in CHF
  ClinicalTrials.gov Identifier: NCT00551499 - Completed
  Heart Failure; Central Sleep Apnea
  
• Cardiac Resynchronization Therapy in Congenital Heart Defects
  ClinicalTrials.gov Identifier: NCT00450684 - Recruiting
  Congenital Heart Defects
  
• Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
  ClinicalTrials.gov Identifier: NCT00203333 - Recruiting
  Refractory Epilepsy; Arrhythmia; Sudden Death
  
• Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
  ClinicalTrials.gov Identifier: NCT00165425 - Recruiting
  Hodgkin's Disease
  
• Cardiac SPECT With Rotating Slant Hole Collimator
  ClinicalTrials.gov Identifier: NCT00328315 - Recruiting
  Coronary Artery Diseases; Chest Pain
  
• Cardiac Surgical Treatment by Radiofrequency Ablation on Valvular Patients : Efficacy at 3 Months
  ClinicalTrials.gov Identifier: NCT00259623 - Recruiting
  Atrial Fibrillation
  
• Cardiac T2* in Beta-Thalassemia Patients on Deferasirox Treatment
  ClinicalTrials.gov Identifier: NCT00447694 - Recruiting
  Beta-Thalassemia; Iron Overload
  
• Cardiac Tumors in Children
  ClinicalTrials.gov Identifier: NCT00215085 - Terminated
  Congenital Heart Disease
  
• Cardiac Valve Complications in Prolactinomas Treated With Cabergoline
  ClinicalTrials.gov Identifier: NCT00460616 - Completed
  Prolactinomas
  
• Cardiac Vulnerability in Potentially Susceptible Patients
  ClinicalTrials.gov Identifier: NCT00012493 - Completed
  Heart Disease
  
• Cardiac Water and Fluoromethane PET
  ClinicalTrials.gov Identifier: NCT00205127 - Active, not recruiting
  Healthy Volunteers
  
• Cardio Vascu-Grow for treatment of coronary heart disease
  ClinicalTrials.gov Identifier: NCT00032318 - Recruiting
  Coronary Disease; Coronary Heart Disease; Myocardial Ischemia; Coronary Arteriosclerosis
  
• Cardio Vascu-Grow for Treatment of Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00117936 - Not yet recruiting
  Coronary Disease; Coronary Heart Disease; Myocardial Ischemia; Coronary Arteriosclerosis
  
• CardioFit™ for the Treatment of Heart Failure
  ClinicalTrials.gov Identifier: NCT00461019 - Recruiting
  Heart Failure
  
• CARDIOLITE-413 A Phase 4 Study Phase IV Study for Patients Who Had a PCI for an Acute MI.
  ClinicalTrials.gov Identifier: NCT00162331 - Active, not recruiting
  Myocardial Infarction
  
• Cardiology Genebank
  ClinicalTrials.gov Identifier: NCT00378924 - Recruiting
  Cardiovascular Disease
  
• CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
  ClinicalTrials.gov Identifier: NCT00531661 - Recruiting
  Heart Failure
  
• Cardiomyopathy Following Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00352209 - Completed
  Cardiomyopathy
  
• Cardiomyopathy Tissue Bank in a Cancer Population
  ClinicalTrials.gov Identifier: NCT00500734 - Recruiting
  Heart Disease
  
• Cardiopulmonary Bypass (CPB) Pumps and Blood Activation
  ClinicalTrials.gov Identifier: NCT00187967 - Recruiting
  Cardiopulmonary Bypass; Coronary Artery Disease
  
• Cardiopulmonary Bypass and Inflammatory Response
  ClinicalTrials.gov Identifier: NCT00167349 - Active, not recruiting
  Thoracic Surgery; Cardiopulmonary Bypass
  
• Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor
  ClinicalTrials.gov Identifier: NCT00385450 - Recruiting
  Cardiopulmonary Bypass
  
• Cardiopulmonary Circuits in the Pediatric Population
  ClinicalTrials.gov Identifier: NCT00208728 - Completed
  Pediatric; Cardiac Surgery
  
• Cardiopulmonary Effects of Particulate Exposure
  ClinicalTrials.gov Identifier: NCT00011310 - Completed
  Respiratory Tract Diseases; Cardiac Diseases; Bronchitis
  
• Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00352430 - Recruiting
  Pulmonary Hypertension
  
• Cardiotropic Viruses in Cardiac Surgery Patients Without Clinical Evidence of Myocarditis or Myocarditic Sequelae
  ClinicalTrials.gov Identifier: NCT00511160 - Not yet recruiting
  Myocarditis
  
• Cardiovascular and Autonomic Reactivity in Women with a History of Pre-Eclampsia
  ClinicalTrials.gov Identifier: NCT00117546 - Recruiting
  Preeclampsia
  
• Cardiovascular and Renal Hemodynamics and the DASH Diet
  ClinicalTrials.gov Identifier: NCT00123006 - Recruiting
  Cardiovascular Diseases; Hypertension; Hypertension, Renovascular; Heart Diseases
  
• Cardiovascular Disease in Black Versus White Physicians
  ClinicalTrials.gov Identifier: NCT00005234 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Hypertension
  
• Cardiovascular Disease Knowledge/Morbidity--Socioeconomic Cohort Outcomes
  ClinicalTrials.gov Identifier: NCT00005480 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Cardiovascular Disease Mortality in The NAS-NRC Twin Registry
  ClinicalTrials.gov Identifier: NCT00005266 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Diabetes Mellitus; Obesity; Coronary Disease; Myocardial Ischemia
  
• Cardiovascular Disease Risk Factors in Chinese American Immigrants
  ClinicalTrials.gov Identifier: NCT00362128 - Recruiting
  Hypertension; Cardiovascular Diseases; Diabetes Mellitus; Metabolic Syndrome X
  
• Cardiovascular Disease Screening
  ClinicalTrials.gov Identifier: NCT00483951 - Recruiting
  Congenital Heart Disease; Atherosclerosis; Myocardial Ischemia; Myocardial Infarction; Acquired Heart Disease
  
• Cardiovascular Disease Trends 1980-91--A Gender Specific Perspective
  ClinicalTrials.gov Identifier: NCT00005473 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Cerebrovascular Accident
  
• Cardiovascular Evaluation of Patients with High Cholesterol and Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00001204 - Active, not recruiting
  Atherosclerosis; Hypercholesterolemia
  
• Cardiovascular Events in Patients With CAD During Emergent Endoscopy for Upper Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00173511 - Recruiting
  Coronary Disease
  
• Cardiovascular Fitness for Robotically Assisted Treadmill Training in Persons With Chronic Incomplete Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00385918 - Recruiting
  Spinal Cord Injury; Tetraplegia; Quadriplegia; Paraplegia
  
• Cardiovascular Health Study (CHS)
  ClinicalTrials.gov Identifier: NCT00005133 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Cerebrovascular Accident; Diabetes Mellitus; Hypertension; Heart Failure, Congestive
  
• Cardiovascular Health Study (CHS) Events Follow-Up Study
  ClinicalTrials.gov Identifier: NCT00149435 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Cerebrovascular Accident; Diabetes Mellitus; Heart Diseases; Hypertension; Heart Failure, Congestive
  
• Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
  ClinicalTrials.gov Identifier: NCT00291824 - Recruiting
  Hypertension; Hyperlipidemia; Hyperglycemia; Cardiovascular Disease; Smoking
  
• Cardiovascular Longitudinal Evaluation & Assessment of Risk (CLEAR) Study
  ClinicalTrials.gov Identifier: NCT00495456 - Recruiting
  Cardiovascular Disease
  
• Cardiovascular Magnetic Resonance Imaging of Pediatric Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00353899 - Not yet recruiting
  Healthy
  
• Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity.
  ClinicalTrials.gov Identifier: NCT00161174 - Recruiting
  non-seminomatous testicular cancer
  
• Cardiovascular Mortality Among Tunnel and Bridge Workers Exposed To Carbon Monoxide
  ClinicalTrials.gov Identifier: NCT00005211 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Cardiovascular Mortality Associated with Abnormal Calcium Metabolism
  ClinicalTrials.gov Identifier: NCT00018395 - Completed
  Cardiovascular Disease; Kidney Disease
  
• Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
  ClinicalTrials.gov Identifier: NCT00081731 - Recruiting
  Atherosclerosis; Cardiovascular Diseases; Hypertension, Renovascular; Renal Artery Obstruction
  
• Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population
  ClinicalTrials.gov Identifier: NCT00431405 - Active, not recruiting
  Rheumatoid Arthritis; Cardiovascular Disease; Coronary Disease
  
• Cardiovascular Outcomes Of Diet Counseling
  ClinicalTrials.gov Identifier: NCT00324545 - Completed
  Coronary Artery Disease; Obesity
  
• Cardiovascular Protective Effect of Spironolactone in Hemodialysis
  ClinicalTrials.gov Identifier: NCT00277693 - Recruiting
  Hemodialysis
  
• Cardiovascular Response and Adverse Events Associated With Perindopril in Treating Methamphetamine Dependent Individuals - 1
  ClinicalTrials.gov Identifier: NCT00249665 - Recruiting
  Methamphetamine Dependence; Substance-Related Disorders
  
• Cardiovascular Responses in Congestive Heart Failure With Cheyne- Stokes Respiration
  ClinicalTrials.gov Identifier: NCT00495196 - Recruiting
  Heart Failure, Congestive; Cheyne-Stokes Respiration
  
• Cardiovascular Risk Assessment in Patients Treated With Caduet
  ClinicalTrials.gov Identifier: NCT00297973 - Completed
  Hypertension
  
• Cardiovascular Risk Disparities: Socio-Emotional Pathways
  ClinicalTrials.gov Identifier: NCT00387166 - Recruiting
  Hypertension; Cardiovascular Disease; Type 2 Diabetes
  
• Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients
  ClinicalTrials.gov Identifier: NCT00171548 - Active, not recruiting
  Metabolic Syndrome
  
• Cardiovascular Risk Factor Management in HIV Infection
  ClinicalTrials.gov Identifier: NCT00264394 - Recruiting
  Coronary Heart Disease; Antiretroviral Therapy; Dyslipidemia; Diabetes Mellitus, Non-Insulin-Dependent; HIV Infection
  
• Cardiovascular Risk Factors and LCH in Adults
  ClinicalTrials.gov Identifier: NCT00483925 - Recruiting
  Histiocytosis, Langerhans-Cell
  
• Cardiovascular Risk Factors in a Cohort of Latina Women
  ClinicalTrials.gov Identifier: NCT00005509 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Cardiovascular Risk Factors in an Ambulatory Urban Patient Population
  ClinicalTrials.gov Identifier: NCT00486993 - Recruiting
  Cardiovascular Risk Factors; Metabolic Syndrome; Lifestyle Modification; Coronary Artery Disease; Stroke
  
• Cardiovascular Risk Factors in Overweight Adolescents
  ClinicalTrials.gov Identifier: NCT00184236 - Recruiting
  Overweight; Obesity
  
• Cardiovascular Risk Factors in United States Adolescents and Adults
  ClinicalTrials.gov Identifier: NCT00005171 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease
  ClinicalTrials.gov Identifier: NCT00305201 - Recruiting
  Kawasaki Disease
  
• Cardiovascular Risk Profile Among Mexican-Americans
  ClinicalTrials.gov Identifier: NCT00005187 - Completed
  Cardiovascular Diseases; Atherosclerosis; Heart Diseases
  
• Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block
  ClinicalTrials.gov Identifier: NCT00523289 - Not yet recruiting
  Injuries, Hand; Anesthesia Conduction; Anesthetics, Local
  
• Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects
  ClinicalTrials.gov Identifier: NCT00310596 - Completed
  Healthy
  
• Cardiovascular System in Obesity: Effect of Treatment
  ClinicalTrials.gov Identifier: NCT00000506 - Completed
  Heart Diseases; Obesity; Vascular Diseases
  
• Cardiovascular Vulnerability to Particulate Exposure
  ClinicalTrials.gov Identifier: NCT00013949 - Completed
  Heart Disease; Lung Disease
  
• Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00196209 - Recruiting
  Atrial Fibrillation
  
• CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
  ClinicalTrials.gov Identifier: NCT00327418 - Completed
  Major Coronary Event; Cerebrovascular Accident; Coronary Artery Bypass Graft; Angina, Unstable; Revascularization
  
• CARE Canadian ALS Riluzole Evaluation
  ClinicalTrials.gov Identifier: NCT00542412 - Completed
  Amyotrophic Lateral Sclerosis
  
• Care Intensification for Depression and Musculoskeletal Pain
  ClinicalTrials.gov Identifier: NCT00118430 - Active, not recruiting
  Pain; Depression
  
• Care Management for Patients With Alzheimer Disease and Their Family Caregivers
  ClinicalTrials.gov Identifier: NCT00246896 - Completed
  Alzheimer's Disease; Dementia
  
• CARE Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)
  ClinicalTrials.gov Identifier: NCT00395304 - Recruiting
  Asthma
  
• CARE Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)
  ClinicalTrials.gov Identifier: NCT00471809 - Terminated
  Asthma
  
• CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
  ClinicalTrials.gov Identifier: NCT00394329 - Recruiting
  Asthma
  
• CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00272584 - Completed
  Psychosis, Schizophrenia
  
• CARE--Childhood Awareness and Recall Evaluation
  ClinicalTrials.gov Identifier: NCT00308984 - Recruiting
  Anesthesia
  
• CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00211939 - Active, not recruiting
  Calcinosis; Arteriosclerosis; Hyperparathyroidism, Secondary
  
• Care-HF CArdiac Resynchronization in Heart Failure
  ClinicalTrials.gov Identifier: NCT00170300 - Completed
  Heart Failure
  
• CARE-HF: CArdiac REsynchronization in Heart Failure Long-Term Follow-up
  ClinicalTrials.gov Identifier: NCT00318357 - Recruiting
  Heart Failure
  
• Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00281814 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Psychosocial Effects/Treatment
  
• Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00281801 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Psychosocial Effects/Treatment; Quality of Life
  
• CARESS in Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00220571 - Completed
  Myocardial Infarction
  
• Caries Transmission Prevention in Alaska Native Infants
  ClinicalTrials.gov Identifier: NCT00067340 - Active, not recruiting
  Dental Caries
  
• Carinal Biopsy Study
  ClinicalTrials.gov Identifier: NCT00280202 - Recruiting
  Non-Small Cell Lung Cancer
  
• Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-Epileptic Drugs (AEDs) in Patients With Epilepsy.
  ClinicalTrials.gov Identifier: NCT00563459 - Not yet recruiting
  Epilepsy; Seizures
  
• CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction
  ClinicalTrials.gov Identifier: NCT00145119 - Active, not recruiting
  Acute Myocardial Infarction
  
• CARMEDAS
  ClinicalTrials.gov Identifier: NCT00131001 - Active, not recruiting
  Carotid Stenosis
  
• Carmustine and O6-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00046878 - Active, not recruiting
  adult glioblastoma multiforme
  
• Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm
  ClinicalTrials.gov Identifier: NCT00009854 - Active, not recruiting
  adult glioblastoma multiforme; brain metastases; adult anaplastic astrocytoma; adult malignant ependymoma; adult anaplastic oligodendroglioma
  
• Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00045721 - Completed
  recurrent childhood cerebral astrocytoma
  
• Carmustine Implants in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00003878 - Completed
  unspecified adult solid tumor, protocol specific; brain metastases
  
• Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00003467 - Active, not recruiting
  recurrent adult brain tumor; adult brain stem glioma; adult noninfiltrating astrocytoma; ...
  
• Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00006656 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme
  
• Carmustine in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00004028 - Completed
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult malignant ependymoma; ...
  
• Carmustine Plus O(6)-benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain
  ClinicalTrials.gov Identifier: NCT00003348 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma
  
• Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
  ClinicalTrials.gov Identifier: NCT00005081 - Completed
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas
  
• Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas
  ClinicalTrials.gov Identifier: NCT00003463 - Completed
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult brain stem glioma; Mixed Gliomas
  
• Carnitine Levels and Carnitine Supplementation in Type I Diabetes
  ClinicalTrials.gov Identifier: NCT00351234 - Recruiting
  Diabetes Mellitus, Type I; Hypoglycemia
  
• Carotenoid Rich Diet in Treating Cervical Dysplasia
  ClinicalTrials.gov Identifier: NCT00003094 - Active, not recruiting
  Cervical Cancer
  
• Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo
  ClinicalTrials.gov Identifier: NCT00532246 - Completed
  Osteoporosis, Post-Menopausal
  
• Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)
  ClinicalTrials.gov Identifier: NCT00231231 - Completed
  Carotid Artery Disease
  
• Carotid Artery Stenting With Protection Registry
  ClinicalTrials.gov Identifier: NCT00318851 - Active, not recruiting
  Carotid Artery Stenosis
  
• Carotid Artery Thickness in HIV Infected and Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00007319 - Completed
  HIV Infections; HIV Seronegativity; Atherosclerosis
  
• Carotid Atherosclerosis Follow-up Study
  ClinicalTrials.gov Identifier: NCT00005189 - Completed
  Cardiovascular Diseases; Carotid Artery Diseases; Myocardial Infarction; Coronary Disease; Heart Diseases; Cerebrovascular Accident
  
• Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
  ClinicalTrials.gov Identifier: NCT00307307 - Completed
  Established Carotid Atherosclerosis
  
• Carotid Atherosclerotic Plaque Study
  ClinicalTrials.gov Identifier: NCT00214006 - Recruiting
  Atherosclerosis
  
• Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women.
  ClinicalTrials.gov Identifier: NCT00163163 - Active, not recruiting
  Postmenopause
  
• Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin Alone.
  ClinicalTrials.gov Identifier: NCT00136981 - Completed
  Hypercholesterolemia, Familial; Hyperlipidemia
  
• Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin.
  ClinicalTrials.gov Identifier: NCT00134238 - Terminated
  Mixed Hyperlipidemia
  
• Carotid IMT (Intima Media Thickening) Study
  ClinicalTrials.gov Identifier: NCT00384293 - Recruiting
  Hypercholesterolemia, Familial
  
• Carotid Intima-Media Thickness in Japan Statin Treatment Against Recurrent Stroke(J-STARS Echo)
  ClinicalTrials.gov Identifier: NCT00361530 - Recruiting
  Ischemic Stroke
  
• Carotid Occlusion Surgery Study
  ClinicalTrials.gov Identifier: NCT00029146 - Recruiting
  Stroke; Ischemic Attack, Transient
  
• Carotid Plaque Regression With High Dose Atorvastatin Versus Conventional Dose Simvastatin Using High Field MRI
  ClinicalTrials.gov Identifier: NCT00388843 - Recruiting
  Carotid Atherosclerosis
  
• Carotid Plaque Screening Trial in Smokers
  ClinicalTrials.gov Identifier: NCT00548665 - Recruiting
  Smoking
  
• Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study
  ClinicalTrials.gov Identifier: NCT00530504 - Recruiting
  Carotid Artery Disease
  
• Carotid Stenting versus Endarterectomy to Treat Severe Carotid Disease in Patients without Symptoms
  ClinicalTrials.gov Identifier: NCT00106938 - Recruiting
  Carotid Artery Disease
  
• Carpal Tunnel Syndrome and Static Magnetic Field Therapy
  ClinicalTrials.gov Identifier: NCT00521495 - Recruiting
  Carpal Tunnel Syndrome
  
• Carpal Tunnel Syndrome Treated With 830nm Diode Laser
  ClinicalTrials.gov Identifier: NCT00514462 - Recruiting
  Carpal Tunnel Syndrome
  
• Carpal Tunnel Syndrome: Diagnosis and Treatment Trial
  ClinicalTrials.gov Identifier: NCT00032227 - Active, not recruiting
  Carpal Tunnel Syndrome
  
• Carperitide in Acute Respiratory Distress Syndrome (ARDS)
  ClinicalTrials.gov Identifier: NCT00030121 - Active, not recruiting
  Respiratory Distress Syndrome
  
• Carriage and Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Patients Admitted to Home Care.
  ClinicalTrials.gov Identifier: NCT00457704 - Terminated
  Methicillin-Resistant Staphylococcus Aureus
  
• Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00198614 - Completed
  Coronary Disease; Atrial Fibrillation
  
• Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00348530 - Recruiting
  Systolic Heart Failure; Myocardial Disease; Cardiomyopathy
  
• Cascade PRFM Study: The Evaluation of Cascade Platelet-Rich Fibrin Matrix (PRFM) on Rotator Cuff Healing
  ClinicalTrials.gov Identifier: NCT00198185 - Recruiting
  Rotator Cuff; Tendon Injuries
  
• Case Control Study of Non Viral Hepatitis Relating to Herbal Drug Use in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00201578 - Recruiting
  Acute Hepatitis
  
• Case Management and Environmental Control in Asthma
  ClinicalTrials.gov Identifier: NCT00514436 - Completed
  Asthma
  
• Case Management and Problem Solving Therapy for Depressed, Homebound, Low-Income Elders
  ClinicalTrials.gov Identifier: NCT00504868 - Recruiting
  Depression; Home-Bound Persons
  
• Case Management Study for Postpartum Depression and Intimate Partner Violence
  ClinicalTrials.gov Identifier: NCT00560027 - Not yet recruiting
  Postpartum Depression; Intimate Partner Violence
  
• Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
  ClinicalTrials.gov Identifier: NCT00230685 - Recruiting
  Telangiectasia, Hereditary Hemorrhagic
  
• Case-Control Association Studies and Genetic Confounding
  ClinicalTrials.gov Identifier: NCT00241709 - Active, not recruiting
  Lung Diseases; Asthma
  
• Case-Control Study of Germ Cell Testicular Cancer Among U.S. Servicemen
  ClinicalTrials.gov Identifier: NCT00341588 - Active, not recruiting
  Testicular Germ Cell Cancer
  
• Case-Control Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
  ClinicalTrials.gov Identifier: NCT00495235 - Recruiting
  Endometrial Cancer; Control
  
• Case-Control Study on Analgesics and Nephropathy (SAN)
  ClinicalTrials.gov Identifier: NCT00302835 - Completed
  Kidney Failure, Chronic
  
• Case-Control Viramune (Nevirapine) Toxicogenomics Study
  ClinicalTrials.gov Identifier: NCT00310843 - Recruiting
  HIV Infections
  
• Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Other Contraceptive Methods
  ClinicalTrials.gov Identifier: NCT00461253 - Recruiting
  Breast Cancer Risk
  
• Casodex/Zoladex Biomarkers in Localised Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00293696 - Completed
  Prostate Cancer
  
• Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts
  ClinicalTrials.gov Identifier: NCT00523484 - Recruiting
  Prostate Cancer
  
• Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
  ClinicalTrials.gov Identifier: NCT00326248 - Completed
  Postoperative Nausea and Vomiting
  
• Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
  ClinicalTrials.gov Identifier: NCT00334152 - Completed
  Postoperative Nausea and Vomiting
  
• CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease
  ClinicalTrials.gov Identifier: NCT00174759 - Completed
  Arterial Occlusive Diseases
  
• Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00008359 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; Eye Cancer; kidney tumor
  
• Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00110045 - Recruiting
  Cancer; Infection
  
• Caspofungin Acetate in Treating Children With Fever and Neutropenia
  ClinicalTrials.gov Identifier: NCT00020527 - Completed
  Fever, Sweats, and Hot Flashes; Infection; Kidney Cancer; Leukemia; Lymphoma; Neuroblastoma; Neutropenia; Sarcoma
  
• Caspofungin for the Treatment of Non-blood Candida Infections
  ClinicalTrials.gov Identifier: NCT00083343 - Active, not recruiting
  Candidiasis
  
• Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
  ClinicalTrials.gov Identifier: NCT00404092 - Recruiting
  Invasive Aspergillosis
  
• Caspofungin study
  ClinicalTrials.gov Identifier: NCT00095316 - Terminated
  Candidiasis
  
• Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units
  ClinicalTrials.gov Identifier: NCT00099775 - Completed
  Candidiasis
  
• Cast Sores With Waterproof Vs. Standard Cast Padding
  ClinicalTrials.gov Identifier: NCT00504855 - Recruiting
  Pressure Ulcer
  
• Cataract Surgery to Obtain Human Lens Material for the Study of Nuclear Cataracts
  ClinicalTrials.gov Identifier: NCT00001613 - Completed
  Cataract
  
• Catechin Gargling for Influenza Infection
  ClinicalTrials.gov Identifier: NCT00239213 - Completed
  Influenza Infection
  
• Catechin Mouth-Washing for Removal of Intraoral Bacteria
  ClinicalTrials.gov Identifier: NCT00377507 - Recruiting
  Elderly
  
• Catechol Thioethers in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00042692 - Completed
  Parkinson's Disease
  
• Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients with Congenital Adrenal Hyperplasia
  ClinicalTrials.gov Identifier: NCT00011791 - Active, not recruiting
  Congenital Adrenal Hyperplasia; Healthy
  
• Catecholamines Can Attenuate Intermittent Hypoxia-Induced Expression of TNF in Human Monocytes
  ClinicalTrials.gov Identifier: NCT00498862 - Recruiting
  Healthy
  
• Cath Lab Performance Improvement
  ClinicalTrials.gov Identifier: NCT00277966 - Terminated
  Congenital Disorders
  
• Catheter Ablation as the First Line Therapy for Typical Atrial Flutter
  ClinicalTrials.gov Identifier: NCT00213408 - Terminated
  Atrial Flutter
  
• Catheter Ablation Registry
  ClinicalTrials.gov Identifier: NCT00005195 - Completed
  Cardiovascular Diseases; Arrhythmia; Heart Diseases
  
• Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00296166 - Recruiting
  Atrial Fibrillation
  
• Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter
  ClinicalTrials.gov Identifier: NCT00318565 - Active, not recruiting
  Atrial Flutter
  
• Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia
  ClinicalTrials.gov Identifier: NCT00412607 - Recruiting
  Ventricular Tachycardia
  
• Catheter Related - Gram Positive Bloodstream Infections
  ClinicalTrials.gov Identifier: NCT00467272 - Recruiting
  Bloodstream Infection
  
• Catheter Thrombectomy in Patients With Massive Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00314002 - Recruiting
  Pulmonary Embolism
  
• Catheter-Based Treatment of Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00380016 - Recruiting
  Obstructive Coronary Artery Disease; Obstructive Peripheral Artery Disease; Structural Heart Disease
  
• Catheterization Laboratory Study: Acute Responses in Diastolic Heart Failure
  ClinicalTrials.gov Identifier: NCT00204945 - Recruiting
  Heart Failure, Congestive
  
• Catheterization to Locate Mesenchymal Tumors in Patients with Tumor-Induced Osteomalacia or Oncogenic Osteomalacia
  ClinicalTrials.gov Identifier: NCT00099762 - Recruiting
  Osteomalacia; Neoplasms
  
• Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00563342 - Recruiting
  End Stage Renal Failure, Hemodialysis
  
• Cathflo Activase Pediatric Study
  ClinicalTrials.gov Identifier: NCT00307580 - Completed
  Dysfunctional Central Venous Access Devices (CVADS)
  
• CATIE- Schizophrenia Trial
  ClinicalTrials.gov Identifier: NCT00014001 - Completed
  Schizophrenia
  
• CATIE-Alzheimer's Disease Trial
  ClinicalTrials.gov Identifier: NCT00015548 - Completed
  Alzheimer's Disease
  
• Cause and Natural Course of Pediatric-Onset Mastocytosis
  ClinicalTrials.gov Identifier: NCT00050193 - Recruiting
  Mastocytosis
  
• Cause and Pathogenesis of Neurometabolic Disorders
  ClinicalTrials.gov Identifier: NCT00016562 - Recruiting
  Neurodegenerative Disease
  
• Cause of Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00001392 - Recruiting
  AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections
  
• Cause of Pigment Dispersion Syndrome
  ClinicalTrials.gov Identifier: NCT00005919 - Completed
  Glaucoma; Healthy; Pigment Dispersion Syndrome
  
• Cause, Development, and Progression of Stiff-Person Syndrome
  ClinicalTrials.gov Identifier: NCT00030940 - Active, not recruiting
  Stiff-Person Syndrome
  
• Causes and Natural History of Dyslipidemias
  ClinicalTrials.gov Identifier: NCT00353782 - Recruiting
  Dyslipidemias
  
• Causes, Characteristics and Mechanisms of Infective Exacerbations in Subjects With Asthma and COPD
  ClinicalTrials.gov Identifier: NCT00512954 - Recruiting
  Asthma; COPD
  
• CavatermTM vs TCRE in Women With DUB
  ClinicalTrials.gov Identifier: NCT00549159 - Recruiting
  Dysfunctional Uterine Bleeding
  
• CaVenT: Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis
  ClinicalTrials.gov Identifier: NCT00251771 - Recruiting
  Deep Vein Thrombosis
  
• Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream
  ClinicalTrials.gov Identifier: NCT00193908 - Active, not recruiting
  Breast Cancer
  
• Cavotricuspid Isthmusblock and Circumferential Pulmonary Vein Isolation in Patients With Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00247780 - Active, not recruiting
  Atrial Fibrillation
  
• CBT as an Adjunct to SRIs in the Treatment of BDD
  ClinicalTrials.gov Identifier: NCT00211809 - Recruiting
  Body Dysmorphic Disorder
  
• CBT for Comorbid Anxiety Disorders in Children With Asperger Syndrome or PDD-NOS
  ClinicalTrials.gov Identifier: NCT00280670 - Recruiting
  Autistic Disorder; Asperger Syndrome; Anxiety Disorders
  
• CBT in Adolescents With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00360061 - Completed
  Type 1 Diabetes Mellitus
  
• CBT to Treat Depression in Renal Patients
  ClinicalTrials.gov Identifier: NCT00530296 - Recruiting
  Depression; End Stage Renal Disease
  
• CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00558896 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment
  ClinicalTrials.gov Identifier: NCT00482521 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00540579 - Not yet recruiting
  Pancreas
  
• CC-5013 and Rituximab in Waldenstrom''s Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00142168 - Active, not recruiting
  Waldenstrom''s Macroglobulinemia
  
• CC-5013 in Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00087672 - Active, not recruiting
  Myelofibrosis
  
• CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00031941 - Active, not recruiting
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• CC-5013 in Treating Patients With Progressive or Relapsed Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00060281 - Completed
  Recurrent Melanoma; Stage IV Melanoma
  
• CC-5013 in Treating Patients With Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00036894 - Completed
  Brain and Central Nervous System Tumors
  
• CC-5013 in Treating Patients With Red Blood Cell Transfusion-Dependent Myelodysplastic Syndromes and a Cytogenetic Abnormality
  ClinicalTrials.gov Identifier: NCT00074126 - Active, not recruiting
  de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes
  
• CC-5013 in Treating Patients With Transfusion-Dependent Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00077506 - Active, not recruiting
  Chronic Myelomonocytic Leukemia; previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; ...
  
• CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects with Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00056160 - Active, not recruiting
  Multiple Myeloma
  
• CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00091260 - Completed
  primary systemic amyloidosis
  
• CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas
  ClinicalTrials.gov Identifier: NCT00074243 - Completed
  Brain and Central Nervous System Tumors
  
• CCB Safety Study in Treatment of Hypertension of ADPKD
  ClinicalTrials.gov Identifier: NCT00541853 - Not yet recruiting
  Kidney, Polycystic, Autosomal Dominant
  
• CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00112840 - Recruiting
  recurrent renal cell cancer; renal clear cell carcinoma; Stage IV Renal Cell Cancer
  
• CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00098501 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• CCI-779 and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00101088 - Recruiting
  accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
  
• CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00109967 - Recruiting
  recurrent mantle cell lymphoma
  
• CCI-779 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003712 - Active, not recruiting
  recurrent adult brain tumor; unspecified adult solid tumor, protocol specific; brain metastases
  
• CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00028028 - Active, not recruiting
  extensive stage small cell lung cancer
  
• CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00075647 - Completed
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer; ...
  
• CCI-779 in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00022724 - Completed
  adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
  
• CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00033267 - Active, not recruiting
  recurrent mantle cell lymphoma
  
• CCI-779 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00022464 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00072176 - Active, not recruiting
  Endometrial Cancer
  
• CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00093782 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• CCI-779 in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00012142 - Completed
  stage IV prostate cancer
  
• CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00016328 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00084474 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
  ClinicalTrials.gov Identifier: NCT00084916 - Completed
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00086840 - Completed
  refractory chronic lymphocytic leukemia; recurrent adult diffuse large cell lymphoma; recurrent adult Hodgkin's lymphoma
  
• CCI-779 in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00079456 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
  ClinicalTrials.gov Identifier: NCT00087074 - Active, not recruiting
  recurrent adult soft tissue sarcoma; stage I adult soft tissue sarcoma; stage II adult soft tissue sarcoma; stage III adult soft tissue sarcoma; ...
  
• CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00079235 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• CCRC: Walnuts, Walnut-Oil, Glucose Homeostasis, PCOS
  ClinicalTrials.gov Identifier: NCT00579904 - Recruiting
  Polycystic Ovary Syndrome; Insulin Resistance
  
• CCRT with Twice Weekly Taxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00154804 - Completed
  Esophageal Cancer
  
• CD-ROM Intervention for Prostate Cancer Screening
  ClinicalTrials.gov Identifier: NCT00164437 - Completed
  Prostate Cancer
  
• CD133+ Autologous Cells After Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00400959 - Completed
  Acute Myocardial Infarction
  
• CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant
  ClinicalTrials.gov Identifier: NCT00186680 - Active, not recruiting
  Breast Cancer
  
• CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00038818 - Terminated
  Chronic Myelogenous Leukemia; Multiple Myeloma; Non Hodgkin's Lymphoma; Hodgkin's Disease; Chronic Lymphocytic Leukemia
  
• CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00333190 - Active, not recruiting
  Hematologic Malignancy; AML; ALL; CML; Multiple Myeloma; NHL; Hodgkin's Lymphoma
  
• CD8+ T-Cell Depleted Donor Lymphocyte Infusion (DLI) After Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00242515 - Recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndromes
  
• CDC Anthrax Vaccine Clinical Trial
  ClinicalTrials.gov Identifier: NCT00119067 - Active, not recruiting
  Healthy
  
• CDC HIV Testing Guidelines: Unresolved Ethical Concerns
  ClinicalTrials.gov Identifier: NCT00564369 - Recruiting
  HIV Infections
  
• CDC-501 therapy in relapsed or refractory multiple myeloma
  ClinicalTrials.gov Identifier: NCT00044018 - Completed
  Multiple Myeloma
  
• CDDO in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00352040 - Active, not recruiting
  Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• CE-MRA Using Gadovist in Comparison to Ia DSA Using Ultravist
  ClinicalTrials.gov Identifier: NCT00154648 - Recruiting
  Angiography, Digital Subtraction; Magnetic Resonance Angiography
  
• CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00365833 - Recruiting
  Kidney Transplantation; Cardiovascular Abnormalities; Cardiovascular Diseases
  
• Cediranib (AZD2171, RECENTINtm) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00399035 - Recruiting
  Metastatic Colorectal Cancer
  
• Cediranib (AZD2171, RECENTINTM) in Metastatic or Recurrent Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00423332 - Active, not recruiting
  Renal Cell Carcinoma
  
• Cediranib in Treating Young Patients With Refractory or Recurrent Solid Tumors or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00354848 - Recruiting
  Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Leukemia; Liver Cancer; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit
  ClinicalTrials.gov Identifier: NCT00177931 - Recruiting
  Liver Transplantation
  
• Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00358202 - Completed
  Pneumonia
  
• Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
  ClinicalTrials.gov Identifier: NCT00463762 - Terminated
  Abscess, Intra-Abdominal; Cholecystitis; Wound Infections; Peritonitis; Appendicitis
  
• Cefpodoxime vs Ciprofloxacin for Acute Cystitis
  ClinicalTrials.gov Identifier: NCT00194532 - Recruiting
  Urinary Tract Infection
  
• Ceftobiprole in the Treatment of Hospital-Acquired Pulmonary Infections
  ClinicalTrials.gov Identifier: NCT00210964 - Active, not recruiting
  Pneumonia
  
• Ceftobiprole in the Treatment of Hospital-Acquired Pulmonary Infections
  ClinicalTrials.gov Identifier: NCT00229008 - Active, not recruiting
  Pneumonia
  
• Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia
  ClinicalTrials.gov Identifier: NCT00505258 - Recruiting
  Bacteremia
  
• Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00326287 - Active, not recruiting
  Pneumonia
  
• Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
  ClinicalTrials.gov Identifier: NCT00210899 - Completed
  Staphylococcal Skin Infections; Skin Diseases, Infectious; Skin Diseases, Bacterial
  
• Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
  ClinicalTrials.gov Identifier: NCT00228982 - Completed
  Staphylococcal Skin Infections; Skin Diseases, Infectious; Skin Diseases, Bacterial
  
• Ceftriaxone in the Management of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00566111 - Recruiting
  Bipolar Depression
  
• Ceftriaxone to Treat Depression in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00512616 - Recruiting
  Bipolar Disorder; Depression; Mood Disorders
  
• Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children
  ClinicalTrials.gov Identifier: NCT00372541 - Recruiting
  Pneumonia
  
• Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
  ClinicalTrials.gov Identifier: NCT00429975 - Terminated
  Pneumonia, Pneumococcal
  
• Celebrex - Cervix
  ClinicalTrials.gov Identifier: NCT00152828 - Active, not recruiting
  Cervix Neoplasms
  
• Celebrex for Pain Relief After Oral Surgery
  ClinicalTrials.gov Identifier: NCT00006299 - Completed
  Facial Pain
  
• Celebrex In Acute Gouty Arthritis Study
  ClinicalTrials.gov Identifier: NCT00549549 - Not yet recruiting
  Gout
  
• Celebrex Los Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population.
  ClinicalTrials.gov Identifier: NCT00137033 - Completed
  Peptic Ulcers
  
• Celebrex Short Versus Long Therapy In Ostheoarthritis Of The Knee
  ClinicalTrials.gov Identifier: NCT00137410 - Completed
  Osteoarthritis
  
• Celebrex Total Knee Arthroplasty Study
  ClinicalTrials.gov Identifier: NCT00359151 - Terminated
  Osteoarthritis
  
• Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
  ClinicalTrials.gov Identifier: NCT00290901 - Completed
  Back Pain
  
• Celebrex With Preoperative Chemoradiation - Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00188565 - Recruiting
  Colorectal Neoplasms
  
• Celecoxib (Celebrex) in the Management of Acute Renal Colic
  ClinicalTrials.gov Identifier: NCT00304317 - Recruiting
  Ureteral Calculi
  
• Celecoxib (Celebrex) Vs. Placebo in Men with Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00136487 - Completed
  Prostate Cancer
  
• Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00030420 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00030407 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00520845 - Recruiting
  Lung Cancer
  
• Celecoxib and Erlotinib in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00293436 - Active, not recruiting
  Liver Cancer
  
• Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00072072 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Celecoxib and Gefitinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00088959 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00046839 - Active, not recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00450736 - Recruiting
  Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
  
• Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
  ClinicalTrials.gov Identifier: NCT00084578 - Completed
  stage 0 bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; ...
  
• Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006381 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Celecoxib and/or EKB-569 in Preventing Oral Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00088842 - Not yet recruiting
  lip and oral cavity cancer; Salivary Gland Cancer; Precancerous Condition
  
• Celecoxib and/or Selenium in Treating Patients With Adenomatous Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00078897 - Recruiting
  Colon Cancer; Rectal Cancer
  
• Celecoxib as a Post-Tonsillectomy Pain Medication
  ClinicalTrials.gov Identifier: NCT00583453 - Recruiting
  Tonsillitis
  
• Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer
  ClinicalTrials.gov Identifier: NCT00527982 - Recruiting
  Head and Neck Cancer; Lung Cancer
  
• Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
  ClinicalTrials.gov Identifier: NCT00085163 - Active, not recruiting
  adenocarcinoma of the colon; stage III colon cancer
  
• Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00022399 - Completed
  stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00520338 - Recruiting
  Postoperative Pain; Thyroidectomy; Cyclooxygenase 2 Inhibitors
  
• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00093678 - Not yet recruiting
  Cachexia; Cancer; Pain
  
• Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
  ClinicalTrials.gov Identifier: NCT00023621 - Completed
  basal cell carcinoma of the skin
  
• Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
  ClinicalTrials.gov Identifier: NCT00056082 - Completed
  Breast Cancer
  
• Celecoxib in Preventing Breast Cancer in Premenopausal Women
  ClinicalTrials.gov Identifier: NCT00088972 - Recruiting
  Breast Cancer; breast cancer in situ; lobular breast carcinoma in situ
  
• Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
  ClinicalTrials.gov Identifier: NCT00084370 - Active, not recruiting
  ovarian epithelial cancer
  
• Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
  ClinicalTrials.gov Identifier: NCT00052611 - Active, not recruiting
  Head and Neck Cancer
  
• Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia
  ClinicalTrials.gov Identifier: NCT00043043 - Completed
  Colorectal Cancer
  
• Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis
  ClinicalTrials.gov Identifier: NCT00393016 - Recruiting
  Colorectal Cancer; Precancerous/Nonmalignant Condition
  
• Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine in Patients With Metastatic Breast or Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00305643 - Recruiting
  Breast Cancer; Colorectal Cancer; Drug Toxicity; Pain; Palmar-Plantar Erythrodysesthesia
  
• Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00101335 - Completed
  Hypopharyngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; Precancerous Condition
  
• Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
  ClinicalTrials.gov Identifier: NCT00055978 - Recruiting
  Non-small cell lung cancer; stage I non-small cell lung cancer
  
• Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
  ClinicalTrials.gov Identifier: NCT00099047 - Not yet recruiting
  Multiple Myeloma; monoclonal gammopathy of undetermined significance
  
• Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
  ClinicalTrials.gov Identifier: NCT00020878 - Active, not recruiting
  Non-small cell lung cancer
  
• Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
  ClinicalTrials.gov Identifier: NCT00087256 - Completed
  stage I colon cancer; adenocarcinoma of the colon
  
• Celecoxib in Preventing Skin Cancer
  ClinicalTrials.gov Identifier: NCT00025051 - Recruiting
  basal cell carcinoma of the skin; squamous cell carcinoma of the skin
  
• Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
  ClinicalTrials.gov Identifier: NCT00027976 - Active, not recruiting
  actinic keratosis
  
• Celecoxib in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00006124 - Active, not recruiting
  recurrent bladder cancer
  
• Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00081263 - Recruiting
  Cervical Cancer; high-grade squamous intraepithelial lesion
  
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
  Head and Neck Cancer; thorax and respiratory cancer
  
• Celecoxib in Treating Patients With Familial Adenomatous Polyposis
  ClinicalTrials.gov Identifier: NCT00258219 - Recruiting
  Colorectal Cancer; Precancerous/Nonmalignant Condition
  
• Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00357617 - Recruiting
  Head and Neck Cancer
  
• Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
  ClinicalTrials.gov Identifier: NCT00072540 - Not yet recruiting
  stage 0 cervical cancer; high-grade squamous intraepithelial lesion
  
• Celecoxib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Who Are Receiving Anticonvulsant Drugs and Undergoing Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00068770 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
  ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00061906 - Active, not recruiting
  insular thyroid cancer; recurrent thyroid cancer; stage II follicular thyroid cancer; stage II papillary thyroid cancer; ...
  
• Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00073970 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00104767 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00045591 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00274898 - Recruiting
  Lung Cancer
  
• Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00005878 - Completed
  Esophageal Cancer
  
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
  ClinicalTrials.gov Identifier: NCT00005094 - Active, not recruiting
  prevention of colorectal cancer; Colon Cancer; Rectal Cancer
  
• Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy
  ClinicalTrials.gov Identifier: NCT00043680 - Completed
  Macular Degeneration
  
• Celecoxib Treatment for Lung Cancer
  ClinicalTrials.gov Identifier: NCT00108186 - Recruiting
  Non-Small-Cell Lung Carcinoma
  
• Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip
  ClinicalTrials.gov Identifier: NCT00174317 - Completed
  Osteoarthritis, Hip
  
• Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00153660 - Recruiting
  Arthritis; Cardiovascular Diseases; Cerebrovascular Disorders
  
• Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis.
  ClinicalTrials.gov Identifier: NCT00033371 - Recruiting
  Colon Cancer; Rectal Cancer
  
• Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00258232 - Active, not recruiting
  Colorectal Cancer
  
• Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00336960 - Active, not recruiting
  Colorectal Cancer
  
• Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin
  ClinicalTrials.gov Identifier: NCT00565500 - Completed
  Ischemic Heart Disease; Osteoarthritis
  
• Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00177853 - Active, not recruiting
  Pancreatic Cancer
  
• Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00072553 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ...
  
• Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00066716 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
  
• Celecoxib/Oxaliplatin/Capecitabine for Gastric/GE Junction Carcinoma
  ClinicalTrials.gov Identifier: NCT00256321 - Completed
  Gastric Carcinoma; Gastroesophageal Junction Carcinoma
  
• Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
  ClinicalTrials.gov Identifier: NCT00190411 - Active, not recruiting
  Ehlers-Danlos Syndrome, Type Iv, Autosomal Dominant; Gene Map Locus 2q31
  
• Cell Biology of Steroid Resistant Asthma
  ClinicalTrials.gov Identifier: NCT00361920 - Recruiting
  Asthma
  
• Cell Infusions and Interleukin-2 to Treat Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00092248 - Recruiting
  
  
• Cell Lines from High-Risk Breast Tissue
  ClinicalTrials.gov Identifier: NCT00032201 - Recruiting
  Healthy
  
• Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00436384 - Active, not recruiting
  Transplant
  
• Cell Repair in Heart Failure
  ClinicalTrials.gov Identifier: NCT00285454 - Recruiting
  Heart Failure; Ischemia
  
• Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
  ClinicalTrials.gov Identifier: NCT00001872 - Recruiting
  Graft vs Host Disease; Hematologic Neoplasm
  
• Cell Studies of Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00076505 - Completed
  Parkinson Disease
  
• Cell Therapy for Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00289822 - Terminated
  Coronary Artery Disease
  
• Cell Therapy in Chagas Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00349271 - Recruiting
  Chagas Cardiomyopathy
  
• Cell Therapy in Chronic Ischemic Heart Disease
  ClinicalTrials.gov Identifier: NCT00362388 - Recruiting
  Ischemic Heart Disease; Coronary Artery Disease
  
• Cell Therapy in Chronic Limb Ischemia
  ClinicalTrials.gov Identifier: NCT00533104 - Recruiting
  Peripheral Vascular Diseases
  
• Cell Therapy In Dilated Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00333827 - Recruiting
  Dilated Cardiomyopathy
  
• Cell Therapy in Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00350766 - Recruiting
  Acute Myocardial Infarction
  
• Cell Therapy of Cancer with Allogeneic Blood Lymphocytes Activated with rIL-2 for Metastatic Solid Tumors.
  ClinicalTrials.gov Identifier: NCT00149006 - Recruiting
  Metastatic solid tumor.; Mismatch allogeneic cell mediated immunotherapy
  
• Cell Therapy With Bone Marrow Mononuclear Cells in CLI
  ClinicalTrials.gov Identifier: NCT00377897 - Recruiting
  Critical Leg Ischemia
  
• Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
  ClinicalTrials.gov Identifier: NCT00311727 - Active, not recruiting
  Influenza
  
• CellCept in p-ANCA Vasculitis
  ClinicalTrials.gov Identifier: NCT00405860 - Recruiting
  MPO-ANCA Vasculitis; Microscopic Polyangiitis
  
• CellCept® (Mycophenolate Mofetil) in Pemphigus Vulgaris
  ClinicalTrials.gov Identifier: NCT00140127 - Recruiting
  Pemphigus Vulgaris
  
• CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00227045 - Completed
  End Stage Renal Disease
  
• Cellular Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00093574 - Recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung
  ClinicalTrials.gov Identifier: NCT00301730 - Completed
  Breast Cancer; Metastatic Cancer
  
• Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00107354 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
  
• Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00331526 - Recruiting
  Brain and Central Nervous System Tumors
  
• Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00182650 - Recruiting
  Lymphoma
  
• Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00101257 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
  ClinicalTrials.gov Identifier: NCT00335179 - Completed
  Actinic Keratosis
  
• Cellular Immune Augmentation in Colon and Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00257322 - Active, not recruiting
  Metastatic Colon Cancer; Metastatic Rectal Cancer
  
• Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
  ClinicalTrials.gov Identifier: NCT00168194 - Recruiting
  Hepatitis B; HIV Infections
  
• Cellular Immunotherapy with Autologous T Lymphocytes Stimulated with the Patient's Tumor-Specific Mutated Ras Peptides
  ClinicalTrials.gov Identifier: NCT00001583 - Completed
  Neoplasm
  
• Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00327301 - Recruiting
  Parkinson's Disease; Glaucoma
  
• Cellular Therapy With Cord Blood Cells
  ClinicalTrials.gov Identifier: NCT00427557 - Recruiting
  Hematologic Malignancies; Leukemia; Lymphoma; Myeloma
  
• Cellulose Sulfate (CS) Gel and HIV in Nigeria
  ClinicalTrials.gov Identifier: NCT00120770 - Terminated
  HIV Infections; Gonorrhea; Chlamydia Infections
  
• Cellulose Sulfate and HIV Transmission Among Women
  ClinicalTrials.gov Identifier: NCT00153777 - Terminated
  HIV Infection
  
• Cellwave Study: Combined Extracorporal Shock Wave Therapy and Intracoronary Cell Therapy in Chronic Ischemic Myocardium
  ClinicalTrials.gov Identifier: NCT00326989 - Recruiting
  Congestive Heart Failure
  
• Cemented Vs. No Cemented TSA for OA of the Shoulder
  ClinicalTrials.gov Identifier: NCT00158418 - Active, not recruiting
  Osteoarthritis
  
• Center for Reducing Asthma Disparities - Harvard University/Boston Area Community Health Centers
  ClinicalTrials.gov Identifier: NCT00281086 - Active, not recruiting
  Lung Diseases; Asthma
  
• Center for Reducing Asthma Disparities - Howard/Hopkins Centers
  ClinicalTrials.gov Identifier: NCT00281112 - Active, not recruiting
  Asthma; Lung Diseases
  
• Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers
  ClinicalTrials.gov Identifier: NCT00281151 - Active, not recruiting
  Asthma; Lung Diseases
  
• Center for Reducing Asthma Disparities - Northwestern University/Cook County Hospital Centers
  ClinicalTrials.gov Identifier: NCT00281177 - Active, not recruiting
  Asthma; Lung Diseases
  
• Center for Reducing Asthma Disparities - Rhode Island/Puerto Rico Centers
  ClinicalTrials.gov Identifier: NCT00281138 - Active, not recruiting
  Asthma; Lung Diseases
  
• Center for the Study of Vascular Disease in Hispanic and Native Americans
  ClinicalTrials.gov Identifier: NCT00018590 - Completed
  Vascular Disease
  
• Centocor Microarry Study of Patients
  ClinicalTrials.gov Identifier: NCT00462072 - Recruiting
  Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis; Crohn's Disease
  
• Central Auditory Processing Disorders Associated With Blast Exposure
  ClinicalTrials.gov Identifier: NCT00554801 - Recruiting
  Central Auditory Processing Disorders; Traumatic Brain Injury; Hearing Loss
  
• Central Blood Volume in Hypotensive Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00257504 - Completed
  Intradialytic Hypotension
  
• Central Mechanisms in Speech Motor Control Studied with H215O PET
  ClinicalTrials.gov Identifier: NCT00001308 - Recruiting
  Communication Disorder; Healthy; Stuttering; Tourette Syndrome; Voice Disorder
  
• Central Obesity and Disease Risk in Japanese Americans
  ClinicalTrials.gov Identifier: NCT00005365 - Completed
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Hypertension; Obesity; Diabetes Mellitus, non-insulin dependent; Hyperinsulinism; ...
  
• Central Vein Occlusion Study (CVOS)
  ClinicalTrials.gov Identifier: NCT00000131 - Completed
  Retinal Vein Occlusion; Retinal Diseases
  
• Central Venous Access Catheter Placement Using the Sonic Flashlight
  ClinicalTrials.gov Identifier: NCT00330590 - Not yet recruiting
  Catheterization, Central Venous
  
• Central Venous Catheter-Related Infection
  ClinicalTrials.gov Identifier: NCT00533988 - Completed
  Critically Ill Patients; Infection
  
• Centralized Telephone Outreach to Assist Smoking Cessation Among Veterans
  ClinicalTrials.gov Identifier: NCT00012948 - Completed
  Smoking; Smoking cessation
  
• CEP-10953 for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
  ClinicalTrials.gov Identifier: NCT00078312 - Completed
  Narcolepsy; Sleep Apnea, Obstructive; Sleep Apnea Syndromes; Shift-Work Sleep Disorder
  
• CEP-10953 in Treatment of Excessive Sleepiness Associated with Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome
  ClinicalTrials.gov Identifier: NCT00078325 - Completed
  Sleep Apnea, Obstructive; Sleep Apnea Syndromes
  
• CEP-10953 in Treatment of Excessive Sleepiness Associated with Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome
  ClinicalTrials.gov Identifier: NCT00079677 - Completed
  Obstructive Sleep Apnea; Sleep Hypopnea
  
• CEP-701 for PH-Negative Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00494585 - Recruiting
  Leukemia; Myelofibrosis
  
• CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00084422 - Recruiting
  recurrent neuroblastoma; disseminated neuroblastoma
  
• Cephalic Phase in Anorexia Nervosa,Bulimia Nervosa and Obese Binge Eaters
  ClinicalTrials.gov Identifier: NCT00493519 - Recruiting
  Anorexia Nervosa; Bulimia Nervosa
  
• Cephalic Phase of Oncology Patients Before and After Chemotherapy as Compared to Healthy Controls
  ClinicalTrials.gov Identifier: NCT00493740 - Recruiting
  Cephalic Phase, Oncology Patients
  
• Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study
  ClinicalTrials.gov Identifier: NCT00208507 - Active, not recruiting
  Joint Diseases
  
• Ceramide Cream in Treating Women With Cutaneous Breast Cancer
  ClinicalTrials.gov Identifier: NCT00008320 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• CERE-110 in Subjects with Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00087789 - Recruiting
  Alzheimer's Disease
  
• Cerebral Artery Stenosis, Coronary Artery Disease and Arrhythmia
  ClinicalTrials.gov Identifier: NCT00247533 - Recruiting
  Stroke; Coronary Artery Disease; Arrhythmia
  
• Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia
  ClinicalTrials.gov Identifier: NCT00332267 - Active, not recruiting
  Hypoxia; Endotoxemia; Healthy
  
• Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest
  ClinicalTrials.gov Identifier: NCT00441753 - Recruiting
  Cardiac Arrest; Post-Anoxic Encephalopathy
  
• Cerebral Effects of Pegylated Interferon
  ClinicalTrials.gov Identifier: NCT00136214 - Recruiting
  Hepatitis C
  
• Cerebral Hemodynamic Effects of Hypertonic Solutions in Severly Head-Injured Patients
  ClinicalTrials.gov Identifier: NCT00125229 - Recruiting
  Traumatic Brain Injury; Intracranial Hypertension
  
• Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
  ClinicalTrials.gov Identifier: NCT00391378 - Recruiting
  Stroke; Cognitive Symptoms
  
• Cerebral Perfusion Pressure (CPP) Management Information Feedback and Nursing
  ClinicalTrials.gov Identifier: NCT00194441 - Recruiting
  Traumatic Brain Injury; Subarachnoid Hemorrhage
  
• Cerebril™ in Patients with Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy
  ClinicalTrials.gov Identifier: NCT00056238 - Completed
  Stroke; Neurologic Diseases, General
  
• Cerebrospinal Fluid (CSF) Drainage and Cytokine Profiling in the Treatment of Acute Spinal Cord Injury (SCI) -A Pilot Study
  ClinicalTrials.gov Identifier: NCT00135278 - Not yet recruiting
  Spinal Cord Injury
  
• Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00305617 - Recruiting
  Lung Cancer
  
• Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center
  ClinicalTrials.gov Identifier: NCT00005326 - Completed
  Anemia, Sickle Cell; Blood Disease; Cerebrovascular Accident
  
• Certolizumab in Crohn's Disease Patient With Loss of Response or Intolerance to Infliximab
  ClinicalTrials.gov Identifier: NCT00308581 - Active, not recruiting
  Crohn Disease
  
• Certolizumab Pegol for Treatment of Adult Greek Population With Moderate to Severe Crohn's Disease, Who Failed on Infliximab
  ClinicalTrials.gov Identifier: NCT00307931 - Recruiting
  Crohn's Disease
  
• Cervical Block in Thyroid Surgery
  ClinicalTrials.gov Identifier: NCT00472446 - Recruiting
  Thyroidectomy
  
• Cervical I/F Cage for Anterior Cervical Fusion
  ClinicalTrials.gov Identifier: NCT00215293 - Active, not recruiting
  Degenerative Disc Disease in One or Two Adjacent Levels in the Cervical Spine
  
• Cervical Intraepithelial Neoplasm (CIN) in Women
  ClinicalTrials.gov Identifier: NCT00092534 - Completed
  Cervical Cancer; Genital Warts
  
• Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women
  ClinicalTrials.gov Identifier: NCT00092521 - Active, not recruiting
  Cervical Cancer; Genital Warts
  
• Cervical Nodal Metastasis in Squamous Cell Carcinoma of the Head and Neck - Novel Magnetic Resonance Imaging (MRI), Fluorodeoxyglucose-Positron-Emission Tomography (FDG-PET), and Histopathologic Correlation
  ClinicalTrials.gov Identifier: NCT00313027 - Recruiting
  Head and Neck Cancer; Carcinoma, Squamous Cell; Metastasis
  
• Cervical or Endomterial Cancer and Sexual Health Study, Phase 1 & 2
  ClinicalTrials.gov Identifier: NCT00134316 - Recruiting
  Sexual Dysfunctions, Psychological
  
• Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess
  ClinicalTrials.gov Identifier: NCT00545194 - Completed
  Cervical Ripening; Labor, Induced
  
• Cervical Ripening Interventions
  ClinicalTrials.gov Identifier: NCT00383942 - Recruiting
  Induction of Labor
  
• Cervical Rippening With Antiprogesterone in Midtrimester Abortions
  ClinicalTrials.gov Identifier: NCT00410345 - Recruiting
  Abortion, Missed
  
• Cervical Spine Clearance in Obtunded Trauma Patients
  ClinicalTrials.gov Identifier: NCT00573014 - Recruiting
  Coma; Wounds and Injuries
  
• Cervical Volume by Three-Dimensional Ultrasound as a Predictor of Preterm Delivery
  ClinicalTrials.gov Identifier: NCT00342550 - Recruiting
  Pregnancy; Preterm Delivery
  
• Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.
  ClinicalTrials.gov Identifier: NCT00377845 - Recruiting
  Uterine Cervical Dysplasia; Uterine Cervical Neoplasms
  
• Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels
  ClinicalTrials.gov Identifier: NCT00188539 - Recruiting
  Cervix Neoplasms
  
• CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00366925 - Recruiting
  Ulcerative Colitis
  
• Cesarean Delivery and Post-Operative Pain Management With Local Anesthesia
  ClinicalTrials.gov Identifier: NCT00298571 - Recruiting
  Pain, Postoperative
  
• Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis.
  ClinicalTrials.gov Identifier: NCT00490204 - Recruiting
  Perennial Allergic Rhinitis
  
• CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00434031 - Recruiting
  Breast Cancer
  
• Cetrorelix Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
  ClinicalTrials.gov Identifier: NCT00449150 - Recruiting
  Benign Prostatic Hypertrophy
  
• Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
  ClinicalTrials.gov Identifier: NCT00251381 - Recruiting
  Oropharyngeal Neoplasms
  
• Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00468169 - Recruiting
  Head and Neck Cancer
  
• Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00079066 - Active, not recruiting
  Quality of Life; stage IV colon cancer; recurrent colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00571740 - Not yet recruiting
  Colorectal Cancer
  
• Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00407810 - Recruiting
  Head and Neck Cancer
  
• Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00326911 - Recruiting
  Pancreatic Cancer
  
• Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment
  ClinicalTrials.gov Identifier: NCT00538291 - Recruiting
  Colorectal Cancer
  
• Cetuximab and Carbo for ER/PR/HER2 Negative BC
  ClinicalTrials.gov Identifier: NCT00420329 - Active, not recruiting
  Breast Cancer
  
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00086892 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Cetuximab and Celecoxib in Treating Patients With Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00466505 - Active, not recruiting
  Colorectal Cancer
  
• Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor Negative, Progesterone Receptor Negative, and HER2 Negative) Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00463788 - Recruiting
  Breast Neoplasm
  
• Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00101192 - Recruiting
  Cervical Cancer
  
• Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung
  ClinicalTrials.gov Identifier: NCT00557102 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00556413 - Recruiting
  Colorectal Cancer
  
• Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00559741 - Recruiting
  Colorectal Cancer
  
• Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005076 - Completed
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; Quality of Life; recurrent rectal cancer; ...
  
• Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and GE Junction Carcinomas
  ClinicalTrials.gov Identifier: NCT00319735 - Recruiting
  Esophageal Cancer
  
• Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00124618 - Recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
  ClinicalTrials.gov Identifier: NCT00165334 - Completed
  Non-Small Cell Lung Cancer
  
• Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00265850 - Recruiting
  Colorectal Cancer
  
• Cetuximab Combined with Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
  ClinicalTrials.gov Identifier: NCT00154102 - Active, not recruiting
  EGFR-expressing metastatic colorectal cancer
  
• Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases(CELIM)
  ClinicalTrials.gov Identifier: NCT00153998 - Recruiting
  Colorectal cancer, liver metastases
  
• Cetuximab in Patients with Unresectable or Metastatic Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00142428 - Active, not recruiting
  Unresectable hepatocellular carcinoma; Metastatic hepatocellular carcinoma; Hepatocellular Carcinoma
  
• Cetuximab in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00376727 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00477880 - Recruiting
  Gastric Cancer; Precancerous/Nonmalignant Condition
  
• Cetuximab in Treating Patients With Metastatic Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00096031 - Active, not recruiting
  Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage IV esophageal cancer
  
• Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00499031 - Recruiting
  Cervical Cancer
  
• Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
  ClinicalTrials.gov Identifier: NCT00524017 - Recruiting
  Head and Neck Cancer; Precancerous/Nonmalignant Condition
  
• Cetuximab in Treating Patients with Recurrent Or Progressive Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00118118 - Completed
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
  ClinicalTrials.gov Identifier: NCT00103207 - Recruiting
  Bronchoalveolar Cell Lung Cancer; Adenocarcinoma of the Lung; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; ...
  
• Cetuximab in Treating Patients With Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00020930 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004865 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00020917 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer
  
• Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00005591 - Completed
  stage III pancreatic cancer; Quality of Life; adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00275951 - Recruiting
  Gastric Cancer
  
• Cetuximab With or Without Carboplatin in Treating Women With Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00232505 - Active, not recruiting
  Breast Cancer
  
• Cetuximab, Capecitabine and Oxaliplatin in Patients With EGFr Expressing Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00444678 - Recruiting
  Colorectal Cancer; Neoplasm Metastasis
  
• Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00208546 - Recruiting
  Colorectal Cancer
  
• Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00301028 - Active, not recruiting
  Head and Neck Cancer
  
• Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
  ClinicalTrials.gov Identifier: NCT00397904 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005814 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced or Regional Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00096174 - Active, not recruiting
  stage IV squamous cell carcinoma of the hypopharynx; stage IV squamous cell carcinoma of the larynx; ...
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00104910 - Recruiting
  Cervical Cancer
  
• Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
  ClinicalTrials.gov Identifier: NCT00292955 - Suspended
  Cancer of the Cervix
  
• Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Anal Cancer
  ClinicalTrials.gov Identifier: NCT00316888 - Recruiting
  Anal Cancer
  
• Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00089297 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
  
• Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00445861 - Recruiting
  Esophageal Cancer
  
• Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00408564 - Recruiting
  Pancreatic Cancer
  
• Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00448838 - Recruiting
  Pancreatic Cancer
  
• Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00438737 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00425425 - Recruiting
  Esophageal Cancer
  
• Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00368992 - Recruiting
  Lung Cancer
  
• Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00081302 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ...
  
• Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00225784 - Recruiting
  Pancreatic Cancer
  
• Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00017511 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Nasopharyngeal Cancer; ...
  
• CFAR Study in Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00525603 - Recruiting
  Leukemia; Chronic Lymphocytic Leukemia
  
• cG250 Monoclonal Antibody Vs Placebo for Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00209183 - Recruiting
  Renal Cell Carcinoma (Kidney Cancer)
  
• Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity
  ClinicalTrials.gov Identifier: NCT00323973 - Completed
  Chagas Cardiomyopathy; Chronic Heart Failure
  
• Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States
  ClinicalTrials.gov Identifier: NCT00005455 - Completed
  Heart Diseases; Myocardial Diseases; Chagas Disease
  
• Chagas Disease Diagnostic - Inconclusive Serology
  ClinicalTrials.gov Identifier: NCT00511589 - Completed
  Parasitemia; Protozoan Infections
  
• Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
  ClinicalTrials.gov Identifier: NCT00524576 - Not yet recruiting
  Hepatitis B Infection
  
• CHANCE - Candesartan in Hypertrophic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00430833 - Active, not recruiting
  Hypertrophic Cardiomyopathy
  
• Change and Clinical Significance of Plantar Fascia Thickness After ESWT
  ClinicalTrials.gov Identifier: NCT00155324 - Recruiting
  Plantar Fasciitis
  
• Change in Coronary Heart Disease Risk Factors in Young Adults
  ClinicalTrials.gov Identifier: NCT00005406 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
  ClinicalTrials.gov Identifier: NCT00178542 - Recruiting
  Von Willebrand Disease
  
• Change of Heart Rate Variability and Baroreflex Sensitivity After Ventral Cardiac Denervation
  ClinicalTrials.gov Identifier: NCT00190112 - Not yet recruiting
  Atrial Fibrillation
  
• Change of Inspiratory Peak Flow in COPD
  ClinicalTrials.gov Identifier: NCT00561886 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Change of Lifestyle by Persons in Risk of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00202748 - Active, not recruiting
  Type 2 Diabetes
  
• Change of Neural Network Indicators Through Narrative Treatment of PTSD in Torture Victims
  ClinicalTrials.gov Identifier: NCT00563888 - Active, not recruiting
  PTSD
  
• Changes Following Inpatient Child-Oriented Family Treatment
  ClinicalTrials.gov Identifier: NCT00184327 - Recruiting
  Psychiatric Disorders
  
• Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
  ClinicalTrials.gov Identifier: NCT00205660 - Recruiting
  Schizophrenia; Type 2 Diabetes Mellitus
  
• Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00328952 - Active, not recruiting
  Schizophrenia; Hallucinations
  
• Changes in Bleeding and Clotting During the Menstrual Cycle
  ClinicalTrials.gov Identifier: NCT00480545 - Recruiting
  Von Willebrand's Disorder; Healthy
  
• Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis
  ClinicalTrials.gov Identifier: NCT00299637 - Recruiting
  Chorioamnionitis
  
• Changes in Body Composition and Metabolic Risk Parameters by Life Style Intervention.
  ClinicalTrials.gov Identifier: NCT00356785 - Completed
  Obesity; Metabolic Syndrome
  
• Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00536653 - Completed
  Osteoporosis
  
• Changes in Brain Activity (Functional MRI Study) Before and After Behavioral Therapy of Height Phobia
  ClinicalTrials.gov Identifier: NCT00302978 - Completed
  Height Phobia; Fear of Heights
  
• Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00516698 - Not yet recruiting
  Breast Cancer
  
• Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
  ClinicalTrials.gov Identifier: NCT00445445 - Recruiting
  Breast Cancer
  
• Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis
  ClinicalTrials.gov Identifier: NCT00119990 - Recruiting
  Peritoneal Dialysis
  
• Changes in Cerebral Blood Flow in Patients Treated With Spinal Cord Stimulation for Low Back and Leg Pain
  ClinicalTrials.gov Identifier: NCT00418301 - Recruiting
  Pain; Low Back Pain; Leg Pain
  
• Changes in Cerebral Oxygenation During Deliberate Hypotensive Anesthesia
  ClinicalTrials.gov Identifier: NCT00207987 - Recruiting
  Hypotension
  
• Changes in Cerebrovascular Reactivity During Cognitive Activation After Cardiopulmonary Bypass: Relation With Intraoperative Embolic Load and Postoperative Neuropsychological Dysfunctions
  ClinicalTrials.gov Identifier: NCT00394108 - Completed
  CABG-Patients
  
• Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00281242 - Recruiting
  Pulmonary Disease, Chronic Obstructive; Lung Diseases, Obstructive
  
• Changes in Different Fat Compartments and Their Effect on Particular Manifestations of Metabolic Syndrome After Bariatric Procedures.
  ClinicalTrials.gov Identifier: NCT00431587 - Not yet recruiting
  Morbid Obesity; Metabolic Syndrome; Visceral Obesity
  
• Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
  ClinicalTrials.gov Identifier: NCT00563043 - Recruiting
  Non Proliferative Diabetic Retinopathy; Proliferative Diabetic Retinopathy
  
• Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy
  ClinicalTrials.gov Identifier: NCT00452283 - Recruiting
  Glaucoma; Pulmonary Hypertension
  
• Changes in Food Reinforcement During Obesity Treatment
  ClinicalTrials.gov Identifier: NCT00200291 - Active, not recruiting
  Obesity
  
• Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
  ClinicalTrials.gov Identifier: NCT00538122 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Bipolar
  
• Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis
  ClinicalTrials.gov Identifier: NCT00344279 - Not yet recruiting
  Filarial Infection; HIV Infections
  
• Changes in Immunologic Homeostasis of Neonates in the Neonatal Intensive Care Unit
  ClinicalTrials.gov Identifier: NCT00524394 - Recruiting
  Premature Birth; Sepsis
  
• Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diets to American Diet - a Pilot Study
  ClinicalTrials.gov Identifier: NCT00379548 - Recruiting
  Diabetes; Insulin Resistance; Inflammation; Cardiovascular Disease; Periodontal Disease
  
• Changes in Iron Markers Following Iron Loading in Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00308490 - Completed
  Anemia in Chronic Renal Disease
  
• Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors
  ClinicalTrials.gov Identifier: NCT00111241 - Recruiting
  Arthralgia
  
• Changes in Macular Thickness After Patterns Scan Laser
  ClinicalTrials.gov Identifier: NCT00563628 - Recruiting
  Non Proliferative Diabetic Retinopathy.; Proliferative Diabetic Retinopathy.
  
• Changes in mfERG and as Gauge for Illness Activity and Macular Edema in Uveitis
  ClinicalTrials.gov Identifier: NCT00476593 - Recruiting
  Uveitis; Iritis; Macular Edema; Retinitis; Iridocyclitis
  
• Changes in Muscle Tissue in Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00369460 - Recruiting
  Pancreatic Cancer
  
• Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-Refractory Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00528307 - Not yet recruiting
  Atrial Fibrillation
  
• Changes in Nasal Patency with Changes in Posture, Temperature, Humidity and Nasal Patency Seen by Acoustic Rhinometry
  ClinicalTrials.gov Identifier: NCT00147888 - Active, not recruiting
  Mucosal congestion
  
• Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00355290 - Recruiting
  Blood Coagulation Disorders
  
• Changes in Physician Performance through Continuous Professional Development
  ClinicalTrials.gov Identifier: NCT00115284 - Active, not recruiting
  Asthma; Health Personnel
  
• Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia
  ClinicalTrials.gov Identifier: NCT00491296 - Not yet recruiting
  Bladder Cancer
  
• Changes in Retinal Function After Intravitreal Ranibizumab for Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00539734 - Recruiting
  Age-Related Macular Degeneration
  
• Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00499798 - Recruiting
  Brain and Central Nervous System Tumors; Chemotherapeutic Agent Toxicity; Sexual Dysfunction and Infertility
  
• Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation with the Diabetic Parameters and Neurotrophins.
  ClinicalTrials.gov Identifier: NCT00155142 - Recruiting
  Diabetes Mellitus
  
• Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
  ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
  Allergy
  
• Changes in the Infusion Rate in Insulinpump Treatment
  ClinicalTrials.gov Identifier: NCT00449839 - Recruiting
  Diabetes
  
• Changes in Unstable Ankles After Balance Training
  ClinicalTrials.gov Identifier: NCT00432705 - Recruiting
  Ankle Injury
  
• Changes of Cerebral Glucose Metabolism After Escitalpram Treatment in Panic Disorder
  ClinicalTrials.gov Identifier: NCT00461383 - Recruiting
  Panic Disorder
  
• Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
  ClinicalTrials.gov Identifier: NCT00552851 - Recruiting
  Acromegaly; Heart Failure; Hypertrophy, Left Ventricular
  
• Changes of Parameters of Transcranial Magnetic Stimulation in Patients With Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00228085 - Not yet recruiting
  Spinal Cord Injury
  
• Changes of Transforming Growth Factor b1 and Procollagen III in Patients With Acute Respiratory Distress Syndrome
  ClinicalTrials.gov Identifier: NCT00440882 - Active, not recruiting
  Acute Respiratory Distress Syndrome
  
• Changing Eating Behaviors in Young Children: Should Healthy Foods be Increased or Unhealthy Foods Decreased?
  ClinicalTrials.gov Identifier: NCT00200265 - Active, not recruiting
  Obesity
  
• Changing Patterns of Candida Infections in Urban Medical Centers
  ClinicalTrials.gov Identifier: NCT00366223 - Recruiting
  Infection; Candida; Non Albicans Species
  
• Changing Physical Activity Behavior in Individuals With Type 2 Diabetes Using Counceling and Information From Continuous Glucose Monitoring
  ClinicalTrials.gov Identifier: NCT00542698 - Completed
  Type 2 Diabetes Mellitus
  
• Changing to Nonprotease Inhibitor Treatment to Improve Side Effects
  ClinicalTrials.gov Identifier: NCT00021463 - Completed
  HIV Infections; Lipodystrophy
  
• Chantix for Treating Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00567008 - Not yet recruiting
  Cocaine Dependence
  
• Characterisation of Asthma in Obese Subjects
  ClinicalTrials.gov Identifier: NCT00532831 - Active, not recruiting
  Asthma; Obesity
  
• Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines
  ClinicalTrials.gov Identifier: NCT00443131 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00582881 - Recruiting
  Mixed Connective Tissue Disease; Systemic Lupus Erythematosus
  
• Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa
  ClinicalTrials.gov Identifier: NCT00346476 - Active, not recruiting
  HIV Infections; Tuberculosis
  
• Characteristics of Andersen-Tawil Syndrome
  ClinicalTrials.gov Identifier: NCT00521794 - Recruiting
  Andersen-Tawil Syndrome; Andersen Syndrome
  
• Characteristics of Blood- Brain Barrier Permeability in Neurological Patients
  ClinicalTrials.gov Identifier: NCT00419874 - Recruiting
  Traumatic Brain Injury; Cerebral Infarction; Cerebral Hemorrhage
  
• Characteristics of Dendritic Cells Before and After Gastric Banding
  ClinicalTrials.gov Identifier: NCT00488930 - Recruiting
  Morbid Obesity; Hyperglycemia; Diabetes Mellitus
  
• Characteristics of Episodic Ataxia Syndrome
  ClinicalTrials.gov Identifier: NCT00266760 - Recruiting
  Ataxia; Cerebellar Diseases
  
• Characteristics of Glargine in Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00574912 - Recruiting
  Type 2 Diabetes
  
• Characteristics of Hgb C Carriers in Northern Israel and Clinical Features Among Hgb Homozygous
  ClinicalTrials.gov Identifier: NCT00481260 - Not yet recruiting
  Hgb C Hemoglobinopathy
  
• Characteristics of Idiopathic Familial Speech Disorders
  ClinicalTrials.gov Identifier: NCT00001551 - Recruiting
  Developmental Articulation Disorder; Speech Disorder; Stuttering
  
• Characteristics of Idiopathic Familial Voice Disorders
  ClinicalTrials.gov Identifier: NCT00001552 - Recruiting
  Laryngeal Disease; Spastic Dysphonia; Voice Disorder
  
• Characteristics of Mast Cells in Mastocytosis
  ClinicalTrials.gov Identifier: NCT00001356 - Completed
  Mastocytosis
  
• Characteristics of Nondystrophic Myotonias
  ClinicalTrials.gov Identifier: NCT00244413 - Recruiting
  Myotonia Congenita; Myotonic Disorders
  
• Characteristics of Parkinson's Disease Associated With the LRRK-2 Gene Mutation
  ClinicalTrials.gov Identifier: NCT00467090 - Recruiting
  Parkinson Disease
  
• Characteristics of Patients With Amyloidosis & Heart Failure Being Evaluated for a Heart Transplant
  ClinicalTrials.gov Identifier: NCT00456040 - Completed
  Cardiomyopathy
  
• Characteristics of Post-Traumatic Stress Disorder (PTSD) and Non-PTSD Subjects
  ClinicalTrials.gov Identifier: NCT00229359 - Completed
  PTSD
  
• Characteristics of Prader-Willi Syndrome and Early-Onset Morbid Obesity
  ClinicalTrials.gov Identifier: NCT00375089 - Recruiting
  Prader-Willi Syndrome; Obesity
  
• Characteristics of Sleep Patterns in Young Adults With and Without Insomnia
  ClinicalTrials.gov Identifier: NCT00177216 - Recruiting
  Sleep Disorders
  
• Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%
  ClinicalTrials.gov Identifier: NCT00176943 - Completed
  Alopecia Areata
  
• Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
  ClinicalTrials.gov Identifier: NCT00537966 - Recruiting
  HIV Infections
  
• Characterization of Angelman Syndrome
  ClinicalTrials.gov Identifier: NCT00296764 - Recruiting
  Angelman Syndrome
  
• Characterization of Brain Metastases
  ClinicalTrials.gov Identifier: NCT00184275 - Recruiting
  Neoplasm Metastasis; Lung Neoplasms; Breast Neoplasms; Melanoma
  
• Characterization of Childhood-Onset Obsessive-Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00044239 - Active, not recruiting
  Obsessive-Compulsive Disorder
  
• Characterization of Clonal B Cell Populations in HCV Infection
  ClinicalTrials.gov Identifier: NCT00435201 - Recruiting
  Hepatitis C
  
• Characterization Of Coronary Prone Pedigrees
  ClinicalTrials.gov Identifier: NCT00005139 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Characterization of Explanted Hernia Meshes From Human Subjects: A Multi-Center, Prospective Study
  ClinicalTrials.gov Identifier: NCT00484887 - Recruiting
  Pathological Conditions, Signs and Symptoms; Hernia
  
• Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS)
  ClinicalTrials.gov Identifier: NCT00243633 - Completed
  Focal Liver Lesions; Liver Cancer; Liver Cirrhosis
  
• Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
  ClinicalTrials.gov Identifier: NCT00288873 - Active, not recruiting
  Vitamin D Deficiency; Secondary Hyperparathyroidism; Obesity
  
• Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-Enhanced CMR
  ClinicalTrials.gov Identifier: NCT00549861 - Enrolling by invitation
  Cardiomyopathy, Dilated; Cardiomyopathies, Secondary
  
• Characterization of Local Vascular Effects of LNMMA
  ClinicalTrials.gov Identifier: NCT00180063 - Completed
  Healthy Subjects
  
• Characterization of Macroprolactinemia
  ClinicalTrials.gov Identifier: NCT00436111 - Completed
  Hyperprolactinemia
  
• Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00100425 - Completed
  Irritable Bowel Syndrome
  
• Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00108446 - Completed
  Irritable Bowel Syndrome
  
• Characterization of Recently Deployed Veterans
  ClinicalTrials.gov Identifier: NCT00451659 - Completed
  Posttraumatic Stress Disorder
  
• Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients with Malignant Glioma Undergoing Radiotherapy
  ClinicalTrials.gov Identifier: NCT00125697 - Recruiting
  -malignant glioma
  
• Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-Based Regimen
  ClinicalTrials.gov Identifier: NCT00200369 - Recruiting
  HIV Infection
  
• Characterization of the Melanoma-Specific Immune Response
  ClinicalTrials.gov Identifier: NCT00368615 - Not yet recruiting
  Melanoma
  
• Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals
  ClinicalTrials.gov Identifier: NCT00001462 - Completed
  Emphysema; Lung Diseases, Obstructive; alpha 1-Antitrypsin Deficiency
  
• Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation
  ClinicalTrials.gov Identifier: NCT00342966 - Active, not recruiting
  Cancer
  
• Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade
  ClinicalTrials.gov Identifier: NCT00233467 - Completed
  PTSD; Posttraumatic Stress Disorder
  
• Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
  ClinicalTrials.gov Identifier: NCT00230893 - Completed
  PTSD; Post-Traumatic Stress Disorder
  
• Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.
  ClinicalTrials.gov Identifier: NCT00180024 - Completed
  Healthy Subjects
  
• Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors
  ClinicalTrials.gov Identifier: NCT00471588 - Recruiting
  Obsessive-Compulsive Disorder
  
• Characterizing a 5P-Linked BHR Susceptibility Locus
  ClinicalTrials.gov Identifier: NCT00006512 - Completed
  Asthma; Lung Diseases
  
• Characterizing and Diagnosis''s of the Charcot Foot (Charcot Osteoartropati) in Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00157222 - Recruiting
  Charcot Joint; Diabetic Foot
  
• Characterizing PAI-1 Modulation on Monocyte Adhesion
  ClinicalTrials.gov Identifier: NCT00512031 - Recruiting
  Atherosclerosis
  
• Characterizing Psychological Consequences of Childhood Trauma
  ClinicalTrials.gov Identifier: NCT00209105 - Recruiting
  Major Depressive Disorder
  
• Characterizing Serum Protein Patterns in Selected Skin Diseases
  ClinicalTrials.gov Identifier: NCT00063167 - Recruiting
  Psoriasis; Cutaneous T-Cell Lymphoma; Healthy
  
• Characterizing Wheelchair-Related Falls in Elderly Veterans
  ClinicalTrials.gov Identifier: NCT00363246 - Not yet recruiting
  Elderly; Falls
  
• CHARITÉ™ Artificial Disc Compared to Anterior Interbody Fusion for Treatment of Degenerative Disc Disease
  ClinicalTrials.gov Identifier: NCT00215306 - Completed
  Degenerative Disc Disease
  
• CHARITE™ vs. ALIF 5-Year Follow-up
  ClinicalTrials.gov Identifier: NCT00215332 - Recruiting
  Degenerative Disc Disease
  
• Charleston Heart Study - Predictors of Coronary Disease in Blacks
  ClinicalTrials.gov Identifier: NCT00005165 - Completed
  Cardiovascular Diseases; Coronary Disease; Hypertension; Heart Diseases
  
• Chart Review of Antivirals for Influenza in Infants
  ClinicalTrials.gov Identifier: NCT00311701 - Active, not recruiting
  Influenza
  
• Chart Review of Outcome of Treatment for S. Aureus Bacteremia
  ClinicalTrials.gov Identifier: NCT00304902 - Recruiting
  Staphylococcus Aureus
  
• Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00322855 - Active, not recruiting
  Sarcoma
  
• Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
  ClinicalTrials.gov Identifier: NCT00320918 - Active, not recruiting
  Cholangiocarcinoma
  
• CHD Lifestyle Modification for Latinas With Diabetes
  ClinicalTrials.gov Identifier: NCT00233259 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus, Non-Insulin Dependent
  
• CHD Risk, Behavioral Stress and Reproductive Hormones
  ClinicalTrials.gov Identifier: NCT00005538 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Menopause
  
• Checking Smoking Status as a Routine Vital Sign: A Cluster-Randomized Trial of Its Effect on Cessation Counseling
  ClinicalTrials.gov Identifier: NCT00245323 - Completed
  Smoking
  
• Checking the Usability of a Virtual Reality System in Children With Brain Injury
  ClinicalTrials.gov Identifier: NCT00358865 - Recruiting
  Acquired Brain Injury
  
• Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors
  ClinicalTrials.gov Identifier: NCT00449358 - Active, not recruiting
  Basal Cell Carcinoma
  
• Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
  ClinicalTrials.gov Identifier: NCT00000588 - Completed
  Anemia (Iron-Loading); beta-Thalassemia; Hematologic Diseases; Hemoglobinopathies; Thalassemia; Iron Overload
  
• Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00055380 - Completed
  Cancer
  
• Chemical Dependency and Smoking Cessation: Patient's Views - 1
  ClinicalTrials.gov Identifier: NCT00051883 - Not yet recruiting
  Tobacco Use Disorder
  
• Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00049322 - Recruiting
  localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
  ClinicalTrials.gov Identifier: NCT00003907 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00293397 - Recruiting
  Liver Cancer
  
• Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00501644 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
  
• Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects
  ClinicalTrials.gov Identifier: NCT00297076 - Terminated
  HIV Infections
  
• Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
  ClinicalTrials.gov Identifier: NCT00000764 - Completed
  HIV Infections; Anus Neoplasms
  
• Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
  ClinicalTrials.gov Identifier: NCT00382330 - Recruiting
  Vulvar Cancer
  
• Chemoprevention of Colorectal Adenomas
  ClinicalTrials.gov Identifier: NCT00486512 - Recruiting
  Adenomatous Polyps
  
• Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway
  ClinicalTrials.gov Identifier: NCT00498134 - Active, not recruiting
  Stomach Neoplasms
  
• Chemoprevention of Oral Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00036283 - Completed
  Precancerous Conditions
  
• Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00201279 - Completed
  Oral Cavity; Squamous Cell Carcinoma
  
• Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006219 - Active, not recruiting
  Multiple Myeloma
  
• Chemoprevention Therapy Plus Surgery in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003099 - Active, not recruiting
  stage I breast cancer; ductal breast carcinoma; invasive ductal breast carcinoma; prevention of breast cancer; stage II breast cancer
  
• Chemoprevention Trial – Anastrozole in DCIS in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00256217 - Recruiting
  DCIS; Early Invasive Breast Cancer
  
• Chemoprevention Trial in Familial Adenomatous Polyposis Coli Using EPA
  ClinicalTrials.gov Identifier: NCT00510692 - Active, not recruiting
  Familial Adenomatous Polyposis Coli; FAP
  
• Chemoprevention with Folic Acid
  ClinicalTrials.gov Identifier: NCT00018551 - Completed
  Colon Cancer; Adenoma; Colonic Polyps
  
• Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00325871 - Recruiting
  Colorectal Cancer
  
• Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
  ClinicalTrials.gov Identifier: NCT00176800 - Active, not recruiting
  Esophageal Carcinoma
  
• Chemoradiation With Oxaliplatin and 5FU for Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00463840 - Recruiting
  Pancreatic Cancer
  
• Chemoradiation-Induced Nausea and Emesis: Quality of Life
  ClinicalTrials.gov Identifier: NCT00394602 - Recruiting
  Gastric Cancer; Pancreatic Cancer; Cervical Cancer; Vulvar Cancer; Endometrial Cancer; Anal Cancer
  
• Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004031 - Recruiting
  adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ...
  
• Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
  ClinicalTrials.gov Identifier: NCT00062439 - Recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer
  ClinicalTrials.gov Identifier: NCT00347256 - Not yet recruiting
  Paranasal Sinus Neoplasms
  
• Chemoradiotherapy in Patients With Localised Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193921 - Recruiting
  Non Small Cell Lung Carcinoma
  
• Chemoradiotherapy of NSCLC Stage IIIB
  ClinicalTrials.gov Identifier: NCT00198432 - Completed
  NSCLC Stage IIIB; Concomitant Radiochemotherapy
  
• Chemosensitivity Assays in Predicting Response to Chemotherapy in Patients With Persistent, Refractory, or Recurrent Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00301717 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003214 - Active, not recruiting
  Ovarian Cancer
  
• Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00539617 - Not yet recruiting
  Esophageal Cancer
  
• Chemotherapy Administered Every 2 Weeks with or without Pegfilgrastim (Neulasta) in Subjects with Advanced Colon Cancer
  ClinicalTrials.gov Identifier: NCT00094809 - Active, not recruiting
  Colon Cancer; Colorectal Cancer; Rectal Cancer
  
• Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndromes After a Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00526292 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003144 - Active, not recruiting
  Drug Toxicity; unspecified adult solid tumor, protocol specific
  
• Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members
  ClinicalTrials.gov Identifier: NCT00000703 - Completed
  Lymphoma, Non-Hodgkin; HIV Infections
  
• Chemotherapy and Bevacizumab in Treating Women With Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00372866 - Recruiting
  Breast Cancer
  
• Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003239 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00045370 - Completed
  recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002547 - Active, not recruiting
  Leukemia
  
• Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003838 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; ...
  
• Chemotherapy and Filgrastim Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005986 - Suspended
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00403182 - Recruiting
  Breast Cancer
  
• Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer
  
• Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00408551 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00014495 - Recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003963 - Active, not recruiting
  Waldenstrom's Macroglobulinemia; adult non-Hodgkin's lymphoma
  
• Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003727 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00046852 - Active, not recruiting
  Infection; refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006123 - Active, not recruiting
  stage IV breast cancer
  
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003552 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00014508 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00024050 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; ...
  
• Chemotherapy and Peripheral Stem Cell Transplantation With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00012051 - Recruiting
  recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma
  
• Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00030589 - Active, not recruiting
  stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
  
• Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00001507 - Recruiting
  Breast Neoplasm; Neoplasm Metastasis
  
• Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
  ClinicalTrials.gov Identifier: NCT00028795 - Completed
  childhood brain stem glioma; high-grade childhood cerebral astrocytoma; childhood spinal cord tumors; untreated childhood brain stem glioma
  
• Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00052910 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Chemotherapy and Radiation Therapy Compared With Radiation Therapy Alone in Treating Patients With High-Risk Stage I, Stage II, or Stage III Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00411138 - Recruiting
  Endometrial Cancer
  
• Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002510 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; Waldenstrom's Macroglobulinemia; recurrent grade III follicular large cell lymphoma; ...
  
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00011999 - Active, not recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Chemotherapy and Radiation Therapy in Treating Infants With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00005063 - Suspended
  childhood brain tumor; Neuroblastoma
  
• Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx
  ClinicalTrials.gov Identifier: NCT00002999 - Active, not recruiting
  stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002884 - Active, not recruiting
  childhood gastrointestinal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
  
• Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003261 - Recruiting
  AIDS-related primary CNS lymphoma
  
• Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00049348 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
  
• Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00022308 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006107 - Active, not recruiting
  Head and Neck Cancer
  
• Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
  ClinicalTrials.gov Identifier: NCT00014118 - Active, not recruiting
  stage III squamous cell carcinoma of the oropharynx; stage IV squamous cell carcinoma of the oropharynx; ...
  
• Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00003862 - Completed
  stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00392327 - Recruiting
  Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Psychosocial Effects/Treatment
  
• Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004907 - Completed
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003815 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Chemotherapy and Radiation Therapy With or Without Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00503776 - Recruiting
  Chemotherapeutic Agent Toxicity; Dysphagia; Head and Neck Cancer; Mucositis; Radiation Toxicity; Xerostomia
  
• Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00055887 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; ...
  
• Chemotherapy and Radiation Therapy With or Without Epoetin alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00028938 - Completed
  stage IIIA non-small cell lung cancer; Squamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; stage IIIB non-small cell lung cancer; ...
  
• Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
  ClinicalTrials.gov Identifier: NCT00011960 - Completed
  Esophageal Cancer; Gastric Cancer
  
• Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00017225 - Active, not recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; ...
  
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00047008 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00054067 - Completed
  cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; stage IB cervical cancer
  
• Chemotherapy and Radiotherapy for Osteolymphoma
  ClinicalTrials.gov Identifier: NCT00141648 - Active, not recruiting
  Osteolymphoma
  
• Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00494026 - Recruiting
  Small Cell Lung Cancer
  
• Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00039195 - Active, not recruiting
  stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ...
  
• Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00020943 - Active, not recruiting
  stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ...
  
• Chemotherapy and Stem Cell Transplantation in Treating Children with Central Nervous System Cancer
  ClinicalTrials.gov Identifier: NCT00053118 - Active, not recruiting
  central nervous system cancer; childhood brain tumor; hematopoietic and lymphoid cancer; Neuroblastoma; Retinoblastoma
  
• Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003042 - Active, not recruiting
  stage IIIB breast cancer; inflammatory breast cancer
  
• Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00024193 - Active, not recruiting
  stage 4S neuroblastoma
  
• Chemotherapy and Total-Body Irradiation Followed By Autologous Lymphocyte Infusion, Aldesleukin, and Autologous Stem Cell Transplant in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00335127 - Recruiting
  Melanoma (Skin); Non-Melanomatous Skin Cancer
  
• Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00290641 - Completed
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes
  
• Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
  ClinicalTrials.gov Identifier: NCT00014573 - Active, not recruiting
  Brain Tumor
  
• Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002676 - Completed
  primary central nervous system lymphoma
  
• Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
  ClinicalTrials.gov Identifier: NCT00047138 - Recruiting
  Wilms' Tumor; Wilms' tumor and other childhood kidney tumors
  
• Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00044993 - Completed
  Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00059761 - Active, not recruiting
  limited stage small cell lung cancer
  
• Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003780 - Active, not recruiting
  stage III pancreatic cancer; stage IV pancreatic cancer; Quality of Life; stage II pancreatic cancer
  
• Chemotherapy Consisting of Fludarabine and Cyclophosphamide Followed By White Blood Cell Infusion, Vaccine Therapy, and Aldesleukin in Treating Patients With Recurrent or Refractory Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00084500 - Active, not recruiting
  Melanoma (Skin)
  
• Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
  ClinicalTrials.gov Identifier: NCT00068328 - Recruiting
  Quality of Life; psychosocial effects/treatment; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
  ClinicalTrials.gov Identifier: NCT00243685 - Recruiting
  Breast Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Sarcoma, Soft Tissue
  
• Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00020592 - Recruiting
  Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Chemotherapy Followed By Autologous Natural Killer Cells and Aldesleukin in Treating Patients With Metastatic Melanoma or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00354055 - Recruiting
  Kidney Cancer; Melanoma (Skin); Non-Melanomatous Skin Cancer
  
• Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery
  ClinicalTrials.gov Identifier: NCT00014092 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors
  ClinicalTrials.gov Identifier: NCT00002619 - Active, not recruiting
  high-grade childhood cerebral astrocytoma; adult glioblastoma multiforme; adult brain stem glioma; untreated childhood brain stem glioma
  
• Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Young Patients With Recurrent Sarcoma
  ClinicalTrials.gov Identifier: NCT00047372 - Recruiting
  Sarcoma
  
• Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00005802 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia
  
• Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplantation Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00011921 - Active, not recruiting
  limited stage small cell lung cancer; extensive stage small cell lung cancer
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005948 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
  ClinicalTrials.gov Identifier: NCT00003273 - Active, not recruiting
  childhood brain tumor; childhood rhabdomyosarcoma; Neuroblastoma; Retinoblastoma
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00027573 - Completed
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; renal clear cell carcinoma; renal granular cell carcinoma
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00006367 - Active, not recruiting
  idiopathic myelofibrosis; Polycythemia Vera; Essential Thrombocythemia; Agnogenic Myeloid Metaplasia
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003080 - Completed
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
  
• Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma
  ClinicalTrials.gov Identifier: NCT00005824 - Completed
  AIDS-Related Lymphoma
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00020722 - Recruiting
  Cancer
  
• Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplantation Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00016887 - Active, not recruiting
  stage III mantle cell lymphoma; stage IV mantle cell lymphoma
  
• Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
  ClinicalTrials.gov Identifier: NCT00002806 - Completed
  adult infiltrating astrocytoma
  
• Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00019071 - Completed
  adult glioblastoma multiforme; adult anaplastic astrocytoma
  
• Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00002827 - Active, not recruiting
  stage II childhood Hodgkin's disease; stage III childhood Hodgkin's disease; cardiac toxicity; stage I childhood Hodgkin's disease; ...
  
• Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney
  ClinicalTrials.gov Identifier: NCT00025103 - Recruiting
  recurrent Wilms' tumor and other childhood kidney tumors; clear cell sarcoma of the kidney
  
• Chemotherapy Followed By Surgery Compared With Radiation Therapy Plus Chemotherapy in Treating Patients With Stage IB or Stage II Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00039338 - Recruiting
  stage IB cervical cancer; stage IIB cervical cancer; stage IIA cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; ...
  
• Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003953 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
  
• Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002623 - Active, not recruiting
  Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; ...
  
• Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
  ClinicalTrials.gov Identifier: NCT00544414 - Active, not recruiting
  Head and Neck Cancer
  
• Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00049218 - Recruiting
  extensive stage small cell lung cancer
  
• Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00119730 - Active, not recruiting
  Mantle Cell Lymphoma
  
• Chemotherapy for Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00090727 - Active, not recruiting
  Solid Malignancies; Non-Hodgkin's Lymphoma
  
• Chemotherapy for Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00436280 - Recruiting
  Lymphoma, Large Cell, Diffuse
  
• Chemotherapy for Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00380718 - Recruiting
  Carcinoma, Non-Small Cell Lung
  
• Chemotherapy for Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00391274 - Recruiting
  Carcinoma, Non-Small Cell Lung
  
• Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers
  ClinicalTrials.gov Identifier: NCT00409006 - Recruiting
  Carcinoma, Non-Small Cell Lung
  
• Chemotherapy for Patients With Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00523419 - Recruiting
  Osteosarcoma
  
• Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00003294 - Active, not recruiting
  Leukemia; Lymphoma
  
• Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003593 - Completed
  childhood acute monocytic leukemia; childhood acute myeloid leukemia and other myeloid malignancies; Chronic Myelomonocytic Leukemia; ...
  
• Chemotherapy in Treating Children With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003912 - Active, not recruiting
  childhood hepatoblastoma; childhood hepatocellular carcinoma; childhood liver cancer
  
• Chemotherapy in Treating Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002730 - Completed
  recurrent neuroblastoma
  
• Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003178 - Completed
  Acute Myeloid Leukemia
  
• Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
  ClinicalTrials.gov Identifier: NCT00003745 - Completed
  recurrent childhood rhabdomyosarcoma; recurrent osteosarcoma; embryonal childhood rhabdomyosarcoma; alveolar childhood rhabdomyosarcoma; ...
  
• Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003735 - Active, not recruiting
  recurrent childhood acute myeloid leukemia; recurrent childhood acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia
  
• Chemotherapy in Treating Patients Who Have Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004047 - Completed
  refractory chronic lymphocytic leukemia; recurrent adult acute myeloid leukemia; refractory anemia with excess blasts in transformation; ...
  
• Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003343 - Active, not recruiting
  stage IV prostate cancer
  
• Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00018954 - Active, not recruiting
  Lymphoma; Leukemia
  
• Chemotherapy in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00011973 - Completed
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003154 - Completed
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003713 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Chemotherapy in Treating Patients With Advanced Sarcoma
  ClinicalTrials.gov Identifier: NCT00002526 - Active, not recruiting
  stage IVB adult soft tissue sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma; stage IVA adult soft tissue sarcoma; ...
  
• Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003703 - Completed
  unspecified adult solid tumor, protocol specific
  
• Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003709 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003721 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Chemotherapy in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012129 - Completed
  stage IIIB breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00003558 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary
  
• Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006097 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002525 - Active, not recruiting
  stage II colon cancer; stage III colon cancer
  
• Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003129 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer; stage 0 bladder cancer
  
• Chemotherapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003044 - Active, not recruiting
  localized unresectable adult primary liver cancer
  
• Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
  ClinicalTrials.gov Identifier: NCT00010088 - Active, not recruiting
  adenocarcinoma of the extrahepatic bile duct; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; ...
  
• Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00014313 - Active, not recruiting
  metastatic tumors of the Ewing's family
  
• Chemotherapy in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00024388 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002800 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; untreated adult acute myeloid leukemia; de novo myelodysplastic syndrome; ...
  
• Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004218 - Active, not recruiting
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00520676 - Recruiting
  Non-Small Cell Lung Cancer
  
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003829 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
  
• Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors
  ClinicalTrials.gov Identifier: NCT00012038 - Completed
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma
  
• Chemotherapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004045 - Completed
  stage IV prostate cancer; recurrent prostate cancer
  
• Chemotherapy in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00002986 - Active, not recruiting
  recurrent adult brain tumor
  
• Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003446 - Completed
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004060 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; ...
  
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004065 - Completed
  Cancer
  
• Chemotherapy in Treating Patients With Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00002675 - Active, not recruiting
  Retinoblastoma
  
• Chemotherapy in Treating Patients With Sarcoma of the Uterus
  ClinicalTrials.gov Identifier: NCT00005643 - Completed
  uterine leiomyosarcoma; recurrent uterine sarcoma; uterine carcinosarcoma; stage IV uterine sarcoma; Endometrial Stromal Sarcoma
  
• Chemotherapy in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003103 - Active, not recruiting
  Gastrointestinal Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Oral Cancer; Reproductive Cancers
  
• Chemotherapy in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003698 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Chemotherapy in Treating Patients with Stage II or Stage III Colon Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002593 - Completed
  stage III colon cancer; stage II colon cancer
  
• Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004100 - Active, not recruiting
  childhood thorax/respiratory cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; Quality of Life
  
• Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003714 - Active, not recruiting
  advanced adult primary liver cancer; liver metastases; adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
  ClinicalTrials.gov Identifier: NCT00002900 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; ductal breast carcinoma; cardiac toxicity
  
• Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002707 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Chemotherapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004046 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003236 - Completed
  recurrent breast cancer
  
• Chemotherapy in Treating Women With Resected Breast Cancer Following Tamoxifen Therapy
  ClinicalTrials.gov Identifier: NCT00003140 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003073 - Active, not recruiting
  leptomeningeal metastases; recurrent childhood large cell lymphoma; recurrent childhood acute myeloid leukemia; childhood diffuse large cell lymphoma; ...
  
• Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00298415 - Recruiting
  NSCLC
  
• Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients
  ClinicalTrials.gov Identifier: NCT00470340 - Not yet recruiting
  Liver Neoplasms; Liver Cirrhosis; Carcinoma, Hepatocellular; Recurrence; Neoplasm Recurrence, Local
  
• Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004145 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00006237 - Recruiting
  stage III melanoma; Recurrent Melanoma
  
• Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019942 - Recruiting
  Melanoma (Skin)
  
• Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003899 - Completed
  unspecified adult solid tumor, protocol specific
  
• Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004899 - Completed
  Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; childhood acute monocytic leukemia; ...
  
• Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003060 - Active, not recruiting
  Recurrent Melanoma
  
• Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002552 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00005946 - Active, not recruiting
  Leukemia; Lymphoma
  
• Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00193284 - Active, not recruiting
  Head and Neck Cancer
  
• Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006037 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Chemotherapy Plus Interferon alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003152 - Active, not recruiting
  stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
  
• Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00016159 - Active, not recruiting
  adult acute myeloid leukemia in remission; childhood acute myeloid leukemia in remission; adult acute promyelocytic leukemia (M3); ...
  
• Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00003992 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012311 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
  ClinicalTrials.gov Identifier: NCT00003141 - Active, not recruiting
  childhood brain tumor; childhood rhabdoid tumor of the central nervous system; childhood rhabdomyosarcoma; childhood spinal cord tumors; ...
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
  ClinicalTrials.gov Identifier: NCT00007995 - Recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
  ClinicalTrials.gov Identifier: NCT00002768 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004114 - Active, not recruiting
  Leukemia; Lymphoma
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer
  ClinicalTrials.gov Identifier: NCT00007982 - Recruiting
  adult brain tumor; paranasal sinus and nasal cavity cancer; primary central nervous system lymphoma
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
  Leukemia, Myeloid; Leukemia, Myeloid, Chronic
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00004135 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004900 - Completed
  stage IIIB breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002553 - Completed
  Lymphoma; Leukemia
  
• Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00002791 - Completed
  recurrent adult soft tissue sarcoma; stage II adult soft tissue sarcoma; stage III adult soft tissue sarcoma
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002951 - Active, not recruiting
  Gastrointestinal Cancer; Neck Cancer; Oral Cancer; Throat Cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003812 - Active, not recruiting
  limited stage small cell lung cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00004089 - Completed
  anaplastic thyroid cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002551 - Active, not recruiting
  stage III rectal cancer; adenocarcinoma of the rectum; stage II rectal cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003631 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00003200 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00003803 - Active, not recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage III non-small cell lung cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
  ClinicalTrials.gov Identifier: NCT00003596 - Active, not recruiting
  stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00004160 - Completed
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003704 - Active, not recruiting
  Gastrointestinal Cancer; Reproductive Cancers
  
• Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
  ClinicalTrials.gov Identifier: NCT00025298 - Active, not recruiting
  stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer; oral complications of cancer and cancer therapy; ...
  
• Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002550 - Completed
  Squamous Cell Lung Cancer; Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer; stage IIIA non-small cell lung cancer; ...
  
• Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00041132 - Active, not recruiting
  stage III mantle cell lymphoma; stage IV mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma
  
• Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00012376 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003603 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
  ClinicalTrials.gov Identifier: NCT00003804 - Active, not recruiting
  stage I Wilms' tumor
  
• Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00003636 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
  
• Chemotherapy Plus Surgery in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003013 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00014430 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00005780 - No longer recruiting
  Mantle Cell Lymphoma
  
• Chemotherapy Related Anemia
  ClinicalTrials.gov Identifier: NCT00035607 - Completed
  Lymphoma; Leukemia, Lymphocytic, Chronic; Multiple Myeloma; Breast Neoplasms; Lung Neoplasms
  
• Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies
  ClinicalTrials.gov Identifier: NCT00036023 - Completed
  Lymphomas; Breast Neoplasms; Lung Neoplasms; Multiple Myeloma; Leukemia, Lymphocytic, Chronic
  
• Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00580385 - Recruiting
  Osteosarcoma
  
• Chemotherapy Toxicity Reduction Via Urea Cycle Support
  ClinicalTrials.gov Identifier: NCT00223730 - Active, not recruiting
  Cancer
  
• Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00179920 - Active, not recruiting
  Retinoblastoma; Retinal Neoplasms
  
• Chemotherapy Treatment in Re-Occurring NSCLC After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor
  ClinicalTrials.gov Identifier: NCT00356525 - Recruiting
  Lung Neoplasms
  
• Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002793 - Active, not recruiting
  recurrent colon cancer; liver metastases; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003005 - Active, not recruiting
  recurrent adult acute lymphocytic leukemia; TdT positive adult acute lymphocytic leukemia; blastic phase chronic myelogenous leukemia
  
• Chemotherapy with Hematopoietic Stem Cell Support for Children with High Risk Solid Tumors and Lymphomas
  ClinicalTrials.gov Identifier: NCT00152126 - Active, not recruiting
  Neuroblastoma; Central Nervous System Tumors; Lymphomas; Wilms Tumor
  
• Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin’s Disease
  ClinicalTrials.gov Identifier: NCT00352027 - Recruiting
  Hodgkin's Disease
  
• Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma
  ClinicalTrials.gov Identifier: NCT00577629 - Recruiting
  Lymphoma, B-Cell
  
• Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children with Newly Diagnosed Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00025259 - Recruiting
  childhood Hodgkin's lymphoma
  
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00324805 - Recruiting
  Lung Cancer
  
• Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00408408 - Recruiting
  Breast Cancer
  
• Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002700 - Active, not recruiting
  untreated adult acute lymphoblastic leukemia; stage I adult lymphoblastic lymphoma; stage III adult lymphoblastic lymphoma; ...
  
• Chemotherapy With or Without Docetaxel Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004214 - No longer recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00052299 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Chemotherapy With or Without Gene Therapy in Treating Patients With Unresectable Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00040716 - Recruiting
  Head and Neck Cancer
  
• Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003647 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00020501 - Active, not recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Chemotherapy With or Without Monoclonal Antibody in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00012285 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00002819 - Completed
  ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ...
  
• Chemotherapy With or Without Radiation Therapy Before Surgery in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00030771 - Recruiting
  Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer
  
• Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye
  ClinicalTrials.gov Identifier: NCT00360750 - Recruiting
  Retinoblastoma
  
• Chemotherapy With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00043004 - Active, not recruiting
  liver metastases; stage IV colon cancer; Stage IV rectal cancer
  
• Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00024167 - Recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00042887 - Active, not recruiting
  stage 0 bladder cancer; stage I bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
  
• Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00006356 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003695 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer
  
• Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
  ClinicalTrials.gov Identifier: NCT00002610 - Completed
  recurrent Wilms' tumor and other childhood kidney tumors; clear cell sarcoma of the kidney; rhabdoid tumor of the kidney
  
• Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00193141 - Active, not recruiting
  Esophagus Cancer
  
• Chemotherapy With or Without Total-Body Irradiation in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00322101 - Recruiting
  Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002961 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission
  
• Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00023998 - Completed
  metastatic osteosarcoma
  
• Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00014339 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; Quality of Life
  
• Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00402051 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002828 - Completed
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
  ClinicalTrials.gov Identifier: NCT00178802 - Recruiting
  Breast Neoplasms; Endometrial Neoplasms; Cervix Neoplasms; Ovarian Neoplasms
  
• Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003089 - Completed
  stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; Squamous Cell Lung Cancer; ...
  
• Chemotherapy, Biological Therapy, and/or Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00025402 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Chemotherapy, Donor Stem Cell Transplant, and Graft-Versus-Host Disease Prevention in Treating Patients With Advanced Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00520130 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003929 - Active, not recruiting
  AIDS-related primary CNS lymphoma; primary central nervous system lymphoma
  
• Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004172 - Active, not recruiting
  stage IIIB breast cancer; stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer
  
• Chemotherapy, G-CSF, and ABI-007 With or Without Trastuzumab in Treating Women With High-Risk Localized Breast Cancer
  ClinicalTrials.gov Identifier: NCT00407888 - Recruiting
  Breast Cancer
  
• Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00045136 - Active, not recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients with High Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00108290 - Completed
  Prostate Cancer
  
• Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00039377 - Recruiting
  adult acute lymphoblastic leukemia in remission
  
• Chemotherapy, Interferon alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00068575 - Recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002771 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Chemotherapy, Low-Dose Total-Body Irradiation, and Peripheral Stem Cell Transplantation Followed By Chemotherapy and Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003145 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
  
• Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00393068 - Recruiting
  Esophageal Cancer
  
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00551759 - Not yet recruiting
  Esophageal Cancer; Gastric Cancer
  
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00003211 - Completed
  untreated childhood supratentorial primitive neuroectodermal tumors; untreated childhood medulloblastoma
  
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00005092 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer
  
• Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00004169 - Active, not recruiting
  recurrent childhood Hodgkin's disease; recurrent adult Hodgkin's disease
  
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
  ClinicalTrials.gov Identifier: NCT00068406 - Recruiting
  squamous cell carcinoma of the vulva; stage III vulvar cancer; stage IV vulvar cancer
  
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00003799 - Active, not recruiting
  stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer (Pancoast Tumors)
  ClinicalTrials.gov Identifier: NCT00002642 - Active, not recruiting
  stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ...
  
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005065 - Completed
  stage IIIA non-small cell lung cancer
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003270 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003661 - Active, not recruiting
  Leukemia; Lymphoma
  
• Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002634 - Active, not recruiting
  disseminated neuroblastoma; regional neuroblastoma; localized resectable neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Chemotherapy, Radiation Therapy, Peripheral Stem Cell Transplantation, and Immunosuppressive Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00006251 - Active, not recruiting
  Leukemia; Renal Cell Cancer; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
  
• Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00387959 - Recruiting
  Leukemia; Lymphoma
  
• Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00402883 - Recruiting
  Lung Cancer
  
• Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006184 - Recruiting
  Multiple Myeloma
  
• Chemotherapy, Stem Cell Transplantation, and Graft-Versus-Host-Disease Prevention in Treating Patients With Refractory or Relapsed Hematologic Cancer, Myelodysplastic Syndrome, or Myeloproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00055744 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00023738 - Completed
  stage IIC adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage III adult soft tissue sarcoma
  
• Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00003298 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer; stage II gastric cancer; adenocarcinoma of the stomach
  
• Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00025324 - Active, not recruiting
  childhood central nervous system germ cell tumor; adult central nervous system germ cell tumor
  
• Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00033410 - Completed
  stage II non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; ...
  
• Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00053014 - Completed
  adult acute myeloid leukemia in remission; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
  
• Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00425802 - Recruiting
  Leukemia; Lymphoma
  
• Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00024466 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00496613 - Recruiting
  Breast Cancer; Long-Term Survivors
  
• Chemotherapy-Related Toxicities In Ovarian Cancer Patients
  ClinicalTrials.gov Identifier: NCT00508378 - Active, not recruiting
  Ovarian Cancer
  
• CHERL, Connecting Primary Care Patients With Community Resources to Facilitate Behavior Change
  ClinicalTrials.gov Identifier: NCT00269009 - Recruiting
  Tobacco Use; Alcohol Abuse; Lack of Physical Activity; Poor Diet
  
• CHESS Caregivers Study: Web-Based Support for Informal Caregivers in Cancer
  ClinicalTrials.gov Identifier: NCT00214162 - Active, not recruiting
  Breast Cancer; Prostate Cancer
  
• CHESS: Human and Computer Mentors for Prostate Cancer Patients
  ClinicalTrials.gov Identifier: NCT00516256 - Recruiting
  Prostate Cancer
  
• Chest Pain Observation Unit Risk Reduction Trial
  ClinicalTrials.gov Identifier: NCT00536224 - Recruiting
  Chest Pain
  
• Chest Pain Pilot Study
  ClinicalTrials.gov Identifier: NCT00251901 - Completed
  Chest Pain; Gastroesophageal Reflux
  
• Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)
  ClinicalTrials.gov Identifier: NCT00181285 - Recruiting
  Asthma; Chronic Obstructive Pulmonary Disease (COPD); Undifferentiated Asthma/COPD
  
• Chest X-ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006087 - Active, not recruiting
  Small Cell Lung Cancer; screening for lung cancer; Non-small cell lung cancer
  
• Chevron Osteotomy Versus SCARF Osteotomy in the Treatment of Hallux Valgus
  ClinicalTrials.gov Identifier: NCT00455676 - Active, not recruiting
  Hallux Valgus
  
• CHF Management Using Telemedicine
  ClinicalTrials.gov Identifier: NCT00309764 - Completed
  Congestive Heart Failure (CHF)
  
• Chiari Study Looking at Use of Duragen vs Duraguard
  ClinicalTrials.gov Identifier: NCT00565435 - Enrolling by invitation
  Chiari Malformation Type I
  
• Chicago Childhood Diabetes Registry
  ClinicalTrials.gov Identifier: NCT00204009 - Active, not recruiting
  Diabetes Mellitus
  
• Chicken-Diet vs. Enalapril to Reduce Albuminuria
  ClinicalTrials.gov Identifier: NCT00484068 - Completed
  Microalbuminuria; Diabetic Nephropathy
  
• Child & Adolescent Bipolar Disorder Brain Imaging and Treatment Study
  ClinicalTrials.gov Identifier: NCT00006177 - Recruiting
  Healthy
  
• Child and Adolescent Anxiety Disorders (CAMS)
  ClinicalTrials.gov Identifier: NCT00052078 - Active, not recruiting
  Anxiety Disorders
  
• Child and Adolescent Trial for Cardiovascular Health (CATCH)
  ClinicalTrials.gov Identifier: NCT00000467 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis
  
• Child Health Initiative for Lifelong Eating and Exercise (CHILE)
  ClinicalTrials.gov Identifier: NCT00428805 - Recruiting
  Obesity
  
• Child Results Following Preventive Children of Parents With Psychiatric and Addictive Problems (COPP) Groups
  ClinicalTrials.gov Identifier: NCT00184405 - Recruiting
  Child of Impaired Parents
  
• Child With Anomalous Drainage of IVC to Left Atrium
  ClinicalTrials.gov Identifier: NCT00229905 - Terminated
  Anomalous Drainage of the Inferior Vena Cava to the Left Atrium
  
• Child-Parent Psychotherapy for Preschooler Witnesses of Domestic Violence Program
  ClinicalTrials.gov Identifier: NCT00187772 - Completed
  Domestic Violence Exposure
  
• Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
  ClinicalTrials.gov Identifier: NCT00088452 - Active, not recruiting
  Childhood Absence Epilepsy; Petit Mal Epilepsy; Epilepsy; Seizures
  
• Childhood Adenotonsillectomy Study for Children With OSAS
  ClinicalTrials.gov Identifier: NCT00560859 - Recruiting
  Obstructive Sleep Apnea; Snoring
  
• Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression
  ClinicalTrials.gov Identifier: NCT00517764 - Recruiting
  Major Depression
  
• Childhood Asthma Management Program (CAMP) Phases I and II
  ClinicalTrials.gov Identifier: NCT00000575 - Active, not recruiting
  Asthma; Lung Diseases
  
• Childhood Asthma Program in NYC Health Department Clinics
  ClinicalTrials.gov Identifier: NCT00005713 - Completed
  Asthma; Lung Diseases
  
• Childhood Asthma Research and Education (CARE) Network
  ClinicalTrials.gov Identifier: NCT00000622 - Completed
  Asthma; Lung Diseases
  
• Childhood Autism Risks from Genetics and the Environment (The CHARGE Study)
  ClinicalTrials.gov Identifier: NCT00106652 - Recruiting
  Autism; Developmental Disabilities
  
• Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
  ClinicalTrials.gov Identifier: NCT00340522 - Recruiting
  Cancer
  
• Childhood Chronic Illness: An Educational Program for Parents of Children With On-Going Health Care Needs
  ClinicalTrials.gov Identifier: NCT00194584 - Completed
  Chronic Illness
  
• Childhood Hypertonia of Central Origin: an Open Label Trial of Anticholinergic Treatment Effects
  ClinicalTrials.gov Identifier: NCT00122044 - Completed
  pediatric dystonia
  
• Childhood Obesity Treatment Targeting Specific Behaviors
  ClinicalTrials.gov Identifier: NCT00259324 - Active, not recruiting
  Childhood Obesity
  
• Childhood Obesity Treatment: A Maintenance Approach
  ClinicalTrials.gov Identifier: NCT00301197 - Completed
  Obesity
  
• Childhood Obesity: Variations in Management
  ClinicalTrials.gov Identifier: NCT00160914 - Active, not recruiting
  Obesity
  
• Childhood Passive Smoking: Cohort Study of Cardiac Risk
  ClinicalTrials.gov Identifier: NCT00005242 - Completed
  Cardiovascular Diseases; Heart Diseases; Lung Diseases; Coronary Arteriosclerosis
  
• Children and Adolescents Receiving Mechanical and Prosthetic Valves
  ClinicalTrials.gov Identifier: NCT00268008 - Terminated
  Congenital Disorders
  
• Children With Asthma in New Orleans After Hurricane Katrina
  ClinicalTrials.gov Identifier: NCT00426634 - Recruiting
  Asthma; Allergies
  
• Children's Activity and Nutrition III
  ClinicalTrials.gov Identifier: NCT00007111 - Completed
  Cardiovascular Diseases; Hypertension; Coronary Disease
  
• Children's Aid Societies: Differential Response and Wraparound Prevention Trial
  ClinicalTrials.gov Identifier: NCT00559208 - Recruiting
  Children
  
• Children's Exposures/Health Effects/Diesel Exhaust
  ClinicalTrials.gov Identifier: NCT00527345 - Recruiting
  Asthma; Airway Inflammation
  
• Children's Resiliency, Adjustment, and Coping
  ClinicalTrials.gov Identifier: NCT00489632 - Recruiting
  Leukemia
  
• China Case Control Avian Influenza
  ClinicalTrials.gov Identifier: NCT00428753 - Recruiting
  Influenza
  
• China Plant Sterol Trial
  ClinicalTrials.gov Identifier: NCT00145717 - Completed
  Hypercholesterolemia; Cardiovascular Diseases
  
• China Salt Substitute Study
  ClinicalTrials.gov Identifier: NCT00145756 - Completed
  Hypertension; Cardiovascular Diseases
  
• Chinese Community Smoking Cessation Project
  ClinicalTrials.gov Identifier: NCT00139516 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Lung Diseases; Diabetes Mellitus; Chronic Obstructive Pulmonary Disease
  
• Chinese Exercise Modalities in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00029809 - Completed
  Parkinson Disease
  
• CHInese Medicine Neuroaid Efficacy on Stroke Recovery
  ClinicalTrials.gov Identifier: NCT00554723 - Recruiting
  Cerebral Infarct; Stroke
  
• Chinese Versions of the Swanson, Nolan, and Pelham, Version IV (SNAP-IV) Scale and Strengths Difficulties Questionnaire.
  ClinicalTrials.gov Identifier: NCT00491361 - Completed
  Attention-Deficit/Hyperactivity Disorder
  
• CHIPS (Control of Hypertension in Pregnancy Study): A Pilot Trial
  ClinicalTrials.gov Identifier: NCT00187395 - Completed
  Transient Hypertension, Pregnancy
  
• CHIPs or College Health Intervention Projects
  ClinicalTrials.gov Identifier: NCT00244049 - Active, not recruiting
  Alcohol Abuse
  
• CHIR-265 in Treating Patients With Locally Advanced or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00324935 - Recruiting
  Melanoma (Skin)
  
• Chiron Corp HCV E1/E2 Vaccine
  ClinicalTrials.gov Identifier: NCT00500747 - Active, not recruiting
  Hepatitis C
  
• Chiron H9N2 +/- MF59 Adjuvant: Ambulatory Adult Study.
  ClinicalTrials.gov Identifier: NCT00133471 - Active, not recruiting
  Influenza
  
• Chiropractic Adjustment on Physiological Measurements
  ClinicalTrials.gov Identifier: NCT00379873 - Completed
  Healthy
  
• Chiropractic and Exercise for Seniors With Low Back Pain
  ClinicalTrials.gov Identifier: NCT00269321 - Active, not recruiting
  Low Back Pain
  
• Chiropractic and Exercise for Seniors With Neck Pain
  ClinicalTrials.gov Identifier: NCT00269308 - Active, not recruiting
  Neck Pain
  
• Chiropractic and Self-Care for Back-Related Leg Pain
  ClinicalTrials.gov Identifier: NCT00494065 - Recruiting
  Sub-Acute and Chronic Back-Related Leg Pain
  
• Chiropractic Care, Medication, and Self-Care for Neck Pain
  ClinicalTrials.gov Identifier: NCT00029770 - Active, not recruiting
  Neck Pain
  
• Chiropractic Dosage for Lumbar Stenosis
  ClinicalTrials.gov Identifier: NCT00527527 - Recruiting
  Lumbar Spinal Stenosis
  
• Chiropractic Management of Chronic Lower Back Pain in Older Adults
  ClinicalTrials.gov Identifier: NCT00475787 - Not yet recruiting
  Chronic Lower Back Pain
  
• Chiropractic Prone Distraction for Lower Back Pain
  ClinicalTrials.gov Identifier: NCT00269503 - Recruiting
  Sciatica
  
• CHIZAP
  ClinicalTrials.gov Identifier: NCT00148733 - Recruiting
  Pneumonia
  
• Chlamydia and Mycoplasma in Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00561028 - Completed
  Atherosclerosis; Coronary Artery Disease; Chlamydia Infections; Mycoplasma Infections
  
• Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00578188 - Active, not recruiting
  Chlamydia Infection
  
• Chlorambucil Compared With No Further Therapy Following Anti- Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
  ClinicalTrials.gov Identifier: NCT00003617 - Active, not recruiting
  stage I gastric cancer
  
• Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00028691 - Active, not recruiting
  stage III grade 1 follicular lymphoma; stage III grade 2 follicular lymphoma; stage III grade 3 follicular lymphoma; ...
  
• Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00017108 - Active, not recruiting
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates
  ClinicalTrials.gov Identifier: NCT00475930 - Active, not recruiting
  Staphylococcus Aureus; Community-Acquired Infections; Staphylococcal Skin Infections
  
• Chlorhexidine Swabs Effectiveness in Reducing Blood Stream Infections
  ClinicalTrials.gov Identifier: NCT00485992 - Active, not recruiting
  Congenital Disorders
  
• Chlorhexidine Vaginal and Infant Wash in Pakistan
  ClinicalTrials.gov Identifier: NCT00121394 - Recruiting
  Sepsis; Pregnancy
  
• Chlorhexidine Versus Povidone-Iodine for Prevention of Epidural Needle Contamination in the Parturient
  ClinicalTrials.gov Identifier: NCT00223002 - Recruiting
  Asepsis; Analgesia, Epidural; Anesthesia, Epidural
  
• Chlorhexidine vs Povidone Iodine in Alcoholic Solutions for Prevention of Central Venous Catheter Infection
  ClinicalTrials.gov Identifier: NCT00259350 - Completed
  ICU Patients Requiring a Central Venous Access
  
• Chlorhydrate of Ropivacaine and Breast Cancer Surgery
  ClinicalTrials.gov Identifier: NCT00370240 - Active, not recruiting
  Breast Neoplasms; Pain,Postoperative
  
• Chloroquine Alone or in Combination for Malaria in Children in Malawi
  ClinicalTrials.gov Identifier: NCT00379821 - Recruiting
  Plasmodium Falciparum Malaria
  
• Chloroquine and Amodiaquine for Treatment of Malaria in Children.
  ClinicalTrials.gov Identifier: NCT00137514 - Completed
  Malaria, Falciparum
  
• Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau.
  ClinicalTrials.gov Identifier: NCT00426439 - Recruiting
  Malaria, Falciparum
  
• Chloroquine and Post Malaria Anaemia Study
  ClinicalTrials.gov Identifier: NCT00473837 - Not yet recruiting
  Malaria Anaemia
  
• Chloroquine for Treatment of Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00224978 - Completed
  Glioblastoma Multiforme
  
• Chloroquine to Reduce Fatty Deposits in the Arteries of People With Metabolic Syndrome (ARCH-MS)
  ClinicalTrials.gov Identifier: NCT00455403 - Recruiting
  Metabolic Syndrome X; Overweight; Hypertension; Dyslipidemias; Prediabetic State
  
• Chloroquine to Treat People With Metabolic Syndrome (ARCH-MS)
  ClinicalTrials.gov Identifier: NCT00455325 - Recruiting
  Metabolic Syndrome X; Overweight; Hypertension; Dyslipidemias; Prediabetic State
  
• Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00008372 - Completed
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005864 - Completed
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Chlorproguanil-Dapsone in Pregnant Women
  ClinicalTrials.gov Identifier: NCT00126971 - Suspended
  Malaria
  
• Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria
  ClinicalTrials.gov Identifier: NCT00371735 - Completed
  Malaria
  
• Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria
  ClinicalTrials.gov Identifier: NCT00344006 - Completed
  Malaria
  
• Chlorproguanil/Dapsone Compared with Chloroquine and SP for Vivax Malaria
  ClinicalTrials.gov Identifier: NCT00158561 - Completed
  Malaria; Vivax Malaria
  
• Choice of Material for Above-Knee Femoro-Popliteal Bypass Prosthetic Graft (PopUp)
  ClinicalTrials.gov Identifier: NCT00300690 - Completed
  Intermittent Claudication; Critical Limb Ischemia
  
• CHOICE: Carotid Stenting For High Surgical-Risk Patients
  ClinicalTrials.gov Identifier: NCT00406055 - Recruiting
  Carotid Artery Disease
  
• CHOICE: Communicating Health Options Through Information and Cancer Education
  ClinicalTrials.gov Identifier: NCT00134589 - Recruiting
  Colorectal Neoplasms; Rectal Neoplasms; Colonic Polyps
  
• Cholecalciferol (Vitamin D3) Therapy in CKD Subjects
  ClinicalTrials.gov Identifier: NCT00427037 - Completed
  Chronic Kidney Disease; Vitamin D Deficiency
  
• Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00470353 - Recruiting
  Colorectal Cancer
  
• Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00068276 - Completed
  previously treated myelodysplastic syndromes; de novo myelodysplastic syndromes; secondary myelodysplastic syndromes; ...
  
• Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
  ClinicalTrials.gov Identifier: NCT00308776 - Recruiting
  Bulimia Nervosa; Eating Disorders
  
• Cholestanol in Humans
  ClinicalTrials.gov Identifier: NCT00018694 - Completed
  Cerebrotendinous Xanthomatosis
  
• Cholesterol and Pharmacogenetic Study
  ClinicalTrials.gov Identifier: NCT00451828 - Active, not recruiting
  Hyperlipidemia; Hypercholesterolemia; Coronary Heart Disease; Cardiovascular Disease
  
• Cholesterol Homeostasis in Framingham Offspring Study
  ClinicalTrials.gov Identifier: NCT00074464 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Coronary Disease
  
• Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
  ClinicalTrials.gov Identifier: NCT00053599 - Active, not recruiting
  Alzheimer Disease
  
• Cholesterol Lowering Level of an Investigational Drug in Patients with Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease
  ClinicalTrials.gov Identifier: NCT00090168 - Completed
  Hypercholesterolemia; Atherosclerotic Disease; Coronary Disease
  
• Cholesterol Reduction in Seniors Program (CRISP)
  ClinicalTrials.gov Identifier: NCT00000477 - Completed
  Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Heart Diseases; Hypercholesterolemia; Myocardial Ischemia
  
• Cholesterol-Lowering Atherosclerosis Study (CLAS)
  ClinicalTrials.gov Identifier: NCT00000599 - Completed
  Arterial Occlusive Diseases; Cardiovascular Diseases; Carotid Artery Diseases; Cerebral Arteriosclerosis; Cerebrovascular Disorders; ...
  
• Cholesterol-Lowering Effects of Policosanol
  ClinicalTrials.gov Identifier: NCT00288483 - Terminated
  Hypercholesterolemia; Combined Hyperlipidemia
  
• CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners
  ClinicalTrials.gov Identifier: NCT00348751 - Completed
  Decision Support Systems, Clinical
  
• Cholic Acid for Hepatic Steatosis in Lipodystrophy
  ClinicalTrials.gov Identifier: NCT00457639 - Recruiting
  Hepatic Steatosis
  
• Choline Quantification in Breast Cancer by MRS
  ClinicalTrials.gov Identifier: NCT00201487 - Not yet recruiting
  Breast Neoplasms
  
• Chondromodulating Effect of Diacerein in Osteoarthritis of the Hip
  ClinicalTrials.gov Identifier: NCT00451360 - Completed
  Hip Osteoarthritis
  
• CHOOSE : Telithromycin, Acute Bacterial Sinusitis
  ClinicalTrials.gov Identifier: NCT00174694 - Completed
  Sinusitis
  
• Choosing Healthful Interventions
  ClinicalTrials.gov Identifier: NCT00537706 - Recruiting
  Socioeconomic Factors; Low-Income Population; Health Status
  
• CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas
  ClinicalTrials.gov Identifier: NCT00323323 - Recruiting
  Non-Hodgkin's Lymphoma
  
• CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00455897 - Recruiting
  Lymphoma, Non-Hodgkin; Lymphoma, B-Cell; Lymphoma, Diffuse
  
• CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00574730 - Active, not recruiting
  Non-Hodgkins Lymphoma
  
• Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade
  ClinicalTrials.gov Identifier: NCT00280462 - Recruiting
  Ocular Physiology; Regional Blood Flow
  
• Choroidal Blood Flow Response to Hand-Grip Test in Progressive Glaucoma
  ClinicalTrials.gov Identifier: NCT00284440 - Recruiting
  Primary Open Angle Glaucoma
  
• CHP677: I-Metaiodobenzylguanidine (I-MIBG) therapy for refractory neuroblastoma: a Phase II study
  ClinicalTrials.gov Identifier: NCT00013806 - Active, not recruiting
  Neuroblastoma
  
• CHROENDOHNPCC: Early Detection of Pre-Cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome
  ClinicalTrials.gov Identifier: NCT00224601 - Recruiting
  Colorectal Neoplasms, Hereditary Nonpolyposis
  
• Chromium and Insulin Action
  ClinicalTrials.gov Identifier: NCT00283777 - Completed
  Type 2 Diabetes
  
• Chromium Effects in Impaired Glucose Tolerance
  ClinicalTrials.gov Identifier: NCT00067626 - Active, not recruiting
  Obesity
  
• Chromium Picolinate for the Treatment of Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00128154 - Completed
  Metabolic Syndrome X; Prediabetic State; Insulin Resistance; Obesity; Metabolic Diseases
  
• Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening.
  ClinicalTrials.gov Identifier: NCT00245492 - Recruiting
  Colon Cancer; Polyp; Adenoma
  
• Chromoendoscopy for Ulcerative Colitis Surveillance
  ClinicalTrials.gov Identifier: NCT00274209 - Recruiting
  Ulcerative Colitis
  
• Chromogranin-A-Derived Peptides and Periodontitis in Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00399620 - Not yet recruiting
  Periodontitis and Diabetitis
  
• Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia
  ClinicalTrials.gov Identifier: NCT00352404 - Completed
  Ulcerative Colitis; Intraepithelial Neoplasia; Cancer
  
• Chromosomal and Morphological Structure of Mature and Immature Male Germ Cells and Recognition of IL-18 in Testicular Tissue of Azoospermic Men
  ClinicalTrials.gov Identifier: NCT00544089 - Completed
  Infertility
  
• Chromosome 18 Clinical Research Center
  ClinicalTrials.gov Identifier: NCT00227253 - Recruiting
  Chromosome Aberrations; Growth Hormone Deficiency; Delayed Myelination
  
• Chromosome 5Q Gene Variants and Asthma-Related Traits
  ClinicalTrials.gov Identifier: NCT00006511 - Completed
  Asthma; Lung Diseases
  
• Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib
  ClinicalTrials.gov Identifier: NCT00461929 - Recruiting
  Chronic Myeloid Leukemia; Gastrointestinal Stromal Cell Tumors; Chromosome Abnormality
  
• Chronic and Acute Effects of Smoking on the Left and Right Ventricular Relaxation in Young Healthy Smokers
  ClinicalTrials.gov Identifier: NCT00395928 - Completed
  Cardiovascular Diseases
  
• Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
  ClinicalTrials.gov Identifier: NCT00001301 - Completed
  Lymphoma, Non-Hodgkin
  
• Chronic Bronchiolitis or Resistant Asthma?
  ClinicalTrials.gov Identifier: NCT00368342 - Completed
  Asthma
  
• Chronic Electrical Stimulation of the Auditory Cortex for Intractable Tinnitus
  ClinicalTrials.gov Identifier: NCT00486577 - Not yet recruiting
  Hearing Disorders; Hearing Loss; Hyperacusis; Tinnitus
  
• Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario
  ClinicalTrials.gov Identifier: NCT00235326 - Recruiting
  Participants Must Be Residents of Walkerton, Ontario Region at the Time of Outbreak
  
• Chronic Heart Failure - Cheyne Stokes Respiration - CS2 (3C-Study)
  ClinicalTrials.gov Identifier: NCT00563693 - Recruiting
  Heart Failure; Cheyne Stokes Respiration
  
• Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)
  ClinicalTrials.gov Identifier: NCT00418041 - Recruiting
  Heart Failure; Coronary Disease; Heart Valve Diseases; Cardiomyopathies; Left Ventricular Hypertrophy
  
• Chronic Hemodialysis Without Systemic Heparinization : a Randomized Study
  ClinicalTrials.gov Identifier: NCT00473109 - Recruiting
  Contra-Indication to the Use of Low Molecular Weight Heparin
  
• Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine
  ClinicalTrials.gov Identifier: NCT00310336 - Recruiting
  Hepatitis C
  
• Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)
  ClinicalTrials.gov Identifier: NCT00158496 - Completed
  Chronic Hepatitis C
  
• Chronic Illness Care Management (CICM) Study In Primary Care
  ClinicalTrials.gov Identifier: NCT00153829 - Completed
  Chronic Illness; Quality of Life
  
• Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Severe Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00510705 - Recruiting
  Severe Coronary Artery Disease; Adiposity; Impaired Glucose Tolerance
  
• Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00510588 - Recruiting
  Stable Coronary Artery Disease; Adipostiy; Impaired Glucose Tolerance
  
• Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)
  ClinicalTrials.gov Identifier: NCT00327860 - Recruiting
  Chronic Kidney Disease
  
• Chronic Life Stress and Incident Asthma in Adult Women
  ClinicalTrials.gov Identifier: NCT00006498 - Completed
  Asthma; Lung Diseases
  
• Chronic Low Back Pain Research Project
  ClinicalTrials.gov Identifier: NCT00108550 - Recruiting
  Low Back Pain
  
• Chronic Obstructive Pulmonary Disease and Weaning From Mechanical Ventilation in Difficult to Wean Patients
  ClinicalTrials.gov Identifier: NCT00355732 - Completed
  Respiratory Failure
  
• Chronic Obstructive Pulmonary Disease Endpoints Study
  ClinicalTrials.gov Identifier: NCT00358358 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease
  
• Chronic Obstructive Pulmonary Disease Gene Localization
  ClinicalTrials.gov Identifier: NCT00037739 - Completed
  Lung Diseases; Chronic Obstructive Pulmonary Disease
  
• Chronic Pain after Amputation
  ClinicalTrials.gov Identifier: NCT00006427 - Active, not recruiting
  Amputation, Traumatic; Pain; Postoperative Pain
  
• Chronic Pain After Inguinal Herniorrhaphy
  ClinicalTrials.gov Identifier: NCT00226161 - Recruiting
  Inguinal Hernia
  
• Chronic Pain in Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00006428 - Completed
  Spinal Cord Injuries; Pain
  
• Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034
  ClinicalTrials.gov Identifier: NCT00358384 - Terminated
  Plaque Psoriasis
  
• Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?
  ClinicalTrials.gov Identifier: NCT00269464 - Completed
  Schizophrenia; Obsessive Compulsive Disorder
  
• Chronic Sildenafil for Severe Diaphragmatic Hernia
  ClinicalTrials.gov Identifier: NCT00133679 - Recruiting
  Hernia, Diaphragmatic; Hypertension, Pulmonary; Hypoplasia, Lung
  
• Chronic Sleep Deprivation as a Risk Factor for Metabolic Syndrome and Obesity
  ClinicalTrials.gov Identifier: NCT00261898 - Recruiting
  Obesity; Chronic Sleep Deprivation
  
• Chronic Sleep Restriction and Driving
  ClinicalTrials.gov Identifier: NCT00560456 - Not yet recruiting
  Sleep Deprivation
  
• Chronic Stress as a Risk Factor in the Etiology of Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005352 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer
  ClinicalTrials.gov Identifier: NCT00006198 - Active, not recruiting
  Liver Cancer
  
• Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00446810 - Recruiting
  Diabetes Mellitus, Type 2
  
• Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00568542 - Recruiting
  Ischemic Cardiomyopathy
  
• Chronic-Dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics
  ClinicalTrials.gov Identifier: NCT00308685 - Completed
  Asthma
  
• Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-MDI In Pediatric Asthmatics
  ClinicalTrials.gov Identifier: NCT00577655 - Recruiting
  Asthma
  
• ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00385021 - Terminated
  Colorectal Neoplasms
  
• Chronos: the Use of Chronobiological Treatment in Depression
  ClinicalTrials.gov Identifier: NCT00149110 - Recruiting
  Major depression
  
• Chrysalis Day Program Body Mass Index Study
  ClinicalTrials.gov Identifier: NCT00202215 - Completed
  Borderline Personality Disorder; Eating Disorders
  
• CHS 828 in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003979 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
  ClinicalTrials.gov Identifier: NCT00400075 - Active, not recruiting
  Polyarteritis Nodosa; Microscopic Polyangiitis
  
• CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors
  ClinicalTrials.gov Identifier: NCT00399399 - Active, not recruiting
  Churg-Strauss Syndrome
  
• Chylothorax Following Heart Surgery
  ClinicalTrials.gov Identifier: NCT00215098 - Terminated
  Chylothorax
  
• CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00033384 - Completed
  Lung Cancer; Pancreatic Cancer; Colorectal Cancer; Colon Cancer; Breast Cancer
  
• CI-994 in Treating Patients With Advanced Myeloma
  ClinicalTrials.gov Identifier: NCT00005624 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Ciclosporin A and Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00403728 - Active, not recruiting
  Myocardial Infarction
  
• Cidofovir and BKVN in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00138424 - Recruiting
  BK virus (nephropathy)
  
• Cidofovir as a Treatment for Herpes Simplex in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002181 - Completed
  Herpes Simplex; HIV Infections
  
• Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus
  ClinicalTrials.gov Identifier: NCT00550589 - Recruiting
  Precancerous/Nonmalignant Condition
  
• CIFN and IFN γ-1b with or without Ribavirin for treatment of Chronic Hepatitis C (nonresponders)
  ClinicalTrials.gov Identifier: NCT00084279 - Completed
  Chronic Hepatitis C
  
• Cigarette Smoke Nasal and Whole Blood Challenge in Patients with COPD
  ClinicalTrials.gov Identifier: NCT00159341 - Recruiting
  Lung Diseases, Obstructive
  
• Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
  ClinicalTrials.gov Identifier: NCT00093964 - Active, not recruiting
  Glioblastoma Multiforme
  
• Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00077155 - Recruiting
  adult solid tumor; Leukemia; Lymphoma
  
• Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00085254 - Recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Cilengitide in Treating Children With Refractory Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00063973 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood spinal cord tumors
  
• Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00112866 - Active, not recruiting
  recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma; adult glioblastoma
  
• Cilengitide in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00089388 - Completed
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Cilengitide in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00103337 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer
  
• Cilengitide in Treating Patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00121238 - Recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Cilengitide in Treating Patients with Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00119288 - Recruiting
  adult giant cell glioblastoma; adult gliosarcoma; recurrent adult brain tumor
  
• Cilengitide in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00103064 - Recruiting
  recurrent adult brain tumor; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00082875 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma
  
• Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00325637 - Recruiting
  Hypertension; Stroke
  
• Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
  ClinicalTrials.gov Identifier: NCT00272129 - Not yet recruiting
  Cerebral Infarction
  
• Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
  ClinicalTrials.gov Identifier: NCT00272454 - Recruiting
  Cerebral Infarction
  
• Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis
  ClinicalTrials.gov Identifier: NCT00333164 - Recruiting
  Cerebrovascular Disorders
  
• Cimicoxib for the Treatment of Major Depression (SECIM)
  ClinicalTrials.gov Identifier: NCT00510822 - Not yet recruiting
  Major Depression
  
• Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
  ClinicalTrials.gov Identifier: NCT00446329 - Recruiting
  Secondary Hyperparathyroidism
  
• Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis
  ClinicalTrials.gov Identifier: NCT00094484 - Completed
  Kidney Diseases; Chronic Disease
  
• Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
  ClinicalTrials.gov Identifier: NCT00113958 - Completed
  ESRD
  
• Cinacalcet to Treat Familial Primary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00325104 - Completed
  Hypercalcemia; Familial Primary Hyperparathyroidism
  
• Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00415584 - Recruiting
  Secondary Hyperparathyroidism; Hypercalcemia
  
• CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00176462 - Recruiting
  Acute Lymphocytic Leukemia
  
• CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00372216 - Recruiting
  Myocardial Infarction
  
• Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain
  ClinicalTrials.gov Identifier: NCT00227292 - Not yet recruiting
  Low Back Pain; Depression
  
• Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003824 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage 0 bladder cancer; recurrent bladder cancer
  
• Circadian Regulation of Sleep in Habitual Short Sleepers and Long Sleepers
  ClinicalTrials.gov Identifier: NCT00001546 - Completed
  Sleep Disorders
  
• Circadian Rhythms and Sleep in Familial Delayed Sleep Phase Syndrome (DSPS) and Advanced Sleep Phase Syndrome (ASPS)
  ClinicalTrials.gov Identifier: NCT00246454 - Recruiting
  Sleep
  
• Circadian Rhythms of Aqueous Humor Dynamics in Humans
  ClinicalTrials.gov Identifier: NCT00572936 - Recruiting
  Glaucoma
  
• Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity
  ClinicalTrials.gov Identifier: NCT00178230 - Suspended
  Lung Neoplasms
  
• Circulating Tumor Cells and Survival in HRPC Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00133900 - Active, not recruiting
  Hormone Refractory Prostate Cancer
  
• Circulating Tumor Cells in Patients with Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00133913 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
  ClinicalTrials.gov Identifier: NCT00358878 - Active, not recruiting
  Ascites; Liver Cirrhosis
  
• Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00318890 - Completed
  Cancer of Head and Neck; Head Cancer; Head and Neck Cancer; Neck Cancer; Neck Neoplasms
  
• Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00113386 - Active, not recruiting
  stage IIIA non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer; Squamous Cell Lung Cancer; ...
  
• Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
  ClinicalTrials.gov Identifier: NCT00002472 - Active, not recruiting
  childhood central nervous system germ cell tumor; extragonadal germ cell tumor; adult central nervous system germ cell tumor; ...
  
• Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors or Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00423865 - Recruiting
  Head and Neck Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00083122 - Recruiting
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
  
• Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00054626 - Recruiting
  stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
  
• Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00003182 - Active, not recruiting
  Salivary Gland Cancer; Oral Cancer; Lip Cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003358 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; ...
  
• Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00016367 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00072215 - Active, not recruiting
  extragonadal germ cell tumor; Testicular Cancer
  
• Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
  ClinicalTrials.gov Identifier: NCT00215995 - Terminated
  Esophageal Cancer; Gastric Cancer
  
• Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00072527 - Active, not recruiting
  limited stage small cell lung cancer
  
• Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00003055 - Completed
  Esophageal Cancer; Gastric Cancer; Carcinoma, Squamous Cell
  
• Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00002932 - Active, not recruiting
  stage IV squamous cell carcinoma of the larynx; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Cisplatin and Radiation Therapy With or Without Erlotinib in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00410826 - Recruiting
  Head and Neck Cancer
  
• Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00085631 - Recruiting
  Cervical Cancer
  
• Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00262821 - Recruiting
  Cervical Cancer; Ovarian Germ Cell Tumor
  
• Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00360945 - Active, not recruiting
  Brain and Central Nervous System Tumors
  
• Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00185835 - Active, not recruiting
  Head and Neck Cancer; Carcinoma, Squamous Cell
  
• Cisplatin as First Line Therapy for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker Response
  ClinicalTrials.gov Identifier: NCT00483223 - Recruiting
  Breast Cancer
  
• Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00045162 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Cisplatin Combined with Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00008112 - Active, not recruiting
  cervical squamous cell carcinoma; cervical adenocarcinoma; stage IIB cervical cancer; stage III cervical cancer; ...
  
• Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement
  ClinicalTrials.gov Identifier: NCT00507962 - Recruiting
  Advanced Cancer
  
• Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00314678 - Completed
  Epithelial Ovarian Cancer; Primary Peritoneal Cancer
  
• Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
  ClinicalTrials.gov Identifier: NCT00079079 - Recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003108 - Completed
  unspecified adult solid tumor, protocol specific
  
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002659 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003299 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003264 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00022191 - Active, not recruiting
  stage IV bladder cancer; transitional cell carcinoma of the bladder; urethral cancer associated with invasive bladder cancer; ...
  
• Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003345 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; ...
  
• Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00017459 - Completed
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00491127 - Completed
  Non-Hodgkin's Lymphoma
  
• Cisplatin With or Without LY231514 in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00005636 - Completed
  recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma
  
• Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003809 - Completed
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
  ClinicalTrials.gov Identifier: NCT00004920 - Active, not recruiting
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00268450 - Recruiting
  Bladder Cancer
  
• Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00423930 - Recruiting
  Head and Neck Cancer
  
• Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00509561 - Not yet recruiting
  Esophageal Cancer
  
• Cisplatin, Carboplatin, and Oxaliplatin Interactions with Plasma Proteins
  ClinicalTrials.gov Identifier: NCT00131586 - Recruiting
  -lung and colorectal cancer
  
• Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00079040 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00083161 - Recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00066222 - Active, not recruiting
  limited stage small cell lung cancer
  
• Cisplatin, Etoposide, and Two Different Schedules of Radiation Therapy in Treating Patients With Limited Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00433563 - Not yet recruiting
  Lung Cancer
  
• Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer
  ClinicalTrials.gov Identifier: NCT00324415 - Recruiting
  Anal Cancer
  
• Cisplatin, Fluorouracil, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00352105 - Active, not recruiting
  Head and Neck Cancer
  
• Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
  ClinicalTrials.gov Identifier: NCT00234494 - Recruiting
  Bladder Cancer
  
• Cisplatin, Gemcitabine, Interferon alfa, and Hyperthermia in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00004063 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
  localized malignant mesothelioma
  
• Cisplatin, Irinotecan, and Bevacizumab in Treating Patients with Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00118235 - Active, not recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00316862 - Recruiting
  Esophageal Cancer
  
• Cisplatin, Metronomic Low-Dose Interferon alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00082862 - Recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00006118 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
  
• Cisplatin, Paclitaxel, Radiation Therapy, and Surgery in Treating Patients With Advanced Cancer of the Oral Cavity, Oropharynx, or Hypopharynx That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00566540 - Not yet recruiting
  Head and Neck Cancer
  
• Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00295503 - Recruiting
  Mesothelioma
  
• Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00301808 - Recruiting
  Lung Cancer
  
• Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00309972 - Recruiting
  Lung Cancer
  
• Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
  ClinicalTrials.gov Identifier: NCT00304070 - Recruiting
  Adrenocortical Carcinoma
  
• Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022217 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00216125 - Completed
  Non-Small Cell Lung Cancer
  
• Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00417248 - Recruiting
  Non-Small Cell Lung Cancer
  
• Cisptain, CPT-11 and Celecoxib with Radiation Therapy and Surgery for Operable Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00137852 - Active, not recruiting
  Resectable Esophageal Cancer
  
• CIT-HD: Study in Huntington's Disease
  ClinicalTrials.gov Identifier: NCT00271596 - Recruiting
  Huntington Disease; Chorea
  
• Citalopram for Children with Autism and Repetitive Behavior
  ClinicalTrials.gov Identifier: NCT00086645 - Completed
  Autism; Autistic Disorder; Asperger Syndrome; Pervasive Developmental Disorder; PDD
  
• Citalopram in Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00477165 - Recruiting
  Irritable Bowel Syndrome
  
• Citalopram in Treating Postmenopausal Women With Hot Flashes
  ClinicalTrials.gov Identifier: NCT00363909 - Active, not recruiting
  Breast Cancer; Hot Flashes; Psychosocial Effects/Treatment
  
• Citrate Anticoagulation vs. Heparin-Coated Dialyzers
  ClinicalTrials.gov Identifier: NCT00395824 - Completed
  Dialysis
  
• Citrate Effects and Bone Density in Long-Term Apheresis Donors
  ClinicalTrials.gov Identifier: NCT00073060 - Recruiting
  Blood Component Removal
  
• Citrate Versus Heparin Anticoagulation in Continuous Venovenous Hemofiltration
  ClinicalTrials.gov Identifier: NCT00209378 - Recruiting
  Kidney Failure
  
• Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00201214 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital
  
• Citrulline:a Plasmatic Marker to Assess and Monitor Small Bowel Crohn''s Disease Patients
  ClinicalTrials.gov Identifier: NCT00138879 - Completed
  Crohn''s Disease; Short Bowel Syndrome; Granulomatous Enteritis; Malabsorption Syndrome; Celiac Disease
  
• Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial
  ClinicalTrials.gov Identifier: NCT00133822 - Active, not recruiting
  Post-Traumatic Stress Disorder
  
• CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
  ClinicalTrials.gov Identifier: NCT00183092 - Recruiting
  Creutzfeldt-Jakob Disease
  
• Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00072007 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Cladribine in Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00002879 - Active, not recruiting
  noncontiguous stage II mantle cell lymphoma; stage IV mantle cell lymphoma; recurrent mantle cell lymphoma; contiguous stage II mantle cell lymphoma; ...
  
• Cladribine, Cytarabine and Idarubicin in Patients with Relapsed Acute Myelocytic Leukemia (AML)
  ClinicalTrials.gov Identifier: NCT00126321 - Recruiting
  Leukemia, Myelocytic, Acute
  
• Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00258271 - Recruiting
  Leukemia
  
• Clarification(Fine-Tuning) of a Tool of Neurological Prediction of the Patients in the Coma by Multimodal MRI
  ClinicalTrials.gov Identifier: NCT00577954 - Recruiting
  Coma
  
• Clarithromycin in Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00269386 - Recruiting
  Crohn's Disease
  
• Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00367913 - Completed
  Pulmonary Diseases
  
• CLARITY - Safety and Efficacy of Oral Cladribine in Subjects With Relapsing-Remitting MS
  ClinicalTrials.gov Identifier: NCT00213135 - Active, not recruiting
  Relapsing Remitting MS
  
• CLASSIC - Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00411229 - Recruiting
  Stomach Neoplasms
  
• Classical conditioning to treat allergic airway diseases
  ClinicalTrials.gov Identifier: NCT00032526 - Recruiting
  Allergic airway disease
  
• Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00184366 - Recruiting
  Plaque Psoriasis
  
• Classification of Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00228722 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Classification of Cerebral Palsy Subtypes
  ClinicalTrials.gov Identifier: NCT00072800 - Completed
  Cerebral Palsy
  
• Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
  ClinicalTrials.gov Identifier: NCT00466791 - Completed
  Attention Deficit Disorder With Hyperactivity
  
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)
  ClinicalTrials.gov Identifier: NCT00132743 - Recruiting
  Cardiovascular Diseases; Peripheral Vascular Diseases; Atherosclerosis
  
• Clazosentan in Preventing the Occurrence of Cerebral Vasospasm following an Aneurysmal Subarachnoid Hemorrhage (aSAH)
  ClinicalTrials.gov Identifier: NCT00111085 - Completed
  Vasospasm following subarachnoid hemorrhage; Aneurysmal Subarachnoid Hemorrhage; Intracranial Vasospasm
  
• Clazosentan in Reducing Vasospasm-Related Morbidity and All-Cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping
  ClinicalTrials.gov Identifier: NCT00558311 - Recruiting
  Aneurysmal Subarachnoid Hemorrhage
  
• Cleaning of the Nose After Sinus Surgery: Necessary or Only Bothersome?
  ClinicalTrials.gov Identifier: NCT00184392 - Active, not recruiting
  Acute Recurrent Rhinosinusitis
  
• Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response
  ClinicalTrials.gov Identifier: NCT00159926 - Terminated
  Systemic Inflammatory Response Syndrome; Coronary Arteriosclerosis
  
• CLEAR ADL: Effectiveness of Cylos Pacemaker With Closed Loop Stimulation Rate Adaption Technology Over Both Standard Rate Responsive Technology and Non-Rate Responsive Modes
  ClinicalTrials.gov Identifier: NCT00355797 - Recruiting
  Bradycardia
  
• CLEAR Study: Clinical Experience Acquired With Raptiva Study
  ClinicalTrials.gov Identifier: NCT00256139 - Completed
  Moderate to Severe Psoriasis
  
• Cleft Palate Surgery and Speech Development
  ClinicalTrials.gov Identifier: NCT00004639 - Active, not recruiting
  Cleft Lip; Cleft Palate
  
• Clevelox in the Perioperative Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00093912 - Completed
  Hypertension
  
• Clevelox in the Postoperative Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00093925 - Completed
  Hypertension
  
• Clevelox in the Preoperative Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00093886 - Completed
  Hypertension
  
• Clevidipine in the Treatment of Patients With Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00369837 - Completed
  Hypertension
  
• Cliavist in Infectious and Degenerative Diseases of the Spine
  ClinicalTrials.gov Identifier: NCT00372281 - Recruiting
  Spine Infection
  
• Client Centred 'Tune-Ups': do They Enhance Community Reintegration After Stroke?
  ClinicalTrials.gov Identifier: NCT00400712 - Not yet recruiting
  Stroke
  
• Clinical & Web-Based Diet & Activity Counseling for Men
  ClinicalTrials.gov Identifier: NCT00412633 - Active, not recruiting
  Obesity
  
• Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI
  ClinicalTrials.gov Identifier: NCT00412126 - Completed
  Diabetes Mellitus; Coronary Restenosis
  
• Clinical and Basic Investigations into Hermansky-Pudlak Syndrome
  ClinicalTrials.gov Identifier: NCT00001456 - Recruiting
  Albinism; Intestinal Disease; Kidney Disease; Myocardial Disease; Pulmonary Fibrosis
  
• Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Type 2 Diabetes Patients
  ClinicalTrials.gov Identifier: NCT00444899 - Recruiting
  Type 2 Diabetes
  
• Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards
  ClinicalTrials.gov Identifier: NCT00431483 - Recruiting
  Bacterial Infections
  
• Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest (ICEREA Study)
  ClinicalTrials.gov Identifier: NCT00392639 - Recruiting
  Hypothermia; Heart Arrest
  
• Clinical and Genetic Analysis of Inner Ear Malformations
  ClinicalTrials.gov Identifier: NCT00023036 - Recruiting
  Sensorineural Hearing Loss; Cytomegalovirus Infection
  
• Clinical and Genetic Studies in Families With Myopia and Related Diseases
  ClinicalTrials.gov Identifier: NCT00272376 - Recruiting
  Myopia
  
• Clinical and Genetic Studies of Familial Exudative Vitreoretinopathy
  ClinicalTrials.gov Identifier: NCT00106756 - Recruiting
  Exudatiaon; Avascular Retina; Retina Fold
  
• Clinical and Genetic Studies of Familial Presenile Dementia with Neuronal Inclusion Bodies
  ClinicalTrials.gov Identifier: NCT00006176 - Recruiting
  Familial Dementia with Neuroserpin Inclusion Bodies; Nervous System Heredodegenerative Disorder
  
• Clinical and Genetic Studies of Families with Congenital or Hereditary Cataracts
  ClinicalTrials.gov Identifier: NCT00056771 - Recruiting
  Cataract
  
• Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis
  ClinicalTrials.gov Identifier: NCT00055029 - Recruiting
  Retinoschisis
  
• Clinical and Genetic Studies on Holoprosencephaly
  ClinicalTrials.gov Identifier: NCT00088426 - Recruiting
  Holoprosencephaly
  
• Clinical and Genetic Study of Autism Spectrum Disorder
  ClinicalTrials.gov Identifier: NCT00494754 - Recruiting
  Autism
  
• Clinical and Immunological Evaluation of Children with Allergies
  ClinicalTrials.gov Identifier: NCT00102570 - Recruiting
  
  
• Clinical and Immunological Investigations of Subtypes of Autism
  ClinicalTrials.gov Identifier: NCT00298246 - Recruiting
  Autism
  
• Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
  ClinicalTrials.gov Identifier: NCT00512564 - Not yet recruiting
  Sickle Cell Anemia; Sickle Cell Thalassemia
  
• Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren's Syndrome
  ClinicalTrials.gov Identifier: NCT00565526 - Recruiting
  Sjogren's Syndrome; Dysautonomia
  
• Clinical and Laboratory Study of Methylmalonic Acidemia
  ClinicalTrials.gov Identifier: NCT00078078 - Recruiting
  Amino Acid Metabolism; Inborn Errors
  
• Clinical and Molecular Characterization of Familial Microsatellite Stable Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00220246 - Active, not recruiting
  Colorectal Neoplasms
  
• Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
  ClinicalTrials.gov Identifier: NCT00004306 - Recruiting
  Hereditary Ataxia
  
• Clinical and Molecular Studies in Families With Glaucoma and Related Diseases
  ClinicalTrials.gov Identifier: NCT00272363 - Recruiting
  Glaucoma
  
• Clinical and Molecular-Metabolic Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
  ClinicalTrials.gov Identifier: NCT00400920 - Recruiting
  Malignant Glioma; Glioblastoma Multiforme; Glioma
  
• Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood
  ClinicalTrials.gov Identifier: NCT00550667 - Not yet recruiting
  Attention Deficit Disorder With Hyperactivity
  
• Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00398177 - Recruiting
  Non-Hodgkin Lymphoma; Hodgkin Lymphoma
  
• Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
  ClinicalTrials.gov Identifier: NCT00398372 - Recruiting
  Non-Hodgkin Lymphoma
  
• Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00483106 - Recruiting
  ADHD
  
• Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan
  ClinicalTrials.gov Identifier: NCT00183859 - Recruiting
  Adenocarcinoma; Gastric Cancer
  
• Clinical and Quality of Life Outcomes After Open or Laparoscopic Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00578123 - Recruiting
  Prostate Cancer; Quality of Life
  
• Clinical and Radiographic Study of Polished/Non-Polished Collared/Collarless Stems in Total Hip Replacement
  ClinicalTrials.gov Identifier: NCT00208351 - Recruiting
  Osteoarthritis, Hip
  
• Clinical Application of MDCT in Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00155012 - Recruiting
  Coronary Arteriosclerosis
  
• Clinical Applications and Evaluations of A Portable In-Shoe Plantar Pressure Monitoring and Biofeedback Gait System for Ambulation Training in Stroke Rehabilitation
  ClinicalTrials.gov Identifier: NCT00167076 - Active, not recruiting
  Stroke
  
• Clinical Applications for Time-Compressed Speech Tests
  ClinicalTrials.gov Identifier: NCT00371839 - Not yet recruiting
  Hearing Loss
  
• Clinical Approaches to Ileal Pouch Dysfunction
  ClinicalTrials.gov Identifier: NCT00293553 - Recruiting
  Pouchitis
  
• Clinical Assessment of an in-Patient Glucose Monitoring System (Accu-Chek Inform Cobas IT 1000)
  ClinicalTrials.gov Identifier: NCT00486681 - Recruiting
  Diabetes Mellitus; Blood Glucose; Hospital Information Systems; Medical Device
  
• Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00530309 - Recruiting
  Type 2 Diabetes Mellitus
  
• Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00448435 - Active, not recruiting
  Bronchial Asthma
  
• Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma -A Long Term (24-Week) Study-
  ClinicalTrials.gov Identifier: NCT00449046 - Active, not recruiting
  Bronchial Asthma
  
• Clinical Assessment of the Total Vaginal Mesh Technique for Treatment of Genital Prolapse
  ClinicalTrials.gov Identifier: NCT00196495 - Completed
  Vaginal Prolapse
  
• Clinical Assessment of Two Manipulative Protocols in Treatment of Hip Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00523172 - Not yet recruiting
  Osteoarthritis, Hip
  
• Clinical Benefit of CBT for Insomnia in Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00134108 - Active, not recruiting
  Insomnia; Cancer
  
• Clinical Benefit of CBT for Insomnia in Primary Care
  ClinicalTrials.gov Identifier: NCT00170417 - Completed
  Insomnia
  
• Clinical Benefit of Topoisomerase Downregulation
  ClinicalTrials.gov Identifier: NCT00250094 - Completed
  Ovarian Cancer
  
• Clinical Cardiovascular Outcomes of African-Americans
  ClinicalTrials.gov Identifier: NCT00005429 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Clinical Comparison of RPDs Retained by Conical and Galvanoformed Double Crowns.
  ClinicalTrials.gov Identifier: NCT00176215 - Active, not recruiting
  Denture, Partial, Removable; Dental Prosthesis Retention; Oral Health; Tooth Abrasion
  
• Clinical Comparison of the LTS-D, ETC and Proseal Laryngeal Mask Airway
  ClinicalTrials.gov Identifier: NCT00581386 - Recruiting
  Intubation; Endotracheal
  
• Clinical Confirmation of a Pharmacodynamic Interaction Between Tropisetron and Paracetamol
  ClinicalTrials.gov Identifier: NCT00487110 - Not yet recruiting
  Pain
  
• Clinical Course of Coronary Artery Disease Among Blacks
  ClinicalTrials.gov Identifier: NCT00005191 - Completed
  Cardiovascular Diseases; Coronary Disease; Myocardial Infarction; Heart Diseases
  
• Clinical Decision Unit (CDU) - Evaluation of a Novel Approach to Address Emergency Department Overcrowding
  ClinicalTrials.gov Identifier: NCT00497393 - Recruiting
  Acute Illness
  
• Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizioaffective Disorder
  ClinicalTrials.gov Identifier: NCT00137020 - Completed
  Schizophrenia; Psychotic Disorders
  
• Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00561392 - Recruiting
  Alzheimer's Disease
  
• Clinical Effectiveness of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00401622 - Recruiting
  Diabetes Mellitus, Type 2
  
• Clinical Effectiveness of Topical Autologous Platelet Gel for the Treatment of Venous Ulcers
  ClinicalTrials.gov Identifier: NCT00273234 - Not yet recruiting
  Venous Ulcer
  
• Clinical Effects of a Nucleotides-Supplemented Infant Formula
  ClinicalTrials.gov Identifier: NCT00292812 - Completed
  Nutritional Requirements
  
• Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1
  ClinicalTrials.gov Identifier: NCT00228865 - Completed
  Diabetes Mellitus
  
• Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00571285 - Recruiting
  Parkinson's Disease
  
• Clinical Efficacy and Safety of Axiom Worldwide DRX9000 Axial Decompression System for Treatment of Low Back Pain
  ClinicalTrials.gov Identifier: NCT00469118 - Not yet recruiting
  Low Back Pain
  
• Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF
  ClinicalTrials.gov Identifier: NCT00378001 - Completed
  Infertility
  
• Clinical Efficacy of a Cephalic Mask for Noninvasive Ventilation During Acute Hypercapnic Respiratory Failure
  ClinicalTrials.gov Identifier: NCT00213395 - Terminated
  Acute Hypercapnic Respiratory Failure
  
• Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers
  ClinicalTrials.gov Identifier: NCT00580827 - Completed
  Cocaine-Related Disorder; Opiate Dependence
  
• Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
  ClinicalTrials.gov Identifier: NCT00543608 - Recruiting
  Hospital-Acquired Pneumonia; Ventilator-Associated Pneumonia; Health-Care-Associated Pneumonia
  
• Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing
  ClinicalTrials.gov Identifier: NCT00549744 - Not yet recruiting
  Mild Asthma
  
• Clinical Epidemiology of Asthma in An HMO
  ClinicalTrials.gov Identifier: NCT00005291 - Completed
  Asthma; Lung Diseases
  
• Clinical Estradiol Trial in Women With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00206570 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
  
• Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System
  ClinicalTrials.gov Identifier: NCT00026871 - Completed
  Neoplasm
  
• Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma
  ClinicalTrials.gov Identifier: NCT00148213 - Completed
  Thyroid Neoplasms
  
• Clinical Evaluation of a New Reduced Volume Bowel Preparation
  ClinicalTrials.gov Identifier: NCT00321230 - Completed
  Colonoscopy
  
• Clinical Evaluation of a Wheelchair Mounted Robotic Arm
  ClinicalTrials.gov Identifier: NCT00011609 - Completed
  Spinal Cord Injury
  
• Clinical Evaluation of a Wireless Monitoring Device to Reduce Falls in the Elderly and Others at High Risk of Falling
  ClinicalTrials.gov Identifier: NCT00249743 - Completed
  Accidental Falls; Fractures; Injuries
  
• Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid
  ClinicalTrials.gov Identifier: NCT00331045 - Active, not recruiting
  Cancer; Constipation
  
• Clinical Evaluation of Bacitracin. A Phase II Dose-Response Study.
  ClinicalTrials.gov Identifier: NCT00132600 - Completed
  Allergic Contact Dermatitis
  
• Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
  ClinicalTrials.gov Identifier: NCT00557622 - Not yet recruiting
  Stress Disorders, Post-Traumatic
  
• Clinical Evaluation of BW430C in Epilepsy
  ClinicalTrials.gov Identifier: NCT00395694 - Active, not recruiting
  Epilepsy
  
• Clinical Evaluation of Esthetic Restorations Placed in Primary Molars With Composite Resin Enriched With Insoluble Anti Bacterial Nano Particles
  ClinicalTrials.gov Identifier: NCT00389714 - Not yet recruiting
  Dental Carious; Dental Filling
  
• Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
  ClinicalTrials.gov Identifier: NCT00269126 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Clinical Evaluation of Mosquito Coils to Control Malaria in China
  ClinicalTrials.gov Identifier: NCT00442442 - Active, not recruiting
  Malaria
  
• Clinical Evaluation of Navigated 3D Ultrasound Multicentre Study
  ClinicalTrials.gov Identifier: NCT00233350 - Recruiting
  Neuronavigation
  
• Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00406757 - Recruiting
  Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma
  
• Clinical Evaluation of New Computerized Labor Monitoring System
  ClinicalTrials.gov Identifier: NCT00496899 - Recruiting
  Obstetrics; Labor
  
• Clinical Evaluation of Placement of Radiofrequency-Based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis
  ClinicalTrials.gov Identifier: NCT00420875 - Recruiting
  Plantar Fasciosis, Achilles Tendinosis
  
• Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
  Restless Legs Syndrome
  
• Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
  ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
  Parkinson's Disease
  
• Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00540423 - Not yet recruiting
  Chronic Idiopathic Thrombocytopenic Purpura
  
• Clinical Evaluation of Spring-Type Laparoscopic Clip Technology
  ClinicalTrials.gov Identifier: NCT00527644 - Recruiting
  Healthy
  
• Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate
  ClinicalTrials.gov Identifier: NCT00133341 - Completed
  Allergic Contact Dermatitis
  
• Clinical Evaluation of the Care On Line Thermometer
  ClinicalTrials.gov Identifier: NCT00544141 - Recruiting
  Healthy
  
• Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study
  ClinicalTrials.gov Identifier: NCT00449085 - Not yet recruiting
  Cardiac Arrhythmias
  
• Clinical Evaluation of the P.F.C. Sigma (Fixed Bearing) and P.F.C. Sigma (Mobile Bearing) Total Knee Systems
  ClinicalTrials.gov Identifier: NCT00208325 - Recruiting
  Osteoarthritis, Knee
  
• Clinical Evaluation of the P.F.C. Sigma (Fixed Bearing) and P.F.C. Sigma Rotating Platform (Mobile Bearing) Total Knee Systems.
  ClinicalTrials.gov Identifier: NCT00208286 - Recruiting
  Osteoarthritis, Knee
  
• Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)
  ClinicalTrials.gov Identifier: NCT00231062 - Completed
  Chronic Sinusitis
  
• Clinical Evaluations and Laboratory Studies in Patients With Chronic Graft-Versus-Host Disease Who Have Undergone a Previous Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00331968 - Recruiting
  Cancer
  
• Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00430053 - Recruiting
  Lymphoma
  
• Clinical Experiment of H. Pylori Transmission
  ClinicalTrials.gov Identifier: NCT00549224 - Recruiting
  Helicobacter Pylori Infection; Achlorhydria
  
• Clinical Experiment of Helicobacter Pylori Transmission
  ClinicalTrials.gov Identifier: NCT00550368 - Recruiting
  Infection; Achlorhydria
  
• Clinical Factors Associated Floppy Iris
  ClinicalTrials.gov Identifier: NCT00472888 - Completed
  Pupil Constriction; Iris Floppiness; Iris Prolapsus From the Wound
  
• Clinical Feasibility of Computerized Labor Monitor (CLM) -Heart Application (HA)
  ClinicalTrials.gov Identifier: NCT00502918 - Not yet recruiting
  Obstetrics; Labor
  
• Clinical Feasibility Study of Allium's Biliary Stent
  ClinicalTrials.gov Identifier: NCT00448006 - Not yet recruiting
  Malignant Obstruction of the Common Bile Duct
  
• Clinical Identification of Fall Risk Early After Unilateral Transtibial Amputation
  ClinicalTrials.gov Identifier: NCT00163787 - Completed
  Amputation
  
• Clinical IGSP-CHOP Boston
  ClinicalTrials.gov Identifier: NCT00428831 - Recruiting
  Influenza
  
• Clinical Impact of EUS in Staging NSCLC
  ClinicalTrials.gov Identifier: NCT00577746 - Recruiting
  Non Small Cell Lung
  
• Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
  ClinicalTrials.gov Identifier: NCT00414362 - Recruiting
  Urinary Tract Infection; Fluoroquinolone; Bacteremia
  
• Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00166855 - Recruiting
  Multiple Myeloma, Newly Diagnosed
  
• Clinical Implications of Peripheral Plaque Morphology
  ClinicalTrials.gov Identifier: NCT00578422 - Recruiting
  Peripheral Artery Disease
  
• Clinical Indicators of Radiographic Findings in Patients with Suspected Community-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00118651 - Active, not recruiting
  Pneumonia
  
• Clinical Integration of Genetic Risk Assessment in Family Medicine
  ClinicalTrials.gov Identifier: NCT00339794 - Active, not recruiting
  Genomics
  
• Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children
  ClinicalTrials.gov Identifier: NCT00005683 - Completed
  Lung Diseases; Respiratory Distress Syndrome; Bronchopulmonary Dysplasia
  
• Clinical Investigation Into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients with Severe PAH
  ClinicalTrials.gov Identifier: NCT00147199 - Recruiting
  Pulmonary Arterial Hypertension
  
• Clinical Investigation of in-Vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
  ClinicalTrials.gov Identifier: NCT00493363 - Not yet recruiting
  Falciparum Malaria
  
• Clinical Investigation of Infections Due to Leishmanial Parasites
  ClinicalTrials.gov Identifier: NCT00001169 - Completed
  Leishmaniasis; Leishmaniasis, Visceral
  
• Clinical Investigation of Mandibular Implant Overdenture
  ClinicalTrials.gov Identifier: NCT00066014 - Active, not recruiting
  Dental Implantation
  
• Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-Bearing Total Knee System
  ClinicalTrials.gov Identifier: NCT00487565 - Recruiting
  Osteoarthritis; Rheumatoid Arthritis; Post-Traumatic Arthritis; Juvenile Arthritis
  
• Clinical Investigation of the Maxim® Knee System With Removable Molded Polyethylene Tibia and the Regular Maxim® Knee System
  ClinicalTrials.gov Identifier: NCT00579059 - Completed
  Osteoarthritis; Rheumatoid Arthritis; Traumatic Arthritis
  
• Clinical Investigation of the Medtronic Concerto™ Device
  ClinicalTrials.gov Identifier: NCT00268320 - Active, not recruiting
  Congestive Heart Failure, Atrial Arrhythmia, Atrial Tachyarrhythmia, Atrial Fibrillation
  
• Clinical Investigation of the Medtronic EnTrust™ Implantable Cardioverter Defibrillator (ICD), Model D153ATG
  ClinicalTrials.gov Identifier: NCT00273195 - Completed
  Ventricular Arrhythmias
  
• Clinical Investigation of the SelectSecure Pacing Lead
  ClinicalTrials.gov Identifier: NCT00266682 - Completed
  Bradycardia
  
• Clinical Investigation to Evaluate Safety and Performance of the EndoFast Reliant™ System in Vaginal Wall Reinforcement
  ClinicalTrials.gov Identifier: NCT00446693 - Recruiting
  Pelvic Organ Prolapse
  
• Clinical Islet Transplantation Using the Edmonton Protocol
  ClinicalTrials.gov Identifier: NCT00309231 - Not yet recruiting
  Type 1 Diabetes
  
• Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
  ClinicalTrials.gov Identifier: NCT00440986 - Completed
  Hereditary Hemochromatosis
  
• Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
  ClinicalTrials.gov Identifier: NCT00001238 - Recruiting
  Hemangioblastoma; Hereditary Neoplastic Syndrome; Hippel Lindau Disease; Neoplasm; Renal Cell Carcinoma
  
• Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.
  ClinicalTrials.gov Identifier: NCT00184353 - Completed
  Neoplasm Metastases
  
• Clinical Multi-Center Registry of Excel Bioasorbable Rapamycin-Eluting Stent in "Real World"
  ClinicalTrials.gov Identifier: NCT00331578 - Not yet recruiting
  AMI
  
• Clinical Neurophysiology: Training and Normative Values
  ClinicalTrials.gov Identifier: NCT00132353 - Recruiting
  
  
• Clinical Observation of Implementing the MedGem Into a Medical Specialty Practice
  ClinicalTrials.gov Identifier: NCT00489502 - Recruiting
  Obesity
  
• Clinical Outcome of Laparoscopic Versus Open Nissen Fundoplication in Children: 3−Year Follow-up Study of Randomized Controlled Trial.
  ClinicalTrials.gov Identifier: NCT00259961 - Completed
  Gastro -Oesophagal Reflux
  
• Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study
  ClinicalTrials.gov Identifier: NCT00326313 - Not yet recruiting
  Infants With Positive GBS Bacteremia
  
• Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
  ClinicalTrials.gov Identifier: NCT00173355 - Recruiting
  Soft Tissue Neoplasms
  
• Clinical Outcome Study of the Triad Allograft for Posterior Lumbar Fusion
  ClinicalTrials.gov Identifier: NCT00205101 - Completed
  Pain; Stenosis; Spondylolisthesis
  
• Clinical Outcomes After AcrySof® ReStor IOL Surgery in Faculty Practice at UTSW Medical Center at Dallas: A Retrospective Review
  ClinicalTrials.gov Identifier: NCT00344578 - Recruiting
  Outcomes Following Restor IOL Lens Implant
  
• Clinical Outcomes and Global Epidemiology -Data Coordinating Center
  ClinicalTrials.gov Identifier: NCT00524563 - Recruiting
  Acinetobacter Infections
  
• Clinical Outcomes in Hereditary Cancer
  ClinicalTrials.gov Identifier: NCT00580021 - Recruiting
  Breast Cancer; Pancreatic Cancer
  
• Clinical Outcomes of Angioplasty Postconditioning
  ClinicalTrials.gov Identifier: NCT00419198 - Recruiting
  Acute Myocardial Infarction
  
• Clinical Outcomes of Patients With Clostridium Difficile Associated Disease Attributable to Diverse tcdC Genotypes
  ClinicalTrials.gov Identifier: NCT00446355 - Recruiting
  Clostridium Infections
  
• Clinical Outcomes of Three Different Percutaneous Revascularization Strategies for the Treatment of Lifestyle Limiting Claudication: A Retrospective Analysis
  ClinicalTrials.gov Identifier: NCT00512720 - Not yet recruiting
  Peripheral Artery Disease
  
• Clinical Performance of 3-Unit FPDs
  ClinicalTrials.gov Identifier: NCT00223431 - Completed
  Partial Edentulism
  
• Clinical Performance of a Chlorhexidine Antimicrobial Dressing
  ClinicalTrials.gov Identifier: NCT00516906 - Not yet recruiting
  Catheterization
  
• Clinical Performance of Extended All-Ceramic Fixed Partial Dentures Based on Zircon-Oxide Ceramics.
  ClinicalTrials.gov Identifier: NCT00176189 - Completed
  Tooth Loss, Teeth Replaced Using All Ceramic FPDs
  
• Clinical Performance of Extended Wear Silicone Hydrogel Lenses
  ClinicalTrials.gov Identifier: NCT00441233 - Active, not recruiting
  Myopia
  
• Clinical Pharmacogenomics of Antidepressant Response
  ClinicalTrials.gov Identifier: NCT00269334 - Not yet recruiting
  Major Depression
  
• Clinical Pharmacogenomics of Antidepressant Response
  ClinicalTrials.gov Identifier: NCT00384020 - Recruiting
  Depression
  
• Clinical Pharmacology Study of MRA in Patient with Rheumatoid Arthritis(RA) with Renal Impairment
  ClinicalTrials.gov Identifier: NCT00144573 - Completed
  Rheumatoid Arthritis
  
• Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00322634 - Recruiting
  Cancer
  
• Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic
  ClinicalTrials.gov Identifier: NCT00508976 - Recruiting
  Pain, Postoperative; Pain Measurement; Postoperative Care
  
• Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
  ClinicalTrials.gov Identifier: NCT00375258 - Recruiting
  Hemorrhage
  
• Clinical Reminders in Test Reports to Improve Guideline Compliance
  ClinicalTrials.gov Identifier: NCT00414401 - Completed
  Heart Failure, Congestive
  
• Clinical Rescue Protocol - 2
  ClinicalTrials.gov Identifier: NCT00000206 - Completed
  Opioid-Related Disorders
  
• Clinical Research Core Dental Screening Protocol
  ClinicalTrials.gov Identifier: NCT00090818 - Recruiting
  
  
• Clinical Research Network in Non-alcoholic Steatohepatitis - Pediatric Trial
  ClinicalTrials.gov Identifier: NCT00063635 - Active, not recruiting
  Fatty Liver
  
• Clinical Results and Restenosis Analysis of Symptomatic Ostial Vertebral Artery Stenosis Treated With Tubular Coronary Stents
  ClinicalTrials.gov Identifier: NCT00172458 - Recruiting
  Vertebral Artery Stenosis
  
• Clinical Risk Assesment of CS-1 Decision Support System
  ClinicalTrials.gov Identifier: NCT00502645 - Completed
  Hyperglycemia; Critically Ill Patients
  
• Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream
  ClinicalTrials.gov Identifier: NCT00326274 - Recruiting
  Sunburn
  
• Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population
  ClinicalTrials.gov Identifier: NCT00567749 - Not yet recruiting
  HIV Infections
  
• Clinical Significance of Germline BRCA Mutations
  ClinicalTrials.gov Identifier: NCT00579488 - Recruiting
  Breast Cancer
  
• Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
  ClinicalTrials.gov Identifier: NCT00537888 - Active, not recruiting
  Pulmonary Candidiasis
  
• Clinical Studies of Gemcitabine-Oxaliplatin
  ClinicalTrials.gov Identifier: NCT00407433 - Recruiting
  Medulloblastoma; Central Nervous System Tumors; Neuroblastoma; Osteosarcoma
  
• Clinical Studies of Kikuchi''s Disease
  ClinicalTrials.gov Identifier: NCT00172445 - Not yet recruiting
  Lymphadenitis
  
• Clinical Studies of Progeria
  ClinicalTrials.gov Identifier: NCT00094393 - Active, not recruiting
  Progeria
  
• Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children
  ClinicalTrials.gov Identifier: NCT00278044 - Recruiting
  Adrenoleukodystrophy
  
• Clinical Study Assessing SSR126517E Injections Once-Weekly in Pulmonary Embolism Therapeutic Approach
  ClinicalTrials.gov Identifier: NCT00345618 - Recruiting
  Embolism; Thrombosis
  
• Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement
  ClinicalTrials.gov Identifier: NCT00306917 - Active, not recruiting
  Osteoarthritis; Rheumatoid Arthritis; Post-Traumatic Arthritis; Avascular Necrosis; Acute Fracture
  
• Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement
  ClinicalTrials.gov Identifier: NCT00306930 - Active, not recruiting
  Osteoarthritis; Rheumatoid Arthritis; Arthritis; Avascular Necrosis; Acute Fracture
  
• Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
  ClinicalTrials.gov Identifier: NCT00203255 - Completed
  Migraine Headache
  
• Clinical Study of Abdominal Aortic Aneurysm Exclusion (TALENT Abdominal)
  ClinicalTrials.gov Identifier: NCT00549432 - Recruiting
  Abdominal Aortic Aneurysm
  
• Clinical Study of Abiraterone Acetate and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00485303 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Clinical Study of Aneurysm Exclusion
  ClinicalTrials.gov Identifier: NCT00549016 - Recruiting
  Aneurysm Exclusion
  
• Clinical Study of Aneurysm Exclusion
  ClinicalTrials.gov Identifier: NCT00549380 - Recruiting
  Aneurysm
  
• Clinical Study of Antibacterial Nanoparticles Incorporated in Composite Restorations
  ClinicalTrials.gov Identifier: NCT00299598 - Recruiting
  Oral Health
  
• Clinical Study of Asenapine for Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00159796 - Completed
  Bipolar Disorder
  
• Clinical Study of Asenapine for Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00159744 - Completed
  Bipolar Disorder
  
• Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00345761 - Active, not recruiting
  Colorectal Cancer
  
• Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00291668 - Recruiting
  Crohn's Disease
  
• Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00418535 - Recruiting
  Lymphoma, T-Cell
  
• Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).
  ClinicalTrials.gov Identifier: NCT00335894 - Recruiting
  Infertility
  
• Clinical Study of Depodur Efficacy in Decreasing Post Operative Pain After Off Pump Coronary Artery Bypass Grafting (OP-CABG)
  ClinicalTrials.gov Identifier: NCT00456638 - Not yet recruiting
  Pain, Postoperative
  
• Clinical Study Of EYE001 For Wet-Type Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00239928 - Recruiting
  Macular Degeneration
  
• Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
  ClinicalTrials.gov Identifier: NCT00150202 - Completed
  Macular Degeneration
  
• Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
  ClinicalTrials.gov Identifier: NCT00000565 - Completed
  Lung Diseases; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients with Solid Malignancies.
  ClinicalTrials.gov Identifier: NCT00162136 - Recruiting
  Solid Malignancies
  
• Clinical Study of KW-2246 in Patients With Cancer Pain
  ClinicalTrials.gov Identifier: NCT00355628 - Active, not recruiting
  Pain; Cancer
  
• Clinical Study Of Migraine Evolution
  ClinicalTrials.gov Identifier: NCT00460005 - Active, not recruiting
  Migraine Headache
  
• Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)
  ClinicalTrials.gov Identifier: NCT00106977 - Recruiting
  
  
• Clinical Study of New Urine Collection Bag for Infants.
  ClinicalTrials.gov Identifier: NCT00368888 - Completed
  Urinary Tract Infection
  
• Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects
  ClinicalTrials.gov Identifier: NCT00001211 - Completed
  Ectodermal Dysplasia; Jaw, Edentulous
  
• Clinical Study of Previously Untreated Patients With Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00232726 - Completed
  Malignant Melanoma; Neoplasm Metastasis
  
• Clinical Study of R744 to Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00491868 - Active, not recruiting
  Hemodialysis Patients
  
• Clinical Study of R744 to Peritoneal Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00433849 - Active, not recruiting
  Peritoneal Dialysis Patients
  
• Clinical Study of R744 to Predialysis Patients
  ClinicalTrials.gov Identifier: NCT00433615 - Active, not recruiting
  Predialysis Patients
  
• Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)
  ClinicalTrials.gov Identifier: NCT00492427 - Recruiting
  Predialysis Patients
  
• Clinical Study of SARS in Children
  ClinicalTrials.gov Identifier: NCT00173576 - Completed
  Epidemiology
  
• Clinical Study Of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00071747 - Completed
  Schizophrenia
  
• Clinical Study of Spinal Muscular Atrophy
  ClinicalTrials.gov Identifier: NCT00443066 - Recruiting
  Spinal Muscular Atrophy
  
• Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema
  ClinicalTrials.gov Identifier: NCT00427986 - Terminated
  Diabetic Macular Oedema
  
• Clinical Study of the U-Plate Fracture Repair System to Treat Rib Fractures
  ClinicalTrials.gov Identifier: NCT00556543 - Recruiting
  Rib Fracture; Flail Chest; Rib Fracture Non-Union; Chest Wall Deformity
  
• Clinical Study of Thoracic Aortic Aneurysm Exclusion
  ClinicalTrials.gov Identifier: NCT00549315 - Recruiting
  Thoracic Aortic Aneurysm
  
• Clinical Study of Thoracic Excluder Endoprosthesis to Treat Descending Thoracic Aortic Diseases
  ClinicalTrials.gov Identifier: NCT00546312 - Recruiting
  Descending Thoracic Aortic Disease
  
• Clinical Study on Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain
  ClinicalTrials.gov Identifier: NCT00222209 - Recruiting
  Fibromyalgia; Irritable Bowel Syndrome
  
• Clinical Study on Optimised Removal of Protein-Bound Uremic Toxins With Convective Dialysis Treatment.
  ClinicalTrials.gov Identifier: NCT00337831 - Recruiting
  Chronic Renal Failure
  
• Clinical Study to Assess Safety and Effectiveness of the Zenith® Dissection Endovascular System in Patients With Aortic Dissection
  ClinicalTrials.gov Identifier: NCT00526487 - Recruiting
  Aortic Dissection Involving the Descending Thoracis Aorta
  
• Clinical Study to Determine Safety and Effectiveness of KEEPASLEEP Device in Simple Snorers.
  ClinicalTrials.gov Identifier: NCT00211627 - Recruiting
  Snoring; Sleep Apnea Syndromes
  
• Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00219180 - Completed
  Hypertension
  
• Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
  ClinicalTrials.gov Identifier: NCT00219024 - Completed
  Hypertension
  
• Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
  ClinicalTrials.gov Identifier: NCT00426270 - Recruiting
  Idiopathic Thrombocytopenic Purpura
  
• Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash
  ClinicalTrials.gov Identifier: NCT00219466 - Completed
  Diaper Dermatitis
  
• Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-Coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant
  ClinicalTrials.gov Identifier: NCT00171379 - Active, not recruiting
  Prevention of Acute Rejection After Kidney Transplantation
  
• Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-Coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus
  ClinicalTrials.gov Identifier: NCT00171392 - Active, not recruiting
  Prevention of Acute Rejection After Kidney Transplantation
  
• Clinical Study to Examine the Effects of Erythropoietin on Left Ventricular Function After Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00449488 - Recruiting
  Myocardial Infarction
  
• Clinical Study to Test the Effects of a Low-Carbohydrate Diet on Body Weight
  ClinicalTrials.gov Identifier: NCT00351845 - Active, not recruiting
  Obesity
  
• Clinical Study With QAX576 in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00532233 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant hCG in Women Undergoing IVF
  ClinicalTrials.gov Identifier: NCT00335569 - Recruiting
  Infertility
  
• Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures)
  ClinicalTrials.gov Identifier: NCT00376766 - Recruiting
  Epilepsy; Drug Resistant
  
• Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
  ClinicalTrials.gov Identifier: NCT00119665 - Completed
  Hot Flashes
  
• Clinical Trial Ceftriaxone in Subjects With ALS
  ClinicalTrials.gov Identifier: NCT00349622 - Recruiting
  Amyotrophic Lateral Sclerosis; ALS
  
• Clinical Trial Comparing Open and Laparoscopic Nissen Fundoplication in Children
  ClinicalTrials.gov Identifier: NCT00382850 - Recruiting
  Gastroesophageal Reflux
  
• Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)
  ClinicalTrials.gov Identifier: NCT00198302 - Completed
  Staphylococcus Aureus Bacteremia
  
• Clinical Trial Comparing Three Anterior Cruciate Ligament Reconstructive Procedures
  ClinicalTrials.gov Identifier: NCT00418964 - Recruiting
  Knee Injuries
  
• Clinical Trial Comparing Tissue Adhesive Vs. Absorbable Suture Vs. Non-Absorbable Suture
  ClinicalTrials.gov Identifier: NCT00292513 - Recruiting
  Cyst of Face, Neck or Shoulder; Pilomatrixoma of Face, Neck or Shoulder
  
• Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
  ClinicalTrials.gov Identifier: NCT00337779 - Active, not recruiting
  Relapsing Remitting Multiple Sclerosis
  
• Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts
  ClinicalTrials.gov Identifier: NCT00328991 - Completed
  Wart; Common Wart; Verruca Vulgaris; Verruca Plantaris; Plantar Wart
  
• Clinical Trial for Fibrin Sealant in Knee- and Hip Surgery
  ClinicalTrials.gov Identifier: NCT00440921 - Not yet recruiting
  Total Knee-Replacement; Total Hip-Replacement
  
• Clinical Trial for Ovarian Cancer (OvaRex®)
  ClinicalTrials.gov Identifier: NCT00050375 - Terminated
  Ovarian Cancer
  
• Clinical Trial for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00076531 - Active, not recruiting
  Prostate Cancer
  
• Clinical Trial for the Prevention of Vasovagal Syncope
  ClinicalTrials.gov Identifier: NCT00118482 - Recruiting
  Syncope, Vasovagal, Neurally-Mediated
  
• Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON
  ClinicalTrials.gov Identifier: NCT00428727 - Recruiting
  Diabetic Foot
  
• Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix
  ClinicalTrials.gov Identifier: NCT00266084 - Completed
  Uterine Cervical Dysplasia; Uterine Cervical Intraepithelial Neoplasia; Uterine Cervical Neoplasia; Uterine Cervical Cancer
  
• Clinical Trial in Males with BPH (Enlarged Prostate)
  ClinicalTrials.gov Identifier: NCT00029822 - Completed
  Urinary Retention; Prostatic Hyperplasia; Benign Prostatic Hypertrophy
  
• Clinical Trial in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00235898 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Clinical Trial of a COX-2 Inhibitor for the Treatment of Women With Preeclampsia
  ClinicalTrials.gov Identifier: NCT00442676 - Not yet recruiting
  Preeclampsia
  
• Clinical Trial of a Nutritional Supplement in Adults with Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00109577 - Recruiting
  Bipolar Disorder
  
• Clinical Trial of Abstinence-Linked Money Management
  ClinicalTrials.gov Identifier: NCT00536900 - Recruiting
  Substance Abuse
  
• Clinical Trial of Acid Reflux Therapy in Asthma
  ClinicalTrials.gov Identifier: NCT00069823 - Recruiting
  Asthma; Lung Diseases; Lung Diseases, Obstructive
  
• Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition
  ClinicalTrials.gov Identifier: NCT00338221 - Terminated
  Diarrhea, Malnutrition
  
• Clinical Trial of Chemosensitivity Test
  ClinicalTrials.gov Identifier: NCT00287755 - Recruiting
  Gastric Cancer
  
• Clinical Trial of Cognitive Behavioral Treatment for Posttraumatic Stress Disorder in Women Veterans
  ClinicalTrials.gov Identifier: NCT00032617 - Active, not recruiting
  Stress Disorders, Post-Traumatic
  
• Clinical Trial of Combination Paclitaxel, Carboplatin and Temozolomide
  ClinicalTrials.gov Identifier: NCT00249964 - Recruiting
  Lung Diseases; Cancer
  
• Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00005766 - Completed
  Amyotrophic Lateral Sclerosis
  
• Clinical trial of creatine in amyotrophic lateral sclerosis [ALS]
  ClinicalTrials.gov Identifier: NCT00005674 - Completed
  Amyotrophic Lateral Sclerosis
  
• Clinical Trial of Dietary Protein on Blood Pressure
  ClinicalTrials.gov Identifier: NCT00046566 - Recruiting
  Cardiovascular Diseases; Hypertension; Heart Diseases
  
• Clinical Trial of Dipyridamole in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00349973 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
  
• Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
  ClinicalTrials.gov Identifier: NCT00183794 - Recruiting
  Ovarian Carcinoma; Peritoneal Neoplasms
  
• Clinical Trial of Estrogen for Postpartum Depression
  ClinicalTrials.gov Identifier: NCT00059228 - Recruiting
  Postpartum Depression
  
• Clinical Trial of Eye Prophylaxis in the Newborn
  ClinicalTrials.gov Identifier: NCT00000120 - Completed
  Chlamydia Infections; Ophthalmia Neonatorum
  
• Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00034229 - Completed
  Bipolar Disorder
  
• Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes
  ClinicalTrials.gov Identifier: NCT00018057 - Recruiting
  Depression; Mood Disorder; Anxiety Disorder; Healthy
  
• Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma
  ClinicalTrials.gov Identifier: NCT00238927 - Active, not recruiting
  Asthma
  
• Clinical Trial of Footwear in Patients with Diabetes
  ClinicalTrials.gov Identifier: NCT00032864 - Completed
  Amputations; Diabetes; Lower extremity ulcers
  
• Clinical Trial of Gabapentin to Improve Postoperative Pain in Surgical Patients
  ClinicalTrials.gov Identifier: NCT00221338 - Recruiting
  Postoperative Pain
  
• Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00159458 - Terminated
  Recurrent breast cancer; Metastastic breast cancer
  
• Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00326625 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Clinical Trial of High Dose CoQ10 in ALS
  ClinicalTrials.gov Identifier: NCT00243932 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Lou Gehrig's Disease
  
• Clinical Trial of HuMax-CD4, a new drug to treat Advanced Stage T-Cell Lymphoma in the skin.
  ClinicalTrials.gov Identifier: NCT00071084 - Completed
  Cutaneous T-Cell Lymphoma
  
• Clinical Trial of HuMax-CD4, a new drug to treat Early Stage T-Cell Lymphoma in the skin.
  ClinicalTrials.gov Identifier: NCT00071071 - Completed
  Cutaneous T-Cell Lymphoma
  
• Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode Psychosis
  ClinicalTrials.gov Identifier: NCT00157313 - Active, not recruiting
  Psychotic Disorders; Schizophreniform Disorders; Schizoaffective Disorder; Psychosis, Brief Reactive; Schizophrenia, Borderline
  
• Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients
  ClinicalTrials.gov Identifier: NCT00223262 - Active, not recruiting
  Memory Impairment Due to Corticosteroid Use.; Hypomania Due to Corticosteroid Use.; Hippocampal Atrophy Due to Corticosteroid.
  
• Clinical Trial of Leuprolide Acetate for the Treatment of PMS
  ClinicalTrials.gov Identifier: NCT00001259 - Recruiting
  Depressive Disorder; Mood Disorder
  
• Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women
  ClinicalTrials.gov Identifier: NCT00010608 - Completed
  Cardiovascular Diseases
  
• Clinical Trial of Memantine for Major Depression
  ClinicalTrials.gov Identifier: NCT00040261 - Completed
  Depression
  
• Clinical Trial of Mifepristone for Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00043654 - Completed
  Bipolar Disorder
  
• Clinical Trial of MK0683(Vorinostat) in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00423449 - Not yet recruiting
  Non-Small Cell Lung Cancer
  
• Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
  ClinicalTrials.gov Identifier: NCT00414128 - Recruiting
  Vasculitis
  
• Clinical Trial of New Elastomer for Maxillofacial Prosthetics
  ClinicalTrials.gov Identifier: NCT00123097 - Active, not recruiting
  Facial Neoplasms; Head and Neck Neoplasms; Head Injuries, Penetrating; Birth Injuries
  
• Clinical Trial of Pentoxifyllin in Patient with Cirrhosis
  ClinicalTrials.gov Identifier: NCT00162552 - Recruiting
  Cirrhosis; Liver Failure
  
• Clinical Trial of Peripheral Prism Glasses for Hemianopia
  ClinicalTrials.gov Identifier: NCT00494676 - Recruiting
  Homonymous Hemianopia
  
• Clinical Trial of Pramipexole in Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00025792 - Completed
  Bipolar Disorder
  
• Clinical Trial of Propranolol for Seasonal Affective Disorder
  ClinicalTrials.gov Identifier: NCT00016666 - Completed
  Seasonal Affective Disorder; Healthy
  
• Clinical Trial of Protein and Blood Pressure
  ClinicalTrials.gov Identifier: NCT00107744 - Completed
  Hypertension; Hypercholesterolemia
  
• Clinical Trial of PXD101 in Patients With T-Cell Lymphomas
  ClinicalTrials.gov Identifier: NCT00274651 - Recruiting
  Cutaneous T-Cell Lymphoma; Peripheral T-Cell Lymphoma; Non-Hodgkin's Lymphoma
  
• Clinical Trial of Rifampin and Azithromycin for the Treatment of Riverblindness
  ClinicalTrials.gov Identifier: NCT00127504 - Completed
  Onchocerciasis
  
• Clinical Trial of SAHA in Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00416130 - Not yet recruiting
  Breast Cancer
  
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00406458 - Recruiting
  Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy
  
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00476931 - Recruiting
  Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy
  
• Clinical Trial of SB-509-0401 in Subjects with Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00110500 - Recruiting
  Diabetic Neuropathy
  
• Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
  ClinicalTrials.gov Identifier: NCT00424320 - Recruiting
  Acute Kidney Failure
  
• Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I
  ClinicalTrials.gov Identifier: NCT00439218 - Not yet recruiting
  Spinal Muscular Atrophy Type I
  
• Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
  ClinicalTrials.gov Identifier: NCT00439569 - Not yet recruiting
  Spinal Muscular Atrophy Type II; Spinal Muscular Atrophy Type III
  
• Clinical Trial of Teriparatide in Japan
  ClinicalTrials.gov Identifier: NCT00191867 - Completed
  Osteoporosis
  
• Clinical Trial of the "Living Well With Hearing Loss Workshop"
  ClinicalTrials.gov Identifier: NCT00323427 - Not yet recruiting
  Hearing Loss; Stress
  
• Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
  ClinicalTrials.gov Identifier: NCT00497237 - Recruiting
  Asthma
  
• Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation
  ClinicalTrials.gov Identifier: NCT00372502 - Recruiting
  Severe Sepsis; Septic Shock
  
• Clinical Trial of the Use of Intraperitoneal Local Anaesthetic
  ClinicalTrials.gov Identifier: NCT00180687 - Completed
  Postoperative Pain Following Laparoscopic Cholecystectomy
  
• Clinical Trial of Tolcapone for Cognition in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044083 - Recruiting
  Schizophrenia
  
• Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
  ClinicalTrials.gov Identifier: NCT00555464 - Recruiting
  Hemangioma
  
• Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With ALS
  ClinicalTrials.gov Identifier: NCT00372879 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Clinical Trial of Zocor and Vytorin in Adolescents With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00477204 - Recruiting
  Type 1 Diabetes Mellitus; Dyslipidemia
  
• Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids
  ClinicalTrials.gov Identifier: NCT00488007 - Recruiting
  Alzheimer Disease; Presbycusis
  
• Clinical Trial on the Mixture of Gemcitabine, Capecitabine, and Sorafenib (Bay 43-9006) in the Treatment of Patients With Renal Cell Carcinoma (RCC)
  ClinicalTrials.gov Identifier: NCT00496301 - Recruiting
  Carcinoma, Renal Cell
  
• Clinical Trial Studying a Personalized Cancer Vaccine in Patients with Non-Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126178 - Terminated
  Kidney Cancer; Renal Cell Carcinoma
  
• Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics
  ClinicalTrials.gov Identifier: NCT00226109 - Recruiting
  Cardiomyopathy, Alcoholic; Alcoholism
  
• Clinical Trial Testing the Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00115804 - Recruiting
  Juvenile Primary Fibromyalgia Syndrome (JPFS); Fibromyalgia
  
• Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
  ClinicalTrials.gov Identifier: NCT00435760 - Active, not recruiting
  COPD
  
• Clinical Trial to Assess the Effects of Candesartan on the Carbohydrates Metabolism of Subjects With Dysglycemia and Abdominal Obesity."ARAMIA"
  ClinicalTrials.gov Identifier: NCT00319202 - Recruiting
  Glucose Intolerance; Obesity
  
• Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
  ClinicalTrials.gov Identifier: NCT00523952 - Completed
  Dermatitis, Atopic
  
• Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir, Etravirine and MK-0518 in HIV Patients With Resistant Viruses
  ClinicalTrials.gov Identifier: NCT00460382 - Active, not recruiting
  HIV Infections
  
• Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the Mother
  ClinicalTrials.gov Identifier: NCT00180219 - Not yet recruiting
  Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third
  
• Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance
  ClinicalTrials.gov Identifier: NCT00241072 - Completed
  Hypertension; Impaired Glucose Tolerance
  
• Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00444925 - Recruiting
  Overactive Bladder
  
• Clinical Trial to Evaluate the Efficacy and Safety of Org 50081 in the Treatment of Vasomotor Symptoms
  ClinicalTrials.gov Identifier: NCT00535288 - Completed
  Menopause
  
• Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treating Ulcers in Diabetic Foot
  ClinicalTrials.gov Identifier: NCT00448903 - Recruiting
  Foot Ulcer, Diabetic
  
• Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
  ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
  Essential Hypertension
  
• Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
  ClinicalTrials.gov Identifier: NCT00475007 - Recruiting
  Emphysema
  
• Clinical Trial to Evaluate the Safety and Immunogenicity of a Candidate Prophylactic pHIS-HIV-AE DNA Prime and rFPV-HIV-AE Boost HIV Vaccination Strategy
  ClinicalTrials.gov Identifier: NCT00476749 - Recruiting
  HIV Infections
  
• Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00039559 - Recruiting
  ovarian epithelial cancer
  
• Clinical Trial to Slow the Progression of ADPKD
  ClinicalTrials.gov Identifier: NCT00067977 - Not yet recruiting
  Kidney, Polycystic; Kidney, Polycystic, Autosomal Dominant
  
• Clinical Trial to Test the Safety and Effectiveness of an Investigational Drug CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00522938 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism
  ClinicalTrials.gov Identifier: NCT00197951 - Completed
  Depression; Anger; Anxiety; Alcoholism
  
• Clinical Trials of Footwear in Patients with Diabetes-Study Arm 2,3
  ClinicalTrials.gov Identifier: NCT00013299 - Completed
  Diabetic Foot Ulcers
  
• Clinical Trials of Regeneration for Periodontal Tissue
  ClinicalTrials.gov Identifier: NCT00221130 - Active, not recruiting
  Adult Periodontitis
  
• Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)
  ClinicalTrials.gov Identifier: NCT00006517 - Completed
  Seasonal Affective Disorder; Mood Disorders; Depressive Disorders
  
• Clinical trials of two non-drug treatments for chronic depression
  ClinicalTrials.gov Identifier: NCT00006172 - Completed
  Mood Disorders; Depressive Disorders; Depression; Chronic depression; Nonseasonal depression
  
• Clinical Trials Stage of ''SoleSensor'': A Balance-Enhancing Shoe Insert.
  ClinicalTrials.gov Identifier: NCT00151359 - Completed
  Sensation Disorder
  
• Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00269763 - Completed
  Pain; Cancer
  
• Clinical Use of ANDANTE SmartStep System in GAIT REHABILITATION
  ClinicalTrials.gov Identifier: NCT00268658 - Not yet recruiting
  Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Arthroscopy; Ankle Injuries; Femoral Neck Fractures
  
• Clinical Usefulness of Optical Skin Biopsy
  ClinicalTrials.gov Identifier: NCT00154921 - Recruiting
  Skin Neoplasms
  
• Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00108004 - Completed
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
  ClinicalTrials.gov Identifier: NCT00150384 - Completed
  Hypertension; Dyslipidemia
  
• Clinical Utility of Endothelial Dysfunction in PAD
  ClinicalTrials.gov Identifier: NCT00491751 - Recruiting
  Peripheral Arterial Disease
  
• Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
  ClinicalTrials.gov Identifier: NCT00340080 - Active, not recruiting
  HIV Infections
  
• Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant
  ClinicalTrials.gov Identifier: NCT00242099 - Active, not recruiting
  Transplant
  
• Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia
  ClinicalTrials.gov Identifier: NCT00181051 - Suspended
  Scheduled General Anesthesia
  
• Clinical Value of 18F-Ethylcholine-PET Combined With Endorectal MRI for Pre-Therapeutic Staging of Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00520546 - Not yet recruiting
  Prostate Cancer
  
• Clinical, Biochemical, Histological and Biophysical Parameters in the Prediction of Cerebral Palsy in Patients With Preterm Labor and Premature Rupture of Membranes
  ClinicalTrials.gov Identifier: NCT00342667 - Recruiting
  Preterm Labor; Infant Neurological Disorders
  
• Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00040222 - Recruiting
  Breast Neoplasms; Ovarian Neoplasms
  
• Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis
  ClinicalTrials.gov Identifier: NCT00570960 - Recruiting
  Spontaneous Bacterial Peritonitis
  
• Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00039676 - Recruiting
  Lymphoma; Leukemia
  
• Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
  ClinicalTrials.gov Identifier: NCT00001560 - Recruiting
  Acquired Immunodeficiency Syndrome; Kaposi's Sarcoma; Leukemia; Lymphoma; Tumor Virus Infection; HIV Infections
  
• Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
  ClinicalTrials.gov Identifier: NCT00001163 - Recruiting
  Hereditary Neoplastic Syndrome; Neoplasm
  
• Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
  ClinicalTrials.gov Identifier: NCT00040352 - Recruiting
  Melanoma
  
• Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin Mutation
  ClinicalTrials.gov Identifier: NCT00169364 - Recruiting
  Parkinson's Disease
  
• Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions
  ClinicalTrials.gov Identifier: NCT00169325 - Recruiting
  Basal Ganglia Lesions
  
• Clinical-Genetic Variation in GABA/Alcohol Sensitivity
  ClinicalTrials.gov Identifier: NCT00223444 - Recruiting
  Alcoholism
  
• Clinically Important Changes in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00056602 - Recruiting
  Rheumatoid Arthritis
  
• Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence
  ClinicalTrials.gov Identifier: NCT00201149 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Clinician Managed Interpersonal Psychotherapy
  ClinicalTrials.gov Identifier: NCT00043602 - Active, not recruiting
  Depression, Postpartum
  
• Clinico-Pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00310479 - Recruiting
  Prostate Cancer
  
• Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection
  ClinicalTrials.gov Identifier: NCT00520078 - Recruiting
  Acrochordon; Skin Tag; Soft Fibroma; Human Papillomavirus; HPV
  
• ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study
  ClinicalTrials.gov Identifier: NCT00410241 - Recruiting
  Coronary Arteriosclerosis
  
• Clobazam in Patients With Lennox-Gastaut Syndrome
  ClinicalTrials.gov Identifier: NCT00518713 - Recruiting
  Epilepsy; Epilepsy, Generalized; Seizures
  
• Clobazam in Subjects with Lennox-Gastaut Syndrome
  ClinicalTrials.gov Identifier: NCT00162981 - Active, not recruiting
  Epilepsy; Epilepsy, Generalized; Seizures
  
• Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus
  ClinicalTrials.gov Identifier: NCT00393263 - Recruiting
  Lichen Sclerosus
  
• Clodronate With or Without Chemotherapy and/or Tamoxifen in Treating Women With Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00009945 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Clofarabine alone versus Clofarabine in Combination with Low-Dose Cytarabine (ara-C) in Previously Untreated Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00088218 - Active, not recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndrome
  
• Clofarabine and AraC for the Treatment of AML, MDS
  ClinicalTrials.gov Identifier: NCT00334074 - Active, not recruiting
  Acute Myelogenous Leukemia; Myelodysplastic Syndromes; Chronic Myelogenous Leukemia
  
• Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients
  ClinicalTrials.gov Identifier: NCT00412243 - Recruiting
  Burkitt's Lymphoma; Lymphoblastic Lymphoma; Acute Lymphoblastic Leukemia
  
• Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00293410 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases
  
• Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00372619 - Recruiting
  Leukemia
  
• Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00577694 - Not yet recruiting
  Leukemia
  
• Clofarabine Combinations in Relapsed/Refractory AML, MDS and Myeloid Blast Phase CML
  ClinicalTrials.gov Identifier: NCT00067028 - Recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia
  
• Clofarabine for Relapsed or Refractory Diffuse Large Cell B-Cell NHL
  ClinicalTrials.gov Identifier: NCT00156013 - Recruiting
  Relapsed or Refractory Diffuse Large Cell B-Cell NHL
  
• Clofarabine in Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00028418 - Active, not recruiting
  Hematologic Neoplasms; Lymphoproliferative Disorders; Leukemia; Leukemia, Lymphocytic, Chronic
  
• Clofarabine in Treating Patients With Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00305721 - Recruiting
  Lymphoma
  
• Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00416351 - Recruiting
  Leukemia; Lymphoma; Small Intestine Cancer
  
• Clofarabine plus Cytarabine in Patients with Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00065143 - Completed
  Leukemia, Myeloid; Myelodysplastic Syndromes
  
• Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00503880 - Recruiting
  Myelodysplastic Syndromes
  
• Clofarabine, Melphalan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00572546 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition; Secondary Myelofibrosis
  
• Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00423514 - Recruiting
  Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes
  
• Clomiphene Citrate in Infertile PCOS Patients
  ClinicalTrials.gov Identifier: NCT00501839 - Recruiting
  Polycystic Ovary Syndrome; Infertility
  
• Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00025740 - Completed
  Post Traumatic Stress Disorder
  
• Clonidine and Left Ventricular Dysfunction
  ClinicalTrials.gov Identifier: NCT00213902 - Recruiting
  Left Ventricular Diastolic Dysfunction With Preserved Ejection Fraction
  
• Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome
  ClinicalTrials.gov Identifier: NCT00510016 - Completed
  Neonatal Abstinence Syndrome
  
• Clonidine for Neurocognitive Sequelae
  ClinicalTrials.gov Identifier: NCT00166686 - Completed
  Treatment-Related Cancer
  
• Clonidine for Prevention of Relapse to Opiate Abuse
  ClinicalTrials.gov Identifier: NCT00295308 - Recruiting
  Opioid-Related Disorders
  
• Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
  ClinicalTrials.gov Identifier: NCT00031395 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Clonidine Versus Adenosine to Treat Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00349921 - Active, not recruiting
  Pain
  
• Clonidine-Induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00350532 - Recruiting
  Pain
  
• Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial
  ClinicalTrials.gov Identifier: NCT00343876 - Recruiting
  Coronary Artery Disease
  
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
  ClinicalTrials.gov Identifier: NCT00557921 - Not yet recruiting
  Acute Coronary Syndrome; Myocardial Infarction; Coronary Artery Disease; Percutaneous Coronary Intervention
  
• Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
  ClinicalTrials.gov Identifier: NCT00050817 - Completed
  Arteriosclerosis
  
• Clopidogrel Maintaining Dosage in Acute Coronary Syndrome After Drug Eluting Stent Implantation
  ClinicalTrials.gov Identifier: NCT00404053 - Completed
  Acute Coronary Syndrome
  
• Clopidogrel Only Before Percutaneous Coronary Intervention or Before Every Coronarography?
  ClinicalTrials.gov Identifier: NCT00432120 - Completed
  Ischemic Heart Disease
  
• Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS
  ClinicalTrials.gov Identifier: NCT00444132 - Completed
  Clopidogrel Non-Responsiveness
  
• Cloretazine With Hematopoietic Cell Transplant
  ClinicalTrials.gov Identifier: NCT00521859 - Recruiting
  Hematologic Malignancies
  
• Closed Loop Insulin Therapy in Type 1 Diabetics Based on Blood Microdialysis, Online Sensors and an eMPC Algorithm
  ClinicalTrials.gov Identifier: NCT00535483 - Completed
  Type 1 Diabetes
  
• Closed Loop Stimulation, Cognitive Performance, and Quality of Life in Pacemaker Patients
  ClinicalTrials.gov Identifier: NCT00323661 - Recruiting
  Cardiac Pacing, Artificial; Quality of Life
  
• Closed-Loop Anesthesia, Using Bispectral Index as the Control Variable, During Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00477347 - Recruiting
  Liver Transplantation
  
• Closing the Loop Between Glucose Sensor and Insulin Pump-Developing an Algorithm
  ClinicalTrials.gov Identifier: NCT00541515 - Not yet recruiting
  Diabetes, Type I
  
• ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.
  ClinicalTrials.gov Identifier: NCT00509392 - Recruiting
  Great Saphenous Vein Disease; Venous Reflux
  
• Clot Formation and Clot Stability in Patients With Severe Haemophilia A
  ClinicalTrials.gov Identifier: NCT00279578 - Completed
  Hemophilia A
  
• Clotrimazole Enemas for Pouchitis in Children and Adults
  ClinicalTrials.gov Identifier: NCT00061282 - Recruiting
  Ulcerative Colitis; Pouchitis; Ileitis; Inflammatory Bowel Disease
  
• Clotting Genetic Variants, Hormones, and Venous Thrombosis
  ClinicalTrials.gov Identifier: NCT00094185 - Active, not recruiting
  Cardiovascular Diseases; Thromboembolism
  
• Clozapine and Risperidone for Treatment of First Episode Schizophrenia and Cannabis Use Disorder
  ClinicalTrials.gov Identifier: NCT00063349 - Suspended
  Schizophrenia; Marijuana Abuse
  
• Clozapine for Treatment-Resistant Mania
  ClinicalTrials.gov Identifier: NCT00029458 - Completed
  Bipolar Disorder
  
• Clozapine IM and Aggression in Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00189995 - Not yet recruiting
  Schizophrenia
  
• Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
  ClinicalTrials.gov Identifier: NCT00169039 - Terminated
  Schizophrenia
  
• Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00169091 - Terminated
  Schizophrenia
  
• Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00036582 - Completed
  Bipolar Disorder
  
• Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
  ClinicalTrials.gov Identifier: NCT00224315 - Active, not recruiting
  Schizophrenia, Schizoaffective Disorder
  
• CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
  ClinicalTrials.gov Identifier: NCT00522002 - Recruiting
  Connective Tissue Diseases; Blood Coagulation Disorders; Leg Ulcers; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Systemic Scleroderma; Mixed Connective Tissue Disease
  
• Cluster Randomized Trial of Peer Health Education in Malaria in The Gambia
  ClinicalTrials.gov Identifier: NCT00269178 - Completed
  Malaria
  
• CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse
  ClinicalTrials.gov Identifier: NCT00003673 - Active, not recruiting
  recurrent adult acute myeloid leukemia
  
• CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse
  ClinicalTrials.gov Identifier: NCT00003131 - Active, not recruiting
  recurrent adult acute myeloid leukemia
  
• CMC Arthritis - Neoprene Vs. Thermoplast Short Opponens Splinting
  ClinicalTrials.gov Identifier: NCT00438763 - Recruiting
  Carpometacarpal Thumb Arthritis
  
• CMR in the Assessment of Patient With ACS in the Emergency Room
  ClinicalTrials.gov Identifier: NCT00564382 - Recruiting
  Infarction; Ischemia; Magnetic Resonance Imaging
  
• CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone
  ClinicalTrials.gov Identifier: NCT00401856 - Not yet recruiting
  Cardiomyopathy
  
• CMV Disease and IRIS in HIV-1 Infected Persons
  ClinicalTrials.gov Identifier: NCT00456664 - Recruiting
  HIV Infections; Cytomegalovirus
  
• CMV Glycoprotein B Vaccine in Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00299260 - Recruiting
  Cytomegalovirus Infections
  
• CMV Infection in Adolescent Males
  ClinicalTrials.gov Identifier: NCT00302029 - Recruiting
  Cytomegalovirus Infections
  
• CMV Infection in Amniotic Fluid
  ClinicalTrials.gov Identifier: NCT00194142 - Not yet recruiting
  Pregnancy; Cytomegalovirus
  
• CMV Retinitis Retreatment Trial
  ClinicalTrials.gov Identifier: NCT00000766 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• CMV-Ig Replacement in Hypogammaglobulinemic Lung Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00137748 - Active, not recruiting
  Lung Transplantation; Hypogammaglobulinemia
  
• CNF2024 as Single-Agent Treatment in Subjects With HER2‑ Advanced Breast Cancer or in Combination With Trastuzumab in Subjects With HER2+ Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00412412 - Recruiting
  Breast Cancer
  
• CNI-1493 for Treatment of Moderate to Severe Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00038766 - Terminated
  Crohn Disease
  
• CNS Viral Dynamics and Cellular Immunity During AIDS
  ClinicalTrials.gov Identifier: NCT00583167 - Recruiting
  HIV Infections
  
• CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00311545 - Completed
  Kidney Cancer
  
• Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
  ClinicalTrials.gov Identifier: NCT00244023 - Recruiting
  Erectile Dysfunction; Hypogonadism
  
• Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.
  ClinicalTrials.gov Identifier: NCT00481182 - Completed
  Healthy
  
• Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa Versus Individual Administration of Each Vaccine
  ClinicalTrials.gov Identifier: NCT00508261 - Recruiting
  Meningococcal Disease
  
• Co-Administration of Propofol and Remifentanil for Lumbar Puncture in Children
  ClinicalTrials.gov Identifier: NCT00405522 - Recruiting
  Spinal Puncture
  
• Co-administration Study in Patients with Elevated Cholesterol and Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00092612 - Completed
  Hypercholesterolemia; Coronary Disease
  
• Co-administration Study in Patients with Elevated Cholesterol and Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00092625 - Completed
  Hypercholesterolemia; Coronary Disease
  
• Co-Infection of NTM in Patients With Smear Positive Pulmonary TB
  ClinicalTrials.gov Identifier: NCT00567151 - Not yet recruiting
  Tuberculosis, Pulmonary
  
• CO2 Insufflation During Double Balloon Enteroscopy
  ClinicalTrials.gov Identifier: NCT00464022 - Completed
  Pain
  
• COACH - Community Outreach And Cardiovascular Health
  ClinicalTrials.gov Identifier: NCT00385619 - Recruiting
  Cardiovascular Disease; Diabetes
  
• Coaching to Improve Care of Cancer Pain
  ClinicalTrials.gov Identifier: NCT00283166 - Recruiting
  Pain
  
• Coagulation Factor Changes Associated With Postpartum Hysterectomies
  ClinicalTrials.gov Identifier: NCT00456547 - Completed
  Labour; Hemorrhage; Cesarean Section
  
• Coagulation Parameters During Pregnancy in Amniotic Fluid
  ClinicalTrials.gov Identifier: NCT00458666 - Recruiting
  Pregnancy
  
• Coarctation Of the Aorta Stent Trial
  ClinicalTrials.gov Identifier: NCT00552812 - Enrolling by invitation
  Coarctation of the Aorta
  
• COAST (Childhood Origins of ASThma)
  ClinicalTrials.gov Identifier: NCT00204841 - Active, not recruiting
  Childhood Asthma
  
• Coated Endotracheal Tube and Mucus Shaver to Prevent Hospital-Acquired Infections
  ClinicalTrials.gov Identifier: NCT00341354 - Completed
  Infection
  
• Cobalamin Supplementation During Infancy; Effect on B-Vitamin Status, Growth and Psychomotor Development
  ClinicalTrials.gov Identifier: NCT00479479 - Completed
  Vitamin B 12 Deficiency
  
• Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial COSTAR II Trial
  ClinicalTrials.gov Identifier: NCT00165035 - Active, not recruiting
  Coronary Disease
  
• Cocaethylene as a Treatment for Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00124696 - Completed
  Cocaine-Related Disorders
  
• Cocaine Abuse and ADHD - 10
  ClinicalTrials.gov Identifier: NCT00000275 - Completed
  Cocaine-Related Disorders
  
• Cocaine Abuse and Attention Deficit Disorder - 3
  ClinicalTrials.gov Identifier: NCT00000268 - Completed
  Cocaine-Related Disorders
  
• Cocaine Effects in Humans: Physiology and Behavior - 1
  ClinicalTrials.gov Identifier: NCT00000200 - Active, not recruiting
  Cocaine-Related Disorders
  
• Cocaine in Parotid Saliva, Blood and Urine - 4
  ClinicalTrials.gov Identifier: NCT00000190 - Completed
  Cocaine-Related Disorders
  
• Cocaine Vaccine for Methadone Maintained Patients. - 1
  ClinicalTrials.gov Identifier: NCT00142857 - Active, not recruiting
  Cocaine; Study is not suspended. Enrollment started two years ago and completed enrollment in July 2005
  
• Cocaine Withdrawal and Pharmacotherapy Response
  ClinicalTrials.gov Identifier: NCT00566969 - Recruiting
  Cocaine-Related Disorders
  
• Cocaine-Methylphendidate Interaction Study - 4
  ClinicalTrials.gov Identifier: NCT00015067 - Completed
  Cocaine-Related Disorders
  
• Cocaine-Metyrapone Interaction Study - 1
  ClinicalTrials.gov Identifier: NCT00033098 - Active, not recruiting
  Cocaine-Related Disorders; Infusions, Intravenous
  
• Cockroach Allergen Reduction by Extermination Alone in Low-Income, Urban Homes: A Randomized Control Trial
  ClinicalTrials.gov Identifier: NCT00341445 - Active, not recruiting
  Allergens
  
• Cocoa and Endothelial Function in Adults With Elevated BMI
  ClinicalTrials.gov Identifier: NCT00538083 - Completed
  Cardioprotection
  
• Cocoa Butter for Prevention of Stretch Marks
  ClinicalTrials.gov Identifier: NCT00114660 - Active, not recruiting
  Striae Gravidarum; Pregnancy
  
• Codeine in Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00174538 - Recruiting
  Sickle Cell Disease
  
• Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00180037 - Completed
  Parkinson's Disease
  
• Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096356 - Recruiting
  Breast Cancer; Fatigue
  
• Coenzyme Q10 Supplementation and Development of Preeclampsia
  ClinicalTrials.gov Identifier: NCT00300937 - Completed
  Preeclampsia
  
• COGNIShunt® System for Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00056628 - Completed
  Alzheimer Disease
  
• Cognition, Functioning and Quality of Life
  ClinicalTrials.gov Identifier: NCT00182442 - Completed
  Schizophrenia
  
• Cognition, Steroids, and Imaging in Cushings Disease
  ClinicalTrials.gov Identifier: NCT00081341 - Completed
  Cushing Syndrome
  
• Cognitive - Behavioral Therapy
  ClinicalTrials.gov Identifier: NCT00018629 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• COGNITIVE - Cognitive Function After Sevoflurane or Propofol Anesthesia for Open-Heart Operations
  ClinicalTrials.gov Identifier: NCT00541918 - Recruiting
  Heart Surgery; Memory Disorders
  
• Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00455663 - Completed
  Schizophrenia
  
• Cognitive Aging - STAR
  ClinicalTrials.gov Identifier: NCT00571857 - Active, not recruiting
  Breast Cancer
  
• Cognitive and Drug Therapy for Drug-Resistant Depression
  ClinicalTrials.gov Identifier: NCT00000376 - Completed
  Depression; Anxiety Disorders; Personality Disorders; Drug-resistant depression
  
• Cognitive and Emotional Impairment After Stroke
  ClinicalTrials.gov Identifier: NCT00506818 - Recruiting
  Stroke; Cognitive Impairment; Emotional Symptoms; Vascular Risk-Factors; Vascular Dementia
  
• Cognitive and Health Benefits of Expressive Writing for Family Caregivers Under Stress
  ClinicalTrials.gov Identifier: NCT00303147 - Active, not recruiting
  Stress, Psychological; Anxiety
  
• Cognitive and Hormonal Treatment of Sex offendersHormo
  ClinicalTrials.gov Identifier: NCT00379626 - Recruiting
  Paraphilia
  
• Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00065767 - Completed
  Alzheimer Disease
  
• Cognitive aspects of adolescent suicide
  ClinicalTrials.gov Identifier: NCT00005566 - Active, not recruiting
  Suicide, Attempted
  
• Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
  ClinicalTrials.gov Identifier: NCT00218777 - Active, not recruiting
  Tourette Syndrome; Tic Disorders
  
• Cognitive Behavior Therapy for Somatization Disorder
  ClinicalTrials.gov Identifier: NCT00276887 - Completed
  Somatoform Disorders
  
• Cognitive Behavior Therapy for the Treatment of Pathological Gambling
  ClinicalTrials.gov Identifier: NCT00118391 - Completed
  Gambling; Mental Health
  
• Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00321451 - Recruiting
  Fibromyalgia; Sleep Initiation and Maintenance Disorders
  
• Cognitive Behavioral Social Skills Training for Improving Social Functioning in People With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00338975 - Recruiting
  Schizophrenia
  
• Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial
  ClinicalTrials.gov Identifier: NCT00582244 - Not yet recruiting
  Menopausal Symptoms in Breast Cancer Patients With Treatment-Induced Complaints
  
• Cognitive Behavioral Therapy Combined With Antidepressants to Reduce HIV Risk and Drug Relapse Among Depressed Intravenous Drug Users
  ClinicalTrials.gov Identifier: NCT00183768 - Completed
  HIV Infections; Depression; Substance-Related Disorders
  
• Cognitive Behavioral Therapy for Anxiety and Depression in COPD
  ClinicalTrials.gov Identifier: NCT00545922 - Completed
  Anxiety; Depression; Chronic Obstructive Pulmonary Disease
  
• Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00158301 - Recruiting
  Depression
  
• Cognitive Behavioral Therapy for Early-Onset Depression
  ClinicalTrials.gov Identifier: NCT00096642 - Active, not recruiting
  Major Depressive Disorder; Dysthymic Disorder
  
• Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients
  ClinicalTrials.gov Identifier: NCT00133601 - Recruiting
  Insomnia; Chronic Pain
  
• Cognitive Behavioral Therapy for Obesity
  ClinicalTrials.gov Identifier: NCT00569517 - Not yet recruiting
  Obesity
  
• Cognitive Behavioral Therapy for Pathological Gambling
  ClinicalTrials.gov Identifier: NCT00337753 - Recruiting
  Pathological Gambling
  
• Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Homeless Women
  ClinicalTrials.gov Identifier: NCT00353249 - Not yet recruiting
  Post-Traumatic Stress Disorder
  
• Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals with Severe Mental Illness
  ClinicalTrials.gov Identifier: NCT00078741 - Completed
  Stress Disorders, Post-Traumatic; Schizophrenia; Psychotic Disorders
  
• Cognitive Behavioral Therapy for the Treatment of Depression-Related Insomnia
  ClinicalTrials.gov Identifier: NCT00255905 - Recruiting
  Depression
  
• Cognitive Behavioral Therapy for the Treatment of Seasonal Affective Disorder (SAD)
  ClinicalTrials.gov Identifier: NCT00076245 - Active, not recruiting
  Seasonal Affective Disorder; Depression
  
• Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00050050 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00118911 - Recruiting
  Attention Deficit Disorder with Hyperactivity
  
• Cognitive Behavioral Therapy for Treatment of Pathological Gambling
  ClinicalTrials.gov Identifier: NCT00158314 - Completed
  Gambling
  
• Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00045903 - Completed
  Obsessive-Compulsive Disorder
  
• Cognitive Behavioral Therapy Plus Motivational Interviewing for Treatment of Obsessive-Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00316316 - Recruiting
  Obsessive-Compulsive Disorder
  
• Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents
  ClinicalTrials.gov Identifier: NCT00522769 - Recruiting
  Bulimia Nervosa
  
• Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)
  ClinicalTrials.gov Identifier: NCT00475111 - Completed
  Rheumatoid Arthritis
  
• Cognitive Behavioral Therapy Vs. Sertraline in the Treatment of Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00391430 - Recruiting
  Post-Traumatic Stress Disorder
  
• Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental Illnesses
  ClinicalTrials.gov Identifier: NCT00494650 - Not yet recruiting
  Post-Traumatic Stress Disorder
  
• Cognitive Behavioral Treatment of Pediatric Trichotillomania
  ClinicalTrials.gov Identifier: NCT00043563 - Completed
  Trichotillomania
  
• Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance
  ClinicalTrials.gov Identifier: NCT00108628 - Recruiting
  Post-Traumatic Stress Disorder
  
• Cognitive Behavioral vs. Interpersonal Therapy (IPT) Prevention of Depression in Adolescents
  ClinicalTrials.gov Identifier: NCT00374439 - Completed
  Depressive Symptoms
  
• Cognitive Behavioural Therapy for Obesity
  ClinicalTrials.gov Identifier: NCT00294268 - Recruiting
  Obesity
  
• Cognitive Benefits of Treating Sleep Apnea in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00492115 - Not yet recruiting
  Parkinson's Diseae; Sleep Disordered Breathing
  
• Cognitive Characteristics of PTSD Patients With OCD
  ClinicalTrials.gov Identifier: NCT00294970 - Completed
  Post-Traumatic Stress Disorders; Obsessive-Compulsive Disorder
  
• Cognitive Correlates of Substance Abuse - 11
  ClinicalTrials.gov Identifier: NCT00000346 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Cognitive Correlates of Substance Abuse, Part 2 - 16
  ClinicalTrials.gov Identifier: NCT00000351 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Cognitive Decline and Early Signs of Depression in Elderly People: the Efficacy of n-3 Fatty Acid Supplementation
  ClinicalTrials.gov Identifier: NCT00124852 - Active, not recruiting
  Cognitive decline; Depression
  
• Cognitive Effects of Aerobic Exercise for IGT Adults
  ClinicalTrials.gov Identifier: NCT00220441 - Active, not recruiting
  Impaired Glucose Tolerance
  
• Cognitive Effects of Aerobic Exercise for MCI Adults
  ClinicalTrials.gov Identifier: NCT00220467 - Recruiting
  Mild Cognitive Impairment
  
• Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over
  ClinicalTrials.gov Identifier: NCT00170768 - Completed
  Healthy Volunteers
  
• Cognitive Effects of Immunomodulatory Drugs in MS
  ClinicalTrials.gov Identifier: NCT00229502 - Active, not recruiting
  Multiple Sclerosis
  
• Cognitive Effects of Mecamylamine and Varenicline in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00455650 - Recruiting
  Cognition in Schizophrenia
  
• Cognitive Enhancement Therapy for Early-Stage Schizophrenia
  ClinicalTrials.gov Identifier: NCT00167362 - Active, not recruiting
  Schizophrenia
  
• Cognitive Function and Cue-Reactivity Study
  ClinicalTrials.gov Identifier: NCT00194246 - Active, not recruiting
  Cognitive Performance; Food Cravings
  
• Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy
  ClinicalTrials.gov Identifier: NCT00188331 - Recruiting
  Cognition; Fatigue; Colorectal Neoplasm
  
• Cognitive Function in Pediatric Epilepsy
  ClinicalTrials.gov Identifier: NCT00105040 - Completed
  Epilepsy
  
• Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98
  ClinicalTrials.gov Identifier: NCT00343616 - Recruiting
  Breast Cancer; Cognitive/Functional Effects; Fatigue; Psychosocial Effects/Treatment
  
• Cognitive Functioning and Quality of Life in CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00581737 - Recruiting
  Lymphoma; Central Nervous System Lymphoma
  
• Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations
  ClinicalTrials.gov Identifier: NCT00446420 - Recruiting
  Cognitive Impairment
  
• Cognitive Impairment in Parkinson’s Disease Categorised in Accordance to Motor Symptoms
  ClinicalTrials.gov Identifier: NCT00476372 - Not yet recruiting
  Parkinson's Disease
  
• Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)
  ClinicalTrials.gov Identifier: NCT00211380 - Terminated
  Schizophrenia or Schizoaffective Disorder
  
• Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia. (BMS)
  ClinicalTrials.gov Identifier: NCT00211302 - Terminated
  Schizophrenia or Schizoaffective Disorder
  
• Cognitive Interventions and Nutritional Supplementation for Patients With Long-Lasting Back Pain
  ClinicalTrials.gov Identifier: NCT00463970 - Not yet recruiting
  Chronic Low Back Pain
  
• Cognitive Motivational Behavior Therapy for Gamblers
  ClinicalTrials.gov Identifier: NCT00069420 - Active, not recruiting
  Gambling
  
• Cognitive Processing Therapy Versus Its Individual Components in the Treatment of Post-Traumatic Stress Disorder and Depression in Women Who Have Been Sexually Abused
  ClinicalTrials.gov Identifier: NCT00245232 - Active, not recruiting
  Post-Traumatic Stress Disorder
  
• Cognitive Processing Therapy Versus Prolonged Exposure for Treating Women With Post-Traumatic Stress Disorder Brought on by Sexual Assault
  ClinicalTrials.gov Identifier: NCT00239772 - Active, not recruiting
  Post-Traumatic Stress Disorder
  
• Cognitive Protection – Dexmedetomidine and Cognitive Reserve
  ClinicalTrials.gov Identifier: NCT00455143 - Recruiting
  Postoperative Delirium (PD); Postoperative Cognitive Dysfunction (POCD)
  
• Cognitive Rehabilitation in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00248794 - Recruiting
  Schizophrenia; Cognitive Impairment
  
• Cognitive Rehabilitation of Glioma Patients
  ClinicalTrials.gov Identifier: NCT00256425 - Active, not recruiting
  Glioma; Cognition Disorders
  
• Cognitive Remediation and Social Skills Training in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00223535 - Completed
  Schizophrenia; Schizoaffective
  
• Cognitive Remediation for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00261794 - Recruiting
  Schizophrenia
  
• Cognitive Remediation for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00295048 - Completed
  Schizophrenia
  
• Cognitive Remediation in Early Substance Abuse Treatment
  ClinicalTrials.gov Identifier: NCT00334217 - Recruiting
  Substance-Related Disorders
  
• Cognitive Remediation in Supported Employment at HSC
  ClinicalTrials.gov Identifier: NCT00138021 - Active, not recruiting
  Vocational rehabilitation; Schizophrenia; Mental Disorders; Cognitive Symptoms
  
• Cognitive Therapy for Binge-Eating Disorder
  ClinicalTrials.gov Identifier: NCT00050037 - Active, not recruiting
  Obesity; Eating Disorders
  
• Cognitive Therapy for Negative Symptoms and Functioning
  ClinicalTrials.gov Identifier: NCT00350883 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Cognitive Therapy for Recurrent Depression
  ClinicalTrials.gov Identifier: NCT00118404 - Recruiting
  Depression
  
• Cognitive Therapy for Suicidal Older Men in Primary Care Settings
  ClinicalTrials.gov Identifier: NCT00149773 - Recruiting
  Suicide, Attempted
  
• Cognitive Therapy for Treating Depression and Preventing Relapse
  ClinicalTrials.gov Identifier: NCT00183664 - Recruiting
  Depression
  
• Cognitive Therapy to Improve Word Finding
  ClinicalTrials.gov Identifier: NCT00494520 - Recruiting
  Anomia; Aphasia; Traumatic Brain Injury; Cerebrovascular Accident
  
• Cognitive Therapy Versus Medication Treatment for Preventing Depression Relapse
  ClinicalTrials.gov Identifier: NCT00218764 - Recruiting
  Depression
  
• Cognitive Therapy Versus Supportive Therapy in Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00131781 - Active, not recruiting
  Borderline Personality Disorder
  
• Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
  ClinicalTrials.gov Identifier: NCT00498719 - Recruiting
  Leukemia; Lymphoma; Brain Tumor
  
• Cognitive Training in the Elderly
  ClinicalTrials.gov Identifier: NCT00146263 - Recruiting
  mild cognitive impairment and dementia
  
• Cognitive, Emotional, Physical and Psychosocial Effects of Panax Quinquefolius L
  ClinicalTrials.gov Identifier: NCT00527969 - Recruiting
  Memory; Learning; Attention; Cognition; Well-Being
  
• Cognitive-Behavior Therapy for MS-Related Chronic Pain
  ClinicalTrials.gov Identifier: NCT00323271 - Not yet recruiting
  Multiple Sclerosis
  
• Cognitive-Behavioral Therapy and Lexapro for GAD
  ClinicalTrials.gov Identifier: NCT00219349 - Recruiting
  Generalized Anxiety Disorder
  
• Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00072657 - Recruiting
  Rheumatoid Arthritis
  
• Cognitive-Behavioral Treatment of Chronic Back Pain
  ClinicalTrials.gov Identifier: NCT00454064 - Recruiting
  Back Pain
  
• Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the Elderly
  ClinicalTrials.gov Identifier: NCT00295386 - Active, not recruiting
  Insomnia
  
• Cognitive/Cerebrovascular Consequences of HTN Treatment
  ClinicalTrials.gov Identifier: NCT00151138 - Completed
  Hypertension
  
• Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
  ClinicalTrials.gov Identifier: NCT00331357 - Not yet recruiting
  Acute Idiopathic Thrombocytopenic Purpura
  
• Cohort Study for Patients Using Fuzeon (Enfuvirtide)
  ClinicalTrials.gov Identifier: NCT00216359 - Active, not recruiting
  HIV Infections; Antiretroviral Treatment
  
• Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks
  ClinicalTrials.gov Identifier: NCT00540410 - Recruiting
  Malaria
  
• Cohort Study of Heart Rate Variability
  ClinicalTrials.gov Identifier: NCT00005399 - Completed
  Cardiovascular Diseases; Myocardial Ischemia; Carotid Stenosis; Hypertension; Diabetes Mellitus; Heart Diseases
  
• Cohort Study of Respiratory Illness in Early Childhood
  ClinicalTrials.gov Identifier: NCT00005427 - Completed
  Lung Diseases
  
• Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia
  ClinicalTrials.gov Identifier: NCT00238043 - Recruiting
  Chronic Kidney Disease; End-Stage Renal Failure; Anaemia
  
• Cohorts and Collections
  ClinicalTrials.gov Identifier: NCT00142363 - Terminated
  Parkinson''s Disease; Epilepsy
  
• Coil Embolization of Coronary Artery Fistulas
  ClinicalTrials.gov Identifier: NCT00198016 - Completed
  C14; C14907933; C14907933125; G09330582163324; C14280647250
  
• COL-3 in Treating Patients With HIV-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00020683 - Active, not recruiting
  epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
  
• COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors
  ClinicalTrials.gov Identifier: NCT00004147 - Completed
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma
  
• Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2
  ClinicalTrials.gov Identifier: NCT00000250 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Colistin IV-Pilot Study: Pharmacokinetics and Pharmacodynamics of Intravenous Colistin
  ClinicalTrials.gov Identifier: NCT00235690 - Recruiting
  Bacteremia; Pseudomonas Infections
  
• Collaboration to Reduce Disparities in Hypertension
  ClinicalTrials.gov Identifier: NCT00133068 - Recruiting
  Hypertension
  
• Collaborative Care for Heart Failure Patients With the Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00293852 - Recruiting
  Heart Failure, Congestive; Metabolic Syndrome X
  
• Collaborative Corneal Transplantation Studies (CCTS)
  ClinicalTrials.gov Identifier: NCT00000137 - Completed
  Corneal Transplantation; Graft Rejection
  
• Collaborative Initial Glaucoma Treatment Study (CIGTS)
  ClinicalTrials.gov Identifier: NCT00000149 - Active, not recruiting
  Open-Angle Glaucoma
  
• Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-Related Cataract (CTNS)
  ClinicalTrials.gov Identifier: NCT00309387 - Active, not recruiting
  Cataract
  
• Collaborative Ocular Melanoma Study (COMS)
  ClinicalTrials.gov Identifier: NCT00000124 - Active, not recruiting
  Choroid Neoplasms; Uveitis
  
• Collaborative Studies on the Genetics of Asthma (CSGA)
  ClinicalTrials.gov Identifier: NCT00005500 - Active, not recruiting
  Asthma; Lung Diseases
  
• Collaborative Study of 1,3 Butadiene Biomarkers
  ClinicalTrials.gov Identifier: NCT00023140 - Completed
  Cancer
  
• Collaborative Tinnitus Research at Washington University
  ClinicalTrials.gov Identifier: NCT00567892 - Not yet recruiting
  Subjective Tinnitus
  
• Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder)
  ClinicalTrials.gov Identifier: NCT00261196 - Recruiting
  Adhesive Capsulitis; Frozen Shoulder
  
• Collagenase in the Treatment of Cellulite
  ClinicalTrials.gov Identifier: NCT00261144 - Recruiting
  Cellulite
  
• Collagenase in the Treatment of Dupuytrens Disease
  ClinicalTrials.gov Identifier: NCT00260429 - Not yet recruiting
  Dupuytren''s Disease With a Minimum 20 Degree Joint Flexion Contracture of One or More Fingers.
  
• Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand
  ClinicalTrials.gov Identifier: NCT00261209 - Recruiting
  Hand Zone II Flexor Tendon Adhesions
  
• Collecting and Banking Pediatric Brain Tumor Research Specimens
  ClinicalTrials.gov Identifier: NCT00228748 - Recruiting
  Brain Tumor
  
• Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
  ClinicalTrials.gov Identifier: NCT00228735 - Recruiting
  Obtain These Rare Tumor Specimens, as Well as, Specimens From Any Diseases That Do Not Have Their Own Unique Banking Protocol
  
• Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinical Trial
  ClinicalTrials.gov Identifier: NCT00459199 - Recruiting
  Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Leukemia; Long-Term Effects Secondary to Cancer Therapy in Adults; Long-Term Effects Secondary to Cancer Therapy in Children; Lymphoma; Neurofibromatosis Type 1 (nf1); Psychosocial Effects/Treatment; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Collecting Endometrial and Ovarian Tissues Samples From Patients Without Cancer Undergoing a Hysterectomy
  ClinicalTrials.gov Identifier: NCT00342680 - Recruiting
  Endometrial Cancer
  
• Collecting Tissue Samples From Patients With Melanocytic Nevi or Pigmented Lesions
  ClinicalTrials.gov Identifier: NCT00335530 - Recruiting
  Melanoma (Skin); Precancerous/Nonmalignant Condition
  
• Collection and Distribution of Blood Samples From Healthy Donors for In Vitro Research at the NCI Frederick Cancer Research and Development Center
  ClinicalTrials.gov Identifier: NCT00339911 - Recruiting
  Samples
  
• Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00012545 - Recruiting
  Healthy; Sickle Cell Anemia
  
• Collection of Alveolar Soft Part Sarcoma Tumor Specimens for Research
  ClinicalTrials.gov Identifier: NCT00340353 - Recruiting
  Alveolar Soft Part Sarcoma; Sarcoma
  
• Collection of Autologous Blood Products by Double Erythrocytapheresis
  ClinicalTrials.gov Identifier: NCT00202475 - Recruiting
  Preoperative Autologous Donation
  
• Collection of Biological Samples from Patients with Hepatitis-Associated Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00050115 - Recruiting
  Aplastic Anemia
  
• Collection of Blood and Bone Marrow from Normal Volunteers and Patients for Research Purposes
  ClinicalTrials.gov Identifier: NCT00001627 - Active, not recruiting
  Aplastic Anemia; Fanconi's Anemia; Healthy; Hematologic Disease; Myelodysplastic Syndrome
  
• Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00083512 - Recruiting
  Glioblastoma
  
• Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination Services
  ClinicalTrials.gov Identifier: NCT00173940 - Recruiting
  Chronic Diseases, Such as Hypertension, Diabetes, Obesity, Chronic Renal Failure, and So on
  
• Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
  ClinicalTrials.gov Identifier: NCT00320151 - Recruiting
  Pulmonary Diseases
  
• Collection of Blood from Patients with Cancer
  ClinicalTrials.gov Identifier: NCT00034216 - Recruiting
  Neoplasms
  
• Collection of Blood from Patients with Pancytopenia
  ClinicalTrials.gov Identifier: NCT00001214 - Recruiting
  Aplastic Anemia; Pancytopenia
  
• Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research
  ClinicalTrials.gov Identifier: NCT00277849 - Recruiting
  Hemoglobin Mutations; Erythrocyte Variants
  
• Collection of Blood Samples for DNA in Motor Neuron Disease
  ClinicalTrials.gov Identifier: NCT00362362 - Recruiting
  Motor Neuron Diseases
  
• Collection of Blood Samples From Healthy Volunteers for Research Studies
  ClinicalTrials.gov Identifier: NCT00577239 - Recruiting
  Healthy
  
• Collection of Blood Samples from HIV Infected People
  ClinicalTrials.gov Identifier: NCT00096772 - Active, not recruiting
  HIV Infections
  
• Collection of Blood Samples From SMART Study Participants for Future Genetic Studies
  ClinicalTrials.gov Identifier: NCT00377169 - Active, not recruiting
  HIV Infections
  
• Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00442195 - Recruiting
  Healthy
  
• Collection of Blood, Bone Marrow, Tumor or Tissue Samples
  ClinicalTrials.gov Identifier: NCT00043615 - Recruiting
  Neoplasms; Precancerous Conditions
  
• Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with Cancer to Study Drug Resistance
  ClinicalTrials.gov Identifier: NCT00026663 - Recruiting
  Neoplasm
  
• Collection of Bone Marrow Aspirate From Volunteer Donors
  ClinicalTrials.gov Identifier: NCT00183066 - Recruiting
  Aging
  
• Collection of Bone Marrow Samples From Healthy Volunteers for Research Studies
  ClinicalTrials.gov Identifier: NCT00577941 - Recruiting
  Healthy
  
• Collection of Cells and/or Blood Samples From Patients for Research Studies
  ClinicalTrials.gov Identifier: NCT00578253 - Recruiting
  Laboratory Studies; Malignant Cells; Abnormal Cells; Normal Cells
  
• Collection of Convalescent SARS Plasma by Apheresis
  ClinicalTrials.gov Identifier: NCT00342524 - Completed
  Severe Acute Respiratory Syndrome; SARS
  
• Collection of Heart Tissue Sample During Open Heart Surgery
  ClinicalTrials.gov Identifier: NCT00423553 - Completed
  Ischemia
  
• Collection of Liver Tissue for Virologic Studies
  ClinicalTrials.gov Identifier: NCT00005936 - Completed
  Virus Disease
  
• Collection of Lung Fluid and Tissue Samples for Research
  ClinicalTrials.gov Identifier: NCT00471250 - Recruiting
  Mycobacterium Infections, Atypical; Granulomatous Disease, Chronic; Job's Syndrome; Influenza, Human
  
• Collection of Outcomes Data for Pregnant Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00507572 - Recruiting
  Advanced Cancer; Pregnancy
  
• Collection of Peripheral Blood and Bone Marrow from Healthy Donors for Use in In Vitro Research.
  ClinicalTrials.gov Identifier: NCT00090662 - Active, not recruiting
  Healthy
  
• Collection of Samples and Data for the National Marrow Donor Program Repository
  ClinicalTrials.gov Identifier: NCT00495300 - Recruiting
  Hematopoietic Stem Cell Transplantation
  
• Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease
  ClinicalTrials.gov Identifier: NCT00026884 - Recruiting
  Neoplasm
  
• Collection of Specimens for Study of Inflammatory Bowel Disease
  ClinicalTrials.gov Identifier: NCT00086554 - Recruiting
  
  
• Collection of Specimens to be Used for Studying the Causes, Diagnosis, Prevention, and Treatment of Cancer
  ClinicalTrials.gov Identifier: NCT00580554 - Recruiting
  Appendiceal Cancer; Cervical Cancer; Endometrial Cancer; Fallopian Tube Disease; Gestational Trophoblastic Neoplasms; Ovarian Cancer; Peritoneal Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer
  
• Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00582647 - Recruiting
  Esophageal Cancer; Bile Duct Neoplasms; Gastric Cancer; Liver Cancer; Melanoma; Pancreatic Cancer; Sarcoma
  
• Collection of Tissue Specimens from Patients with Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
  ClinicalTrials.gov Identifier: NCT00071045 - Recruiting
  Neoplasms; Hematologic Neoplasms
  
• Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research
  ClinicalTrials.gov Identifier: NCT00341042 - Recruiting
  Tuberculosis; HIV
  
• Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
  ClinicalTrials.gov Identifier: NCT00580203 - Recruiting
  Head and Neck Cancers
  
• Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
  ClinicalTrials.gov Identifier: NCT00580463 - Recruiting
  Primary or Metastatic Central Nervous System (CNS) Tumor
  
• Collections of Blood and Stool Samples in Patients with Acute Hepatitis
  ClinicalTrials.gov Identifier: NCT00001879 - Completed
  
  
• COlon Cancer Laparoscopic or Open Resection
  ClinicalTrials.gov Identifier: NCT00387842 - Active, not recruiting
  Colonic Neoplasms
  
• Colon Investigation - Factors Determining Choice of Procedure
  ClinicalTrials.gov Identifier: NCT00423345 - Recruiting
  Irritable Colon; Colorectal Cancer; Inflammatory Bowel Disease
  
• Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
  ClinicalTrials.gov Identifier: NCT00254527 - Completed
  Methicillin Resistance; Staphylococcus Aureus
  
• Colonizing Neurogenic Bladders With Benign Flora
  ClinicalTrials.gov Identifier: NCT00371631 - Recruiting
  Urinary Tract Infection; Spinal Cord Injury
  
• Colonoscope Passive Bending Function
  ClinicalTrials.gov Identifier: NCT00518349 - Active, not recruiting
  Colitis; Adenoma; Carcinoma; Functional Colonic Disease
  
• Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-Individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00436514 - Not yet recruiting
  Colorectal Cancer
  
• Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00102011 - Recruiting
  Colon Cancer; Rectal Cancer
  
• Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
  ClinicalTrials.gov Identifier: NCT00250770 - Active, not recruiting
  Uterine Neoplasms; Endometrial Neoplasms
  
• Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003597 - Active, not recruiting
  Brain Tumors; Musculoskeletal Tumors; Kidney Tumors; Solid Tumors
  
• Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004192 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Color Flow Doppler Ultrasound in Subclinical Thyroid Dysfunction
  ClinicalTrials.gov Identifier: NCT00437931 - Not yet recruiting
  Subclinical Hypothyroidism; Hyperthyroidism; Thyroid Dysfunction
  
• COLOR II: Laparoscopic Versus Open Rectal Cancer Removal
  ClinicalTrials.gov Identifier: NCT00297791 - Recruiting
  Rectal Cancer
  
• Colorado Women's Prison Project - 1
  ClinicalTrials.gov Identifier: NCT00249561 - Recruiting
  Substance-Related Disorders
  
• Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00063427 - Active, not recruiting
  Colorectal Neoplasms
  
• Colorectal Cancer (CRC) Screening Intervention
  ClinicalTrials.gov Identifier: NCT00491205 - Recruiting
  Colorectal Cancer
  
• Colorectal Cancer Control in Appalachian Churches
  ClinicalTrials.gov Identifier: NCT00137683 - Active, not recruiting
  Colorectal Cancer
  
• Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients
  ClinicalTrials.gov Identifier: NCT00582829 - Recruiting
  Colorectal; Cancer; Screening; Intervention
  
• Colorectal Cancer Screening Intervention in UWPN Clinics
  ClinicalTrials.gov Identifier: NCT00161460 - Recruiting
  Colorectal neoplasia
  
• Colorectal Cancer Screening Intervention Trial
  ClinicalTrials.gov Identifier: NCT00265720 - Recruiting
  Colorectal Cancer; Colorectal Cancer Screening
  
• Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations
  ClinicalTrials.gov Identifier: NCT00476970 - Recruiting
  Colorectal Cancer Screening
  
• Colorectal Neoplasia Screening With Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Centers: The CONCeRN Trial
  ClinicalTrials.gov Identifier: NCT00339950 - Active, not recruiting
  Colorectal Neoplasia
  
• Colpocleisis for Advanced Pelvic Organ Prolapse
  ClinicalTrials.gov Identifier: NCT00271037 - Completed
  Pelvic Organ Prolapse; Stress Urinary Incontinence
  
• Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide
  ClinicalTrials.gov Identifier: NCT00188695 - Recruiting
  Uterine Neoplasms; Cervix Neoplasms; Bladder Neoplasms; Prostatic Neoplasms
  
• Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
  ClinicalTrials.gov Identifier: NCT00442312 - Active, not recruiting
  Glaucoma
  
• Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
  ClinicalTrials.gov Identifier: NCT00351273 - Recruiting
  Arthritis, Reactive; Reiter Disease
  
• Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00022971 - Recruiting
  Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia
  
• Combination Antimalarials in Uncomplicated Malaria
  ClinicalTrials.gov Identifier: NCT00203801 - Completed
  Malaria
  
• Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
  ClinicalTrials.gov Identifier: NCT00426998 - Completed
  Choroidal Neovascularization; Macular Degeneration
  
• Combination Bisphosphonate and Anti-Angiogenesis Therapy with Pamidronate and Thalidomide
  ClinicalTrials.gov Identifier: NCT00083382 - Active, not recruiting
  Multiple Myeloma
  
• Combination Bisphosphonate and Anti-Angiogenesis Therapy with Pamidronate and Thalidomide
  ClinicalTrials.gov Identifier: NCT00083408 - Completed
  Multiple Myeloma
  
• Combination Bortezomib and Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00422799 - Recruiting
  Waldenstrom's Macroglobulinemia
  
• Combination Bortezomib-Containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00570180 - Recruiting
  Multiple Myeloma
  
• Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00319787 - Completed
  Locally Advanced Prostate Cancer
  
• Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00483262 - Recruiting
  Multiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma
  
• Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm
  ClinicalTrials.gov Identifier: NCT00479050 - Completed
  Hepatocellular Carcinoma
  
• Combination Chemotherapy (FLAC) Combined with Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00001239 - Completed
  Breast Cancer; Breast Neoplasms
  
• Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00225173 - Terminated
  Hodgkin Disease
  
• Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00003237 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage II esophageal cancer; ...
  
• Combination Chemotherapy After Surgery in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022516 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028964 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; recurrent breast cancer; Drug Toxicity
  
• Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002611 - Completed
  stage I Wilms' tumor; stage II Wilms' tumor; stage III Wilms' tumor; stage IV Wilms' tumor; stage V Wilms' tumor; clear cell sarcoma of the kidney
  
• Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00262925 - Recruiting
  Recurrent Adult Acute Lymphoblastic Leukemia
  
• Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00054340 - Active, not recruiting
  acute leukemia; chronic myeloproliferative disorders; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease
  
• Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00550784 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227617 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Carcinoma of the Skin
  
• Combination Chemotherapy and Bevacizumab in Treating Patients With Recurrent, Unresectable, or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, or Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00403468 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00321828 - Recruiting
  Colorectal Cancer
  
• Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00449163 - Recruiting
  Colorectal Cancer
  
• Combination Chemotherapy and Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00265824 - Recruiting
  Colorectal Cancer
  
• Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00462501 - Recruiting
  Colorectal Cancer
  
• Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00003667 - Completed
  extraosseous Ewing's sarcoma/primitive neuroectodermal tumor; metastatic tumors of the Ewing's family; nonmetastatic childhood soft tissue sarcoma; ...
  
• Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically
  ClinicalTrials.gov Identifier: NCT00003664 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; Quality of Life
  
• Combination Chemotherapy and Blood-Brain Barrier Disruption Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma
  ClinicalTrials.gov Identifier: NCT00303849 - Recruiting
  Brain and Central Nervous System Tumors
  
• Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002521 - Active, not recruiting
  adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00003101 - Active, not recruiting
  adult anaplastic oligodendroglioma; adult well-differentiated oligodendroglioma; Adult Oligodendroglioma
  
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Aplastic Anemia or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003816 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002502 - Completed
  Lymphoma; Leukemia; Multiple Myeloma; Eye Cancer
  
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Refractory or Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002474 - Completed
  recurrent ovarian epithelial cancer
  
• Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00073866 - Completed
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00381706 - Recruiting
  Esophageal Cancer
  
• Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00033553 - Active, not recruiting
  Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Combination Chemotherapy and Cyclosporine Followed By Cryotherapy and/or Laser Therapy in Treating Patients With Newly Diagnosed Retinoblastoma in Both Eyes
  ClinicalTrials.gov Identifier: NCT00110110 - Recruiting
  intraocular retinoblastoma
  
• Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00513188 - Recruiting
  Lymphoma
  
• Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
  ClinicalTrials.gov Identifier: NCT00544778 - Active, not recruiting
  Sarcoma
  
• Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00041054 - Completed
  extensive stage small cell lung cancer
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Combination Chemotherapy and Filgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00031629 - Active, not recruiting
  recurrent uterine sarcoma; uterine leiomyosarcoma
  
• Combination Chemotherapy and G-CSF in Treating Women With Breast Cancer That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00194779 - Recruiting
  Breast Cancer
  
• Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00049569 - Completed
  recurrent childhood acute lymphoblastic leukemia; non-T, non-B childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00052494 - Active, not recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Combination Chemotherapy and Interferon alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00004897 - Active, not recruiting
  squamous cell carcinoma of the esophagus; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
  
• Combination Chemotherapy and Interferon alfa in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002598 - Completed
  relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; atypical chronic myeloid leukemia
  
• Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00471484 - Recruiting
  Liver Cancer
  
• Combination Chemotherapy and Monoclonal Antibody Therapy Followed by Vaccine Therapy in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00020215 - Completed
  Noncontiguous Stage II Mantle Cell Lymphoma; Stage IV Mantle Cell Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Stage I Mantle Cell Lymphoma; Stage III Mantle Cell Lymphoma
  
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
  ClinicalTrials.gov Identifier: NCT00513266 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00047151 - Active, not recruiting
  recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer
  
• Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00032019 - Active, not recruiting
  adult diffuse large cell lymphoma; adult immunoblastic large cell lymphoma
  
• Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00055822 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00513292 - Recruiting
  Breast Cancer
  
• Combination Chemotherapy and Pegfilgrastim Followed by Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00522366 - Completed
  Lung Cancer
  
• Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00453232 - Recruiting
  Extragonadal Germ Cell Tumor; Teratoma; Testicular Germ Cell Tumor
  
• Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00470366 - Recruiting
  Brain and Central Nervous System Tumors; Extragonadal Germ Cell Tumor; Ovarian Cancer; Teratoma; Testicular Germ Cell Tumor
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003199 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002982 - Completed
  recurrent grade 3 follicular lymphoma; recurrent adult diffuse small cleaved cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003136 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00004903 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00004188 - Completed
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003064 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003194 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00025636 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
  ClinicalTrials.gov Identifier: NCT00002601 - Active, not recruiting
  Bone Cancer; Soft Tissue Sarcoma
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003972 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00004221 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004906 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation With or Without Radiation Therapy and/or Surgery in Treating Patients With Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00020566 - Recruiting
  localized tumors of the Ewing's family; metastatic tumors of the Ewing's family
  
• Combination Chemotherapy and Radiation Therapy Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00303719 - Recruiting
  Breast Cancer; Chronic Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006469 - Active, not recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00004034 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; cardiac toxicity; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00004010 - Active, not recruiting
  stage III childhood Hodgkin's disease; stage IV childhood Hodgkin's disease; childhood lymphocyte predominant Hodgkin's disease; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00255723 - Recruiting
  Lymphoma
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00238147 - Recruiting
  Esophageal Cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
  ClinicalTrials.gov Identifier: NCT00096135 - Recruiting
  recurrent childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002711 - Active, not recruiting
  stage III esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002801 - Active, not recruiting
  stage III rectal cancer; stage I rectal cancer; stage II colon cancer; stage II rectal cancer; stage III colon cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00281788 - Recruiting
  Esophageal Cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain
  ClinicalTrials.gov Identifier: NCT00293358 - Active, not recruiting
  Brain and Central Nervous System Tumors
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00033696 - Active, not recruiting
  limited stage small cell lung cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006012 - Completed
  Drug Toxicity; radiation toxicity; limited stage small cell lung cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00352118 - Recruiting
  Head and Neck Cancer; Mucositis; Oral Complications of Chemotherapy and Head/Neck Radiation
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00354835 - Recruiting
  Sarcoma
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026130 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer
  ClinicalTrials.gov Identifier: NCT00002466 - Active, not recruiting
  small cell bone sarcoma; metastatic tumors of the Ewing's family; nonmetastatic childhood soft tissue sarcoma; localized osteosarcoma; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00268333 - Completed
  Colorectal Cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00004253 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy and Radiation Therapy In Treating Patients With Stage III or Stage IV Cancer of the Hypopharynx or Tongue
  ClinicalTrials.gov Identifier: NCT00002735 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the oropharynx; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054054 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the larynx; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095875 - Recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00268372 - Active, not recruiting
  Stage III Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00014196 - Completed
  Squamous Cell Lung Cancer; large cell lung cancer; stage IIIB non-small cell lung cancer; Adenocarcinoma of the Lung
  
• Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00416832 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas
  ClinicalTrials.gov Identifier: NCT00253487 - Suspended
  Brain and Central Nervous System Tumors
  
• Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002481 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00020345 - Active, not recruiting
  Stage IVA Pancreatic Cancer; Stage III Pancreatic Cancer; Adenocarcinoma of the Pancreas
  
• Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx That Can be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00498953 - Recruiting
  Head and Neck Cancer
  
• Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas
  ClinicalTrials.gov Identifier: NCT00278278 - Recruiting
  Brain and Central Nervous System Tumors
  
• Combination Chemotherapy and Radiation Therapy With or Without Surgery In Treating Patients With Stage II or Stage III Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00055601 - Recruiting
  stage II bladder cancer; stage III bladder cancer
  
• Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00049413 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia
  
• Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia That Did Not Respond to Fludarabine (Closed to Entry as of 10/2006), Chronic Lymphocytic Leukemia With Autoimmune Hemolytic Anemia, or Richter Transformation
  ClinicalTrials.gov Identifier: NCT00309881 - Not yet recruiting
  Leukemia
  
• Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00049036 - Recruiting
  AIDS-related diffuse large cell lymphoma; AIDS-related immunoblastic large cell lymphoma; AIDS-related peripheral/systemic lymphoma; ...
  
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00389818 - Recruiting
  Lymphoma
  
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt''s or Burkitt''s-Like Lymphoma or Leukemia
  ClinicalTrials.gov Identifier: NCT00133991 - Recruiting
  L3 adult acute lymphoblastic leukemia; adult Burkitt''s lymphoma; untreated adult acute lymphoblastic leukemia
  
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00416819 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy and Rituximab in Treating Patients With Previously Untreated AIDS-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00020384 - Recruiting
  Lymphoma
  
• Combination Chemotherapy and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00057772 - Recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
  
• Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00058461 - Completed
  acute leukemia; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma
  
• Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00193479 - Active, not recruiting
  Non-Hodgkins Lymphoma
  
• Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00005060 - Active, not recruiting
  stage II gastric cancer; stage III gastric cancer
  
• Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00003776 - Completed
  metastatic osteosarcoma
  
• Combination Chemotherapy and Surgery in Treating Patients With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00020241 - Active, not recruiting
  Breast Cancer
  
• Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00008138 - Active, not recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00002539 - Active, not recruiting
  localized osteosarcoma
  
• Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00499616 - Recruiting
  Neuroblastoma
  
• Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00416676 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002608 - Completed
  Cancer
  
• Combination Chemotherapy and Thalidomide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00053287 - Completed
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00054158 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
  ClinicalTrials.gov Identifier: NCT00276705 - Recruiting
  Liver Cancer
  
• Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00124644 - Recruiting
  adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with t(16;16)(p13;q22); ...
  
• Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00365287 - Active, not recruiting
  Breast Cancer; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00027547 - Completed
  adult acute lymphoblastic leukemia in remission; childhood acute lymphoblastic leukemia in remission
  
• Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003612 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00417014 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00303771 - Recruiting
  Colorectal Cancer
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00416767 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00112658 - Recruiting
  adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00448682 - Recruiting
  Gastric Cancer
  
• Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003037 - Completed
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00430118 - Recruiting
  Leukemia
  
• Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00019864 - Active, not recruiting
  Cardiac Toxicity; Sarcoma
  
• Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00002783 - Active, not recruiting
  stage III gastric cancer; stage II gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025428 - Active, not recruiting
  localized unresectable neuroblastoma
  
• Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung
  ClinicalTrials.gov Identifier: NCT00030745 - Active, not recruiting
  localized malignant mesothelioma
  
• Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00008034 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer
  
• Combination Chemotherapy Combined with Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00008047 - Active, not recruiting
  stage II esophageal cancer; stage III esophageal cancer
  
• Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00016341 - Completed
  stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer
  
• Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002498 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002823 - Active, not recruiting
  stage III non-small cell lung cancer; Adenosquamous Cell Lung Cancer; stage II non-small cell lung cancer; Squamous Cell Lung Cancer; ...
  
• Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00053911 - Active, not recruiting
  recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00003382 - Completed
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; ...
  
• Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
  ClinicalTrials.gov Identifier: NCT00189410 - Active, not recruiting
  Cancer of the Ovary Treated as 2nd Line Therapy; Muellerian Mixed Tumours; Tumours of the Uterus; Cervical Cancers; Non-Epithelial Ovarian Tumours
  
• Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00278213 - Active, not recruiting
  Leukemia
  
• Combination Chemotherapy Followed By Antiviral Therapy and Interferon alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
  ClinicalTrials.gov Identifier: NCT00041327 - Active, not recruiting
  stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; stage III adult T-cell leukemia/lymphoma; ...
  
• Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00244946 - Recruiting
  Lymphoma
  
• Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002594 - Completed
  recurrent childhood brain tumor; childhood central nervous system germ cell tumor; recurrent childhood medulloblastoma
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002549 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003146 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006373 - Completed
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002461 - Active, not recruiting
  Lymphocytic Lymphoma; Hodgkin's Disease; Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002522 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma; ...
  
• Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002508 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; extragonadal germ cell tumor
  
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00014469 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease
  
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
  ClinicalTrials.gov Identifier: NCT00002515 - Completed
  bone marrow ablation; Cancer
  
• Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00069953 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage II esophageal cancer; stage III esophageal cancer
  
• Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003332 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplantation in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00025038 - Completed
  juvenile myelomonocytic leukemia
  
• Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
  ClinicalTrials.gov Identifier: NCT00008307 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm
  
• Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis
  ClinicalTrials.gov Identifier: NCT00334672 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00574496 - Recruiting
  Lymphoma
  
• Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Young Patients With Epidermolysis Bullosa at High Risk of Developing Squamous Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00478244 - Recruiting
  Non-Melanomatous Skin Cancer; Precancerous/Nonmalignant Condition
  
• Combination Chemotherapy Followed By Donor Umbilical Cord Blood Transplant in Treating Infants With High-Risk Acute Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00357565 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00053131 - Active, not recruiting
  recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004056 - Active, not recruiting
  childhood acute megakaryocytic leukemia (M7); untreated childhood acute myeloid leukemia; ...
  
• Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00045630 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
  ClinicalTrials.gov Identifier: NCT00336024 - Recruiting
  Brain and Central Nervous System Tumors
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00008190 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Low-Dose Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003875 - Recruiting
  adult acute myeloid leukemia; childhood acute myeloid leukemia
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002941 - Active, not recruiting
  recurrent childhood lymphoblastic lymphoma; childhood diffuse large cell lymphoma; childhood immunoblastic large cell lymphoma; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002638 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004174 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002674 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002761 - Active, not recruiting
  relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00027924 - Active, not recruiting
  Myeloid Leukemia; Refractory Anemia
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00006379 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00006747 - Active, not recruiting
  Graft Versus Host Disease; stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00005612 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00003406 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005798 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006032 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer
  ClinicalTrials.gov Identifier: NCT00025558 - Active, not recruiting
  adult brain tumor; childhood central nervous system germ cell tumor; childhood ependymoma; Childhood Medulloblastoma; ...
  
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003619 - Completed
  Polycythemia Vera; Thrombocytopenia; Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; ...
  
• Combination Chemotherapy Followed by Radiation Therapy and/or Chemotherapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00302003 - Recruiting
  Lymphoma
  
• Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00030810 - Active, not recruiting
  Squamous Cell Lung Cancer; large cell lung cancer; stage IIIB non-small cell lung cancer; Adenosquamous Cell Lung Cancer
  
• Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002822 - Active, not recruiting
  Carcinoma, Small Cell
  
• Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma
  ClinicalTrials.gov Identifier: NCT00004224 - Recruiting
  childhood infratentorial ependymoma; childhood supratentorial ependymoma; newly diagnosed childhood ependymoma
  
• Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma
  ClinicalTrials.gov Identifier: NCT00006258 - Completed
  adult brain tumor; childhood infratentorial ependymoma; Childhood Medulloblastoma; childhood supratentorial ependymoma; ...
  
• Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00039039 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy Followed by Radiation Therapy With or Without Surgery in Treating Women With Locally Advanced or Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00017095 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer
  
• Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00006461 - Active, not recruiting
  untreated childhood supratentorial primitive neuroectodermal tumors; untreated childhood medulloblastoma
  
• Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00526318 - Recruiting
  Neuroblastoma
  
• Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00317408 - Recruiting
  Lymphoma
  
• Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00006038 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage IV gastric cancer; ...
  
• Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025649 - Active, not recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025623 - Active, not recruiting
  disseminated neuroblastoma
  
• Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.
  ClinicalTrials.gov Identifier: NCT00025597 - Active, not recruiting
  localized unresectable neuroblastoma
  
• Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00017563 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003231 - Active, not recruiting
  stage IIIA non-small cell lung cancer; Squamous Cell Lung Cancer; Adenocarcinoma of the Lung; large cell lung cancer
  
• Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003111 - Active, not recruiting
  stage IIIA non-small cell lung cancer
  
• Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004103 - Active, not recruiting
  stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
  
• Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00276731 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy Followed By Tipifarnib Plus Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00025480 - Completed
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00054236 - Recruiting
  adult acute erythroid leukemia; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00017290 - Active, not recruiting
  stage III grade 1 follicular lymphoma; stage III grade 2 follicular lymphoma; stage III grade 3 follicular lymphoma; ...
  
• Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003490 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00005637 - Active, not recruiting
  adult ependymoma; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; Mixed Gliomas
  
• Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003133 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
  
• Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00028860 - Completed
  stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
  
• Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003012 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00222469 - Recruiting
  Metastatic Pancreatic Cancer
  
• Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00139230 - Completed
  Squamous Cell Carcinoma; Carcinoma of Head/Neck
  
• Combination Chemotherapy for Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00191815 - Completed
  Breast Cancer
  
• Combination Chemotherapy for Patients With Brain Cancer
  ClinicalTrials.gov Identifier: NCT00002814 - Active, not recruiting
  adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
  
• Combination Chemotherapy for the Treatment of Indian Kala-Azar
  ClinicalTrials.gov Identifier: NCT00370825 - Completed
  Visceral Leishmaniasis
  
• Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00002987 - Active, not recruiting
  stage II adult Hodgkin's disease; stage I adult Hodgkin's disease
  
• Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00002557 - Active, not recruiting
  stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma
  
• Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00002684 - Active, not recruiting
  Bladder Cancer; Urethral Cancer
  
• Combination Chemotherapy in Patients with Zollinger-Ellison Syndrome and tumors of the pancreas
  ClinicalTrials.gov Identifier: NCT00001165 - Completed
  Islet Cell Adenoma; Neoplasm Metastasis; Zollinger Ellison Syndrome
  
• Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002531 - Active, not recruiting
  non-T, non-B adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; B-cell adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00004228 - Active, not recruiting
  stage I childhood lymphoblastic lymphoma; stage II childhood lymphoblastic lymphoma; stage III childhood lymphoblastic lymphoma; ...
  
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005603 - Active, not recruiting
  childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005585 - Active, not recruiting
  childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002738 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent childhood lymphoblastic lymphoma; recurrent osteosarcoma; ...
  
• Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002812 - Completed
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
  ClinicalTrials.gov Identifier: NCT00002463 - Active, not recruiting
  untreated childhood cerebellar astrocytoma; low-grade childhood cerebral astrocytoma; ...
  
• Combination Chemotherapy in Treating Children With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002590 - Active, not recruiting
  stage IV childhood large cell lymphoma; stage IV childhood lymphoblastic lymphoma
  
• Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
  ClinicalTrials.gov Identifier: NCT00025441 - Active, not recruiting
  childhood rhabdomyosarcoma; childhood soft tissue sarcoma; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma
  
• Combination Chemotherapy in Treating Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00003093 - Completed
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002744 - Completed
  L1 childhood acute lymphocytic leukemia; L2 childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005596 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003671 - Active, not recruiting
  B-cell childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002517 - Active, not recruiting
  Myeloid Leukemia; Myelodysplastic Syndromes; Refractory Anemia
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00066482 - Active, not recruiting
  childhood mature and immature teratomas; childhood extragonadal malignant germ cell tumor
  
• Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003423 - Active, not recruiting
  stage I childhood large cell lymphoma; stage III childhood lymphoblastic lymphoma; stage III childhood large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003650 - Active, not recruiting
  stage I childhood lymphoblastic lymphoma; stage II childhood lymphoblastic lymphoma; stage III childhood lymphoblastic lymphoma; ...
  
• Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002489 - Completed
  stage IV ovarian germ cell tumor; extragonadal germ cell tumor; stage II ovarian germ cell tumor; stage III ovarian germ cell tumor; ...
  
• Combination Chemotherapy in Treating Children With Progressive Brain Tumors
  ClinicalTrials.gov Identifier: NCT00002944 - Active, not recruiting
  recurrent childhood brain stem glioma; recurrent childhood visual pathway glioma; recurrent childhood cerebellar astrocytoma; ...
  
• Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006760 - Active, not recruiting
  recurrent/refractory childhood Hodgkin's lymphoma; childhood lymphocyte predominant Hodgkin's lymphoma; ...
  
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002816 - Active, not recruiting
  Quality of Life; recurrent childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002499 - Active, not recruiting
  recurrent childhood acute lymphocytic leukemia
  
• Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003729 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
  ClinicalTrials.gov Identifier: NCT00006095 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00003217 - Active, not recruiting
  Burkitt's Lymphoma; B-cell childhood acute lymphocytic leukemia; stage IV childhood small noncleaved cell lymphoma; ...
  
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003783 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00025610 - Active, not recruiting
  disseminated neuroblastoma; stage 4S neuroblastoma
  
• Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00417053 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00301782 - Recruiting
  Extragonadal Germ Cell Tumor; Teratoma; Testicular Germ Cell Tumor
  
• Combination Chemotherapy in Treating Men With Germ Cell Cancer
  ClinicalTrials.gov Identifier: NCT00003643 - Recruiting
  extragonadal germ cell tumor; Testicular Cancer
  
• Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003602 - Active, not recruiting
  untreated adult acute myeloid leukemia; refractory anemia with excess blasts; refractory anemia with excess blasts in transformation; ...
  
• Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002576 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00039351 - Active, not recruiting
  stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00010075 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003232 - Active, not recruiting
  Pain; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Combination Chemotherapy in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Fanconi's Anemia
  ClinicalTrials.gov Identifier: NCT00258427 - Recruiting
  Fanconi Anemia; Graft Versus Host Disease
  
• Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00020488 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003696 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
  Lymphoma; Leukemia
  
• Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002805 - Completed
  recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia; Previously Treated Myelodysplastic Syndrome
  
• Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00276601 - Suspended
  Leukemia
  
• Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003342 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00024323 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003331 - Active, not recruiting
  Cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003707 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy In Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003925 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003956 - Active, not recruiting
  Cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00004105 - Active, not recruiting
  childhood soft tissue sarcoma; Leukemia; Lymphoma
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00021073 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00043121 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00002955 - Active, not recruiting
  stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
  ClinicalTrials.gov Identifier: NCT00005644 - Active, not recruiting
  Bladder Cancer; Cancer of the Renal Pelvis and Ureter; Gastrointestinal Cancer; Urethral Cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003594 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004102 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00039611 - Completed
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002888 - Completed
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003421 - Active, not recruiting
  stage II adult Hodgkin's disease; stage III adult Hodgkin's disease; stage IV adult Hodgkin's disease; stage I adult Hodgkin's disease
  
• Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002715 - Active, not recruiting
  adult Hodgkin's lymphoma
  
• Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003589 - Active, not recruiting
  stage IV non-small cell lung cancer; Recurrent Small Cell Lung Cancer; stage IIIB non-small cell lung cancer; Quality of Life
  
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005806 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00041314 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00030797 - Active, not recruiting
  stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; stage IV colon cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00005051 - Completed
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003394 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003633 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00009815 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004913 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006372 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006465 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00007878 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00005819 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00045448 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00046917 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00047047 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004873 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer
  
• Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005867 - Completed
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; grade 3 follicular lymphoma
  
• Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003114 - Active, not recruiting
  HIV-associated Hodgkin's disease; AIDS-Related Lymphoma
  
• Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
  ClinicalTrials.gov Identifier: NCT00002524 - Active, not recruiting
  AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related diffuse mixed cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
  ClinicalTrials.gov Identifier: NCT00003388 - Active, not recruiting
  AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related lymphoblastic lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00049439 - Active, not recruiting
  AIDS-related diffuse large cell lymphoma; AIDS-related diffuse mixed cell lymphoma; AIDS-related diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003701 - Active, not recruiting
  stage III bladder cancer; childhood kidney/urinary cancer; transitional cell carcinoma of the bladder; ...
  
• Combination Chemotherapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00005047 - Active, not recruiting
  stage I bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder
  
• Combination Chemotherapy in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00014534 - Active, not recruiting
  stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder
  
• Combination Chemotherapy in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003088 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Combination Chemotherapy in Treating Patients With Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00005659 - No longer recruiting
  stage I breast cancer; stage II breast cancer
  
• Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
  ClinicalTrials.gov Identifier: NCT00040690 - Active, not recruiting
  L3 adult acute lymphoblastic leukemia; adult Burkitt's lymphoma; untreated adult acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00045513 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; refractory chronic lymphocytic leukemia
  
• Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003166 - Active, not recruiting
  recurrent adult lymphoblastic lymphoma; recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002693 - Completed
  Leukemia, Myeloid, Aggressive-Phase; Neutropenia; recurrent adult acute lymphoblastic leukemia; relapsing chronic myelogenous leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Colon Cancer
  ClinicalTrials.gov Identifier: NCT00046995 - Recruiting
  adenocarcinoma of the colon; stage II colon cancer; stage III colon cancer
  
• Combination Chemotherapy in Treating Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006103 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ...
  
• Combination Chemotherapy in Treating Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00039208 - Active, not recruiting
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Combination Chemotherapy in Treating Patients With Colorectal Cancer and Liver Metastases
  ClinicalTrials.gov Identifier: NCT00268398 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00006050 - Active, not recruiting
  liver metastases; Stage IV rectal cancer; stage IV colon cancer
  
• Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00301925 - Recruiting
  Breast Cancer
  
• Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
  ClinicalTrials.gov Identifier: NCT00003334 - Completed
  stage IV endometrial cancer; stage IV uterine sarcoma; uterine leiomyosarcoma; Fallopian Tube Cancer; recurrent uterine sarcoma; ...
  
• Combination Chemotherapy in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00041262 - Recruiting
  stage II esophageal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus
  
• Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003606 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006374 - Active, not recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00030433 - Completed
  extensive stage small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00041015 - Active, not recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00025272 - Completed
  extensive stage small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin
  ClinicalTrials.gov Identifier: NCT00002559 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor
  
• Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004092 - Recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
  
• Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002905 - Active, not recruiting
  AIDS-related peripheral/systemic lymphoma
  
• Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection
  ClinicalTrials.gov Identifier: NCT00003262 - Active, not recruiting
  stage II adult Hodgkin's disease; AIDS-related peripheral/systemic lymphoma; stage III adult Hodgkin's disease; stage IV adult Hodgkin's disease; ...
  
• Combination Chemotherapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00014209 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy
  ClinicalTrials.gov Identifier: NCT00002488 - Active, not recruiting
  recurrent adult lymphoblastic lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002565 - Completed
  Lymphoma
  
• Combination Chemotherapy in Treating Patients With Liver Metastases from Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002716 - Completed
  Colon Cancer; liver metastases; Rectal Cancer
  
• Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003834 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; liver metastases; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00030862 - Active, not recruiting
  stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; squamous cell carcinoma of the esophagus; ...
  
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003810 - Completed
  recurrent pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003742 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00005791 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00042874 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002835 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
  ClinicalTrials.gov Identifier: NCT00003549 - Active, not recruiting
  neuroendocrine carcinoma of the skin
  
• Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006260 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
  ClinicalTrials.gov Identifier: NCT00022178 - Active, not recruiting
  squamous cell carcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; undifferentiated carcinoma of unknown primary; ...
  
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005981 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006115 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan
  ClinicalTrials.gov Identifier: NCT00016978 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00274872 - Active, not recruiting
  Colorectal Cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003683 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003105 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter
  
• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
  ClinicalTrials.gov Identifier: NCT00005607 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006248 - Completed
  Nose Cancers; Oral Cancer; Throat Cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004242 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00005068 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00058253 - Recruiting
  unspecified adult solid tumor, protocol specific; stage IV prostate cancer; recurrent prostate cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003072 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; stage III non-small cell lung cancer; stage IV non-small cell lung cancer; ...
  
• Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00303758 - Completed
  Pancreatic Cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00006114 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003711 - Completed
  Cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00003127 - Active, not recruiting
  endometrial adenosquamous cell carcinoma; endometrial adenocarcinoma; stage IV endometrial cancer; endometrial clear cell carcinoma; ...
  
• Combination Chemotherapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003493 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Combination Chemotherapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002678 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003827 - Active, not recruiting
  de novo myelodysplastic syndromes; refractory anemia with excess blasts in transformation; refractory anemia with excess blasts; ...
  
• Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
  ClinicalTrials.gov Identifier: NCT00030264 - Recruiting
  childhood soft tissue sarcoma; childhood neurofibrosarcoma
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00016302 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00109837 - Recruiting
  L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00274807 - Active, not recruiting
  Leukemia
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00482833 - Recruiting
  Leukemia
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00003311 - Completed
  noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma; contiguous stage II mantle cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00002643 - Completed
  metastatic tumors of the Ewing's family; Neutropenia
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00086801 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00109928 - Recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; anaplastic large cell lymphoma
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006250 - Active, not recruiting
  stage III grade 1 follicular lymphoma; stage III grade 2 follicular lymphoma; stage III grade 3 follicular lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002494 - Active, not recruiting
  stage I adult diffuse small noncleaved cell/Burkitt's lymphoma; noncontiguous stage II adult diffuse small noncleaved cell/Burkitt's lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00005977 - Completed
  L3 adult acute lymphoblastic leukemia; stage IV adult diffuse small noncleaved cell/Burkitt's lymphoma; Burkitt's Lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00019045 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00031954 - Active, not recruiting
  stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003449 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Combination Chemotherapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005793 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00041210 - Recruiting
  adult Hodgkin's lymphoma
  
• Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00003958 - Completed
  childhood rhabdomyosarcoma; childhood soft tissue sarcoma; Muscle Cancer
  
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00448760 - Recruiting
  Esophageal Cancer
  
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003378 - Active, not recruiting
  peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
  ClinicalTrials.gov Identifier: NCT00004082 - Active, not recruiting
  stage III endometrial cancer; peritoneal cavity cancer; endometrial adenocarcinoma; Fallopian Tube Cancer; stage III ovarian epithelial cancer; ...
  
• Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003322 - Active, not recruiting
  ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ...
  
• Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005960 - Active, not recruiting
  stage II prostate cancer; Pain; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00014105 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme
  
• Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003260 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00002993 - Active, not recruiting
  recurrent uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma
  
• Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003001 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; childhood gastrointestinal cancer; stage IV colon cancer
  
• Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003287 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; adenocarcinoma of the rectum; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00002813 - Active, not recruiting
  recurrent cervical cancer; cervical squamous cell carcinoma
  
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia
  ClinicalTrials.gov Identifier: NCT00002588 - Completed
  adult acute myelomonocytic leukemia (M4); adult acute differentiated monocytic leukemia (M5b); recurrent adult acute lymphocytic leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00047021 - Completed
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases
  
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005972 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00019513 - Active, not recruiting
  Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Lung Cancer; Lymphoma; Pancreatic Cancer; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003004 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003758 - Active, not recruiting
  acute leukemia; childhood cancer; hematopoietic/lymphoid cancer; Cancer; Leukemia; cellular diagnosis, childhood acute myeloid leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002532 - Active, not recruiting
  recurrent adult acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053105 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; recurrent grade III follicular large cell lymphoma; recurrent cutaneous T-cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006029 - Completed
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006125 - Completed
  recurrent grade III follicular large cell lymphoma; recurrent adult diffuse large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Resected Colon Cancer
  ClinicalTrials.gov Identifier: NCT00378716 - Active, not recruiting
  Colorectal Cancer
  
• Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004186 - Completed
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer; limited stage small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00002492 - Active, not recruiting
  stage II adult soft tissue sarcoma; stage III adult soft tissue sarcoma; stage I adult soft tissue sarcoma
  
• Combination Chemotherapy in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00009932 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00003053 - Active, not recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Stage II Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00002919 - Active, not recruiting
  stage II bladder cancer; transitional cell carcinoma of the bladder
  
• Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00104676 - Recruiting
  extragonadal germ cell tumor; Testicular Cancer
  
• Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00006232 - Completed
  stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003018 - Completed
  childhood gastrointestinal cancer; stage II pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer
  
• Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003732 - Recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
  ClinicalTrials.gov Identifier: NCT00004164 - Active, not recruiting
  stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• Combination Chemotherapy in Treating Patients With Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002696 - Suspended
  stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00003835 - Completed
  stage III colon cancer; adenocarcinoma of the colon
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
  ClinicalTrials.gov Identifier: NCT00304083 - Recruiting
  Neurofibromatosis Type 1 (nf1); Sarcoma
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003346 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00011986 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005026 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004003 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer
  
• Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00005049 - Active, not recruiting
  female reproductive cancer; Gastrointestinal Cancer; unclassified and other cancer
  
• Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00063999 - Recruiting
  recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer
  
• Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003587 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer; ...
  
• Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004209 - Active, not recruiting
  Quality of Life; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005825 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006116 - Active, not recruiting
  stage IV non-small cell lung cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; ...
  
• Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054392 - Active, not recruiting
  Non-small cell lung cancer
  
• Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00005086 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage IV bladder cancer
  
• Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00014274 - Recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases from Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00008294 - Active, not recruiting
  Colon Cancer; liver metastases; Rectal Cancer
  
• Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00006081 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage IV gastric cancer; ...
  
• Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00008060 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00009893 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; ...
  
• Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00003700 - Active, not recruiting
  L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00003385 - Active, not recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00002618 - Active, not recruiting
  stage III childhood large cell lymphoma; stage IV childhood large cell lymphoma; childhood diffuse large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002691 - Completed
  stage III childhood lymphoblastic lymphoma; stage III childhood large cell lymphoma; stage IV childhood large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00093795 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer
  
• Combination Chemotherapy in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003519 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer
  
• Combination Chemotherapy in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003679 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer
  
• Combination Chemotherapy in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00041119 - Recruiting
  stage I breast cancer; stage II breast cancer
  
• Combination Chemotherapy in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00047099 - Recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
  
• Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery
  ClinicalTrials.gov Identifier: NCT00015886 - Active, not recruiting
  stage IIIB breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
  ClinicalTrials.gov Identifier: NCT00039546 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Combination Chemotherapy in Treating Women With Resected Breast Cancer
  ClinicalTrials.gov Identifier: NCT00033683 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer and Positive Axillary Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00003782 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005581 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer; Quality of Life
  
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00004125 - Active, not recruiting
  Breast Cancer
  
• Combination Chemotherapy in Treating Women With Stage III Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003896 - Active, not recruiting
  stage III ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003352 - Completed
  stage IIIB breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00398554 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00365755 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00343369 - Recruiting
  Leukemia
  
• Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00281944 - Recruiting
  Unspecified Childhood Solid Tumor, Protocol Specific
  
• Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00369317 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00433459 - Recruiting
  Lymphoma
  
• Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
  ClinicalTrials.gov Identifier: NCT00276757 - Recruiting
  Langerhans Cell Histiocytosis
  
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00103285 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00558519 - Recruiting
  Leukemia
  
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00408005 - Recruiting
  Leukemia
  
• Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00379457 - Recruiting
  Sarcoma
  
• Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00467051 - Recruiting
  Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00462787 - Recruiting
  Leukemia
  
• Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00334802 - Active, not recruiting
  Metastatic Breast Cancer
  
• Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002803 - Active, not recruiting
  stage IVS neuroblastoma; localized unresectable neuroblastoma; regional neuroblastoma; localized resectable neuroblastoma
  
• Combination Chemotherapy Plus Alemtuzumab Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00027560 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00003811 - Active, not recruiting
  childhood malignant testicular germ cell tumor; childhood mature and immature teratomas; Drug Toxicity; recurrent childhood malignant germ cell tumor; ...
  
• Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00004036 - Active, not recruiting
  Cancer
  
• Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer
  ClinicalTrials.gov Identifier: NCT00003657 - Active, not recruiting
  Lung Cancer; Gastrointestinal Cancer; Reproductive Cancers; Head and Neck Cancer; Bone Cancer; Kaposi's Sarcoma; Soft Tissue Sarcoma
  
• Combination Chemotherapy Plus Augmerosen in Treating Patients With Untreated Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00017251 - Completed
  extensive stage small cell lung cancer
  
• Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006786 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016107 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003405 - Active, not recruiting
  untreated adult acute myeloid leukemia; childhood acute megakaryocytic leukemia (M7); adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00004141 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022230 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00002792 - Active, not recruiting
  Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia
  
• Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases from Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00056030 - Active, not recruiting
  liver metastases; stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00003937 - Completed
  cardiac toxicity; localized osteosarcoma
  
• Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00059787 - Active, not recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00014456 - Active, not recruiting
  Cancer
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00032149 - Active, not recruiting
  AIDS-Related Lymphoma
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
  ClinicalTrials.gov Identifier: NCT00005958 - Active, not recruiting
  stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004137 - Completed
  extensive stage small cell lung cancer
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005810 - Completed
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00028717 - Active, not recruiting
  adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; grade 3 follicular lymphoma; Mantle Cell Lymphoma
  
• Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005850 - Active, not recruiting
  Anxiety Disorder; Depression; Fatigue; Non-small cell lung cancer
  
• Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
  ClinicalTrials.gov Identifier: NCT00005796 - Active, not recruiting
  Brain Tumor
  
• Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00017303 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003243 - Completed
  childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases
  
• Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
  ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
  
• Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
  ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00026208 - Recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; ...
  
• Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003784 - Completed
  stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
  
• Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00054548 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002740 - Active, not recruiting
  disseminated neuroblastoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00017368 - Completed
  regional neuroblastoma; disseminated neuroblastoma; localized unresectable neuroblastoma; stage 4S neuroblastoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00003852 - Active, not recruiting
  recurrent testicular cancer; recurrent ovarian germ cell tumor; pediatric germ cell tumor; extragonadal germ cell tumor
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002558 - Completed
  recurrent testicular cancer; recurrent ovarian germ cell tumor; extragonadal germ cell tumor
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.
  ClinicalTrials.gov Identifier: NCT00003943 - Active, not recruiting
  extensive stage small cell lung cancer; newly diagnosed carcinoma of unknown primary
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003400 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00005792 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003215 - Active, not recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003632 - Active, not recruiting
  primary central nervous system lymphoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002838 - Active, not recruiting
  stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer
  ClinicalTrials.gov Identifier: NCT00002931 - Recruiting
  extragonadal germ cell tumor; ovarian germ cell tumor; Testicular Cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003957 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003860 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003297 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00003413 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Quality of Life
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003944 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002772 - Completed
  stage IIIA breast cancer; stage II breast cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005589 - Active, not recruiting
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
  
• Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003190 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002925 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002912 - Completed
  recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia; recurrent childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002697 - Completed
  adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00006472 - Active, not recruiting
  stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
  
• Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021112 - Active, not recruiting
  stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
  ClinicalTrials.gov Identifier: NCT00003309 - Active, not recruiting
  Adult Medulloblastoma; adult anaplastic ependymoma; adult ependymoma; adult supratentorial primitive neuroectodermal tumor (PNET)
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
  ClinicalTrials.gov Identifier: NCT00003935 - Active, not recruiting
  untreated childhood brain stem glioma
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00003203 - Active, not recruiting
  untreated childhood supratentorial primitive neuroectodermal and pineal tumors; untreated childhood medulloblastoma
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004097 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003888 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00004901 - Completed
  lip and oral cavity cancer; Oropharyngeal Cancer; Head and Neck Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002984 - Completed
  Esophageal Cancer; Adenocarcinoma; Carcinoma, Squamous Cell
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026403 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002631 - Completed
  squamous cell carcinoma of the esophagus; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00002714 - Completed
  stage II adult Hodgkin's disease; Quality of Life; stage I adult Hodgkin's disease
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00005638 - Completed
  Esophageal Cancer; Gastric Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00021320 - Active, not recruiting
  stage 0 esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients with Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006051 - Active, not recruiting
  Throat Cancer; Oral Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006487 - Active, not recruiting
  limited stage small cell lung cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00025168 - Completed
  stage III pancreatic cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
  ClinicalTrials.gov Identifier: NCT00003955 - Active, not recruiting
  adult soft tissue sarcoma; alveolar childhood rhabdomyosarcoma; childhood malignant mesenchymoma; embryonal childhood rhabdomyosarcoma; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Astrocytoma
  ClinicalTrials.gov Identifier: NCT00003621 - Completed
  adult anaplastic astrocytoma; Quality of Life
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
  ClinicalTrials.gov Identifier: NCT00003625 - Completed
  untreated childhood brain stem glioma
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003996 - Active, not recruiting
  adult glioblastoma multiforme; Quality of Life
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00032032 - Recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004094 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the nasopharynx; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00003061 - Active, not recruiting
  primary central nervous system lymphoma
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002858 - Active, not recruiting
  limited stage small cell lung cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
  ClinicalTrials.gov Identifier: NCT00003652 - Active, not recruiting
  stage II anal cancer; stage III anal cancer; squamous cell carcinoma of the anus; cloacogenic carcinoma of the anus; basaloid carcinoma of the anus
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00014417 - Recruiting
  stage II esophageal cancer; stage III esophageal cancer; squamous cell carcinoma of the esophagus; Adenocarcinoma of the Esophagus
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004093 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006378 - Active, not recruiting
  stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00003235 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IIIA non-small cell lung cancer; Squamous Cell Lung Cancer; Adenocarcinoma of the Lung; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00005830 - Active, not recruiting
  stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma; endometrial clear cell carcinoma; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00005840 - Active, not recruiting
  stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma; endometrial clear cell carcinoma
  
• Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
  ClinicalTrials.gov Identifier: NCT00002839 - Active, not recruiting
  stage II squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00005838 - Completed
  Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00009880 - Completed
  Esophageal Cancer; Gastric Cancer
  
• Combination Chemotherapy Plus Radiation Therapy With or Without Gefitinib in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00020709 - Active, not recruiting
  Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026104 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Combination Chemotherapy Plus Rituximab and Filgrastim in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00018980 - Recruiting
  Lymphoma
  
• Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005089 - Active, not recruiting
  contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II mantle cell lymphoma; ...
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00019253 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00007865 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005601 - Completed
  Non-Hodgkin's Lymphoma; Lymphoblastic Lymphoma
  
• Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00033644 - Completed
  stage IV uterine sarcoma; recurrent uterine sarcoma; uterine leiomyosarcoma
  
• Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003728 - Recruiting
  acute undifferentiated leukemia; childhood acute lymphoblastic leukemia; childhood lymphoblastic lymphoma
  
• Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002516 - Active, not recruiting
  metastatic tumors of the Ewing's family; localized tumors of the Ewing's family
  
• Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00025285 - Completed
  Non-small cell lung cancer
  
• Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006015 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00014352 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; Thromboembolism; recurrent prostate cancer
  
• Combination Chemotherapy Treatment For Advanced Non-Small Cell Lung Cancer Patients Having Prior Chemotherapy
  ClinicalTrials.gov Identifier: NCT00065182 - Terminated
  Non-small cell lung cancer
  
• Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00230399 - Active, not recruiting
  Colorectal Cancer
  
• Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002566 - Active, not recruiting
  recurrent testicular cancer; extragonadal germ cell tumor
  
• Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003084 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006721 - Recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003143 - Completed
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003994 - Active, not recruiting
  stage I childhood liver cancer; recurrent childhood liver cancer; childhood hepatoblastoma
  
• Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated
  ClinicalTrials.gov Identifier: NCT00025337 - Active, not recruiting
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; ...
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00303628 - Recruiting
  Colorectal Cancer
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00112918 - Active, not recruiting
  stage II colon cancer; stage III colon cancer
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021060 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00070122 - Completed
  Colon Cancer; Rectal Cancer
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00027703 - Completed
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma; epithelial mesothelioma; ...
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00012272 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic or Locally Advanced Colorectal Cancer or Other Solid Tumors That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00296062 - Recruiting
  Colorectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Previously Untreated Stomach Cancer or Gastroesophageal Junction Cancer That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00450203 - Not yet recruiting
  Gastric Cancer
  
• Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
  ClinicalTrials.gov Identifier: NCT00005021 - Completed
  Lymphoma; Leukemia
  
• Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00002596 - Completed
  childhood extragonadal malignant germ cell tumor; childhood malignant testicular germ cell tumor; childhood mature and immature teratomas; ...
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002798 - Completed
  Myeloid Leukemia; Refractory Anemia
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003436 - Active, not recruiting
  refractory anemia with excess blasts in transformation; refractory anemia with excess blasts; childhood acute promyelocytic leukemia (M3); ...
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002701 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3)
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
  Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
  
• Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00513955 - Recruiting
  Lymphoma
  
• Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00288002 - Recruiting
  Breast Cancer
  
• Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00064181 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; stage IV colon cancer; Stage IV rectal cancer
  
• Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00182715 - Recruiting
  Colorectal Cancer
  
• Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00482222 - Recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00265811 - Recruiting
  Colorectal Cancer
  
• Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00023868 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; liver metastases; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00014222 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
  
• Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002653 - Active, not recruiting
  Multiple Myeloma
  
• Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00309920 - Recruiting
  Breast Cancer
  
• Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005578 - Completed
  stage II childhood Hodgkin's disease; stage III childhood Hodgkin's disease; stage IV childhood Hodgkin's disease; cardiac toxicity; ...
  
• Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00022126 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; L2 childhood acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003577 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00392886 - Recruiting
  Brain and Central Nervous System Tumors
  
• Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00060385 - Active, not recruiting
  adult T-cell leukemia and lymphoma; Cutaneous T-Cell Lymphoma; Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005863 - Active, not recruiting
  Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; childhood acute monocytic leukemia; ...
  
• Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00030719 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00008125 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00028925 - Completed
  extensive stage small cell lung cancer
  
• Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00433420 - Active, not recruiting
  Breast Cancer
  
• Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002719 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00416910 - Active, not recruiting
  Leukemia
  
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00003691 - Active, not recruiting
  stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer
  
• Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotexate or Observation in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00492856 - Recruiting
  Leukemia
  
• Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00372593 - Recruiting
  Leukemia
  
• Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00454480 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00003052 - Active, not recruiting
  adult soft tissue sarcoma
  
• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002989 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• Combination Chemotherapy With or Without Imatinib Mesylate and/or Peripheral Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00458848 - Recruiting
  Leukemia
  
• Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003639 - Active, not recruiting
  stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
  
• Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy With or Without Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003027 - Active, not recruiting
  Stage IV Melanoma
  
• Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00005979 - Active, not recruiting
  stage III colon cancer; adenocarcinoma of the colon
  
• Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00557193 - Not yet recruiting
  Leukemia
  
• Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00036985 - Active, not recruiting
  stage IIIA breast cancer
  
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy Followed by Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00049517 - Recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003150 - Completed
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003595 - Completed
  AIDS-related small noncleaved cell lymphoma; Burkitt's Lymphoma; AIDS-related immunoblastic large cell lymphoma; ...
  
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00006045 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003204 - Active, not recruiting
  stage III grade I follicular small cleaved cell lymphoma; stage III grade II follicular mixed cell lymphoma; ...
  
• Combination Chemotherapy With or Without Oblimersen in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00042978 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Combination Chemotherapy with Or Without Pegfilgrastim As First-Line Or Second-Line Therapy in Treating Patients with Locally Advanced Or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00119327 - Recruiting
  Colon Cancer; Infection; Neutropenia; Rectal Cancer
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00022737 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Previously Untreated Germ Cell Cancer
  ClinicalTrials.gov Identifier: NCT00003941 - Active, not recruiting
  bone metastases; brain metastases; liver metastases; Mediastinal Cancer; Testicular Cancer
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005090 - Active, not recruiting
  adult Hodgkin's disease
  
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002926 - Active, not recruiting
  Myelodysplastic Syndromes; Myeloid Leukemia; Refractory Anemia; Refractory Cytopenia
  
• Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003584 - Active, not recruiting
  Stage IV Renal Cell Cancer; childhood kidney/urinary cancer; recurrent renal cell cancer
  
• Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00002878 - Completed
  refractory plasma cell neoplasm
  
• Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006363 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Children With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00025064 - Active, not recruiting
  stage II childhood Hodgkin's lymphoma; stage I childhood Hodgkin's lymphoma; stage III childhood Hodgkin's lymphoma; ...
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00281905 - Active, not recruiting
  Brain and Central Nervous System Tumors; Neuroblastoma
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005584 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; adult lymphocyte predominant Hodgkin's lymphoma
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003389 - Active, not recruiting
  adult Hodgkin's lymphoma
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00002995 - Completed
  adult soft tissue sarcoma; childhood malignant mesenchymoma; embryonal childhood rhabdomyosarcoma; embryonal-botryoid childhood rhabdomyosarcoma; ...
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00113399 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003317 - Completed
  stage IIIA non-small cell lung cancer
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
  ClinicalTrials.gov Identifier: NCT00379340 - Recruiting
  Kidney Cancer
  
• Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00052936 - Recruiting
  adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00053092 - Active, not recruiting
  contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage I mantle cell lymphoma; stage III mantle cell lymphoma; ...
  
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004112 - Active, not recruiting
  stage IV mantle cell lymphoma; stage II adult diffuse small cleaved cell lymphoma; stage IV diffuse small lymphocytic/marginal zone lymphoma; ...
  
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00064116 - Completed
  stage I adult diffuse large cell lymphoma; contiguous stage II adult diffuse large cell lymphoma; ...
  
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00337246 - Active, not recruiting
  Leukemia
  
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004179 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006708 - Active, not recruiting
  recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma
  
• Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00021281 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; ...
  
• Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00354393 - Active, not recruiting
  Malignant Mesothelioma
  
• Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00253409 - Recruiting
  Malignant Mesothelioma
  
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00002568 - Active, not recruiting
  ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; ovarian endometrioid adenocarcinoma; ...
  
• Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00028886 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy With or Without Thalidomide in Treating Patients With Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00005834 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006484 - Completed
  stage IV non-small cell lung cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; ...
  
• Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00334867 - Not yet recruiting
  Sarcoma
  
• Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00559104 - Active, not recruiting
  Lymphoma
  
• Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00182793 - Recruiting
  Breast Cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00295893 - Recruiting
  Breast Cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00021255 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00054587 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004888 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00045461 - Recruiting
  Fallopian Tube Cancer; peritoneal cavity cancer; recurrent ovarian epithelial cancer
  
• Combination Chemotherapy With or Without Zoledronic Acid in Treating Patients With Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00470223 - Recruiting
  Sarcoma
  
• Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003038 - Completed
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00036868 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003927 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; stage II breast cancer
  
• Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00554788 - Not yet recruiting
  Retinoblastoma
  
• Combination Chemotherapy, Bevacizumab, and Cetuximab in Treating Patients With Stage IV Colorectal Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00100841 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; ...
  
• Combination Chemotherapy, Bevacizumab, Radiation Therapy, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00280150 - Recruiting
  Lung Cancer
  
• Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002658 - Active, not recruiting
  Myeloid Leukemia; Neutropenia
  
• Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00004231 - Active, not recruiting
  stage III mantle cell lymphoma; stage IV mantle cell lymphoma; recurrent mantle cell lymphoma
  
• Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00002600 - Completed
  ovarian serous cystadenocarcinoma; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; ...
  
• Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002785 - Completed
  untreated childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy, Celecoxib, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00089024 - Recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
  
• Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002669 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004128 - Recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Combination Chemotherapy, Monoclonal Antibody Therapy, and Surgery in Treating Women With Stage II, Stage III, or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006110 - Active, not recruiting
  stage II breast cancer; stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; ...
  
• Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00068250 - Recruiting
  primary central nervous system lymphoma
  
• Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00134030 - Recruiting
  localized osteosarcoma; metastatic osteosarcoma
  
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00027937 - Completed
  adult solid tumor; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; childhood solid tumor; Lymphoma
  
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Donor Lymphocyte Infusion in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006261 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00003081 - Active, not recruiting
  recurrent childhood rhabdomyosarcoma; adult rhabdomyosarcoma; recurrent peripheral primitive neuroectodermal tumor; ...
  
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00004088 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00165490 - Active, not recruiting
  Adenocarcinoma of Esophagus; Squamous Cell Carcinoma of Esophagus
  
• Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003087 - Active, not recruiting
  stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II esophageal cancer; squamous cell carcinoma of the esophagus
  
• Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma
  ClinicalTrials.gov Identifier: NCT00002571 - Active, not recruiting
  AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related diffuse mixed cell lymphoma; ...
  
• Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00334815 - Recruiting
  Lung Cancer
  
• Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00004006 - Active, not recruiting
  extraocular retinoblastoma; recurrent retinoblastoma; intraocular retinoblastoma
  
• Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00040794 - Recruiting
  Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Combination Chemotherapy, Radiation Therapy, and Interferon Alfa in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00262951 - Recruiting
  Pancreatic Cancer
  
• Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00003541 - Active, not recruiting
  stage IV mantle cell lymphoma; stage III mantle cell lymphoma
  
• Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004202 - Completed
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00005978 - Active, not recruiting
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; ...
  
• Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
  ClinicalTrials.gov Identifier: NCT00017160 - Suspended
  stage III adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage IIB adult soft tissue sarcoma; ...
  
• Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00045617 - Active, not recruiting
  limited stage small cell lung cancer
  
• Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
  ClinicalTrials.gov Identifier: NCT00335556 - Recruiting
  Kidney Cancer
  
• Combination Chemotherapy, Rituximab, and Bevacizumab in Treating Older Patients with Stage II, Stage III, Or Stage IV Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00121199 - Recruiting
  stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; contiguous stage II adult diffuse large cell lymphoma; ...
  
• Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors
  ClinicalTrials.gov Identifier: NCT00025077 - Active, not recruiting
  recurrent childhood supratentorial primitive neuroectodermal tumors; recurrent childhood medulloblastoma
  
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00002804 - Active, not recruiting
  nonmetastatic childhood soft tissue sarcoma; metastatic childhood soft tissue sarcoma
  
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00287950 - Active, not recruiting
  Neuroblastoma
  
• Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00043108 - Active, not recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00016276 - Completed
  cardiac toxicity; stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer
  
• Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00134017 - Recruiting
  childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; plasma cell neoplasm
  
• Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00276809 - Active, not recruiting
  Leukemia
  
• Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00006233 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Combination Daclizumab/Denileukin Diftitox to Treat Uveitis
  ClinicalTrials.gov Identifier: NCT00326508 - Completed
  Non-Infectious Intermediate and Posterior Uveitis
  
• Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL
  ClinicalTrials.gov Identifier: NCT00178841 - Completed
  Cutaneous T-Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome
  
• Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00076570 - Active, not recruiting
  Kidney Transplantation
  
• Combination Drug Therapy for Patients with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00001729 - Completed
  Chronic Hepatitis C; Fibrosis; Hemolytic Anemia
  
• Combination Drug Treatment of Pediatric HIV Infection
  ClinicalTrials.gov Identifier: NCT00001818 - Completed
  HIV Infection
  
• Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193076 - Active, not recruiting
  Breast Cancer
  
• Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Combination Iron Chelation Therapy
  ClinicalTrials.gov Identifier: NCT00004982 - Completed
  Iron Overload; Thalassemia
  
• Combination Methotrexate and Infliximab
  ClinicalTrials.gov Identifier: NCT00432432 - Completed
  Ankylosing Spondylitis
  
• Combination Nicotine Replacement for Alcoholic Smokers
  ClinicalTrials.gov Identifier: NCT00064844 - Completed
  Smoking; Alcoholism
  
• Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00367094 - Completed
  Hypertension
  
• Combination of Capecitabine (Xeloda) and Bevacizumab (Avastin) for Treatment of Metastatic Breast Cancer in Patients Who Are HER2 Negative (Do Not Have Too Many Copies of the HER2 Gene) Followed by Chemotherapy Combined with Bevacizumab If Disease Progres
  ClinicalTrials.gov Identifier: NCT00121836 - Active, not recruiting
  Breast Cancer
  
• Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00056173 - Recruiting
  Carcinoma, Renal Cell; Metastases, Neoplasm
  
• Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00363831 - Recruiting
  Nasopharyngeal Neoplasms
  
• Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00568529 - Recruiting
  Gastric Cancer
  
• Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients with Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00148135 - Recruiting
  Carcinoma of Unknown Primary Site (CUP)
  
• Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock
  ClinicalTrials.gov Identifier: NCT00320099 - Recruiting
  Septic Shock
  
• Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients
  ClinicalTrials.gov Identifier: NCT00447967 - Recruiting
  Gastric Cancer
  
• Combination of Efavirenz and Truvada - COMET Study
  ClinicalTrials.gov Identifier: NCT00224458 - Completed
  HIV Infections
  
• Combination of Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (Ontak), and Pentostatin With Steroids
  ClinicalTrials.gov Identifier: NCT00474149 - Recruiting
  Graft-Versus-Host Disease
  
• Combination of Glinides With Premixed Insulin
  ClinicalTrials.gov Identifier: NCT00369148 - Completed
  Type 2 Diabets Mellitus
  
• Combination of GTI 2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)
  ClinicalTrials.gov Identifier: NCT00565058 - Recruiting
  Acute Myeloid Leukemia
  
• Combination of Irinotecan and Temozolomide in Children With Brain Tumors.
  ClinicalTrials.gov Identifier: NCT00404495 - Recruiting
  Glioma; Medulloblastoma
  
• Combination Of Lapatinib With Carboplatin, Paclitaxel and Trastuzumab In Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00367471 - Recruiting
  Breast Cancer
  
• Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)
  ClinicalTrials.gov Identifier: NCT00454662 - Recruiting
  Hypertension; Cardiovascular Disease; Diabetes
  
• Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00430950 - Not yet recruiting
  Essential Hypertension
  
• Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00250835 - Recruiting
  Rectal Cancer
  
• Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00113295 - Active, not recruiting
  Anxiety Disorder
  
• Combination Of PAXIL Tablet And Benzodiazepines
  ClinicalTrials.gov Identifier: NCT00259883 - Terminated
  Depression
  
• Combination of Pioglitazone and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00362440 - Recruiting
  HIV Lipodystrophy
  
• Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00456833 - Recruiting
  Non Small Cell Lung Cancer
  
• Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-Small-Cell Lung Cancer (NSCLC) Patients Not Treated Previously With Systemic Therapy
  ClinicalTrials.gov Identifier: NCT00457119 - Recruiting
  Non Small Cell Lung Cancer
  
• Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00184028 - Suspended
  Carcinoma of the Head and Neck
  
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00316095 - Active, not recruiting
  Hypertension; Dyslipidemias
  
• Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study
  ClinicalTrials.gov Identifier: NCT00256815 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Combination Osteogenic Therapy in Established Osteoporosis
  ClinicalTrials.gov Identifier: NCT00018447 - Completed
  Osteoporosis, Post-Menopausal
  
• Combination Stem Cell (MESENDO) Therapy for Utilization and Rescue of Infarcted Myocardium
  ClinicalTrials.gov Identifier: NCT00548613 - Recruiting
  Coronary Artery Disease; Coronary Arteriosclerosis; Coronary Atherosclerosis; Coronary Disease
  
• Combination Stem Cell Therapy for the Treatment of Severe Leg Ischemia
  ClinicalTrials.gov Identifier: NCT00518401 - Recruiting
  Limb Ischemia; Peripheral Vascular Disease
  
• Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00327743 - Recruiting
  Breast Cancer; Cancer
  
• Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00565487 - Not yet recruiting
  Pancreatic Cancer
  
• Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
  ClinicalTrials.gov Identifier: NCT00147537 - Recruiting
  Non-small cell lung cancer
  
• Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-Risk Patients With Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00556049 - Not yet recruiting
  Metastatic Renal Cell Carcinoma
  
• Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS
  ClinicalTrials.gov Identifier: NCT00210301 - Recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Combination Therapy for Age-Related Macular Degeneration.
  ClinicalTrials.gov Identifier: NCT00376701 - Recruiting
  Age Related Macular Degeneration
  
• Combination Therapy for Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00119158 - Completed
  Atopic Dermatitis
  
• Combination Therapy for Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00447031 - Recruiting
  Macular Degeneration
  
• Combination Therapy for the Treatment of Bipolar Disorders
  ClinicalTrials.gov Identifier: NCT00063362 - Active, not recruiting
  Bipolar Disorder
  
• Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling
  ClinicalTrials.gov Identifier: NCT00221975 - Completed
  Bipolar Disorder
  
• Combination Therapy in Indian Visceral Leishmaniasis - Phase IIb
  ClinicalTrials.gov Identifier: NCT00523965 - Not yet recruiting
  Leishmaniasis, Visceral
  
• Combination Therapy in Patients With Depression
  ClinicalTrials.gov Identifier: NCT00485862 - Completed
  Depressive Symptoms
  
• Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
  ClinicalTrials.gov Identifier: NCT00211887 - Recruiting
  Relapsing Remitting Multiple Sclerosis
  
• Combination Therapy in Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00433329 - Recruiting
  Pulmonary Arterial Hypertension
  
• Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00298662 - Active, not recruiting
  Multiple Sclerosis
  
• Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)
  ClinicalTrials.gov Identifier: NCT00120380 - Active, not recruiting
  Hypertension
  
• Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00005655 - Recruiting
  Kidney Cancer; Lung Carcinoma; Sarcomas
  
• Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII
  ClinicalTrials.gov Identifier: NCT00284193 - Active, not recruiting
  Hemophilia A
  
• Combination Therapy of Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00001964 - Active, not recruiting
  Aplastic Anemia
  
• Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00355576 - Completed
  Amyotrophic Lateral Sclerosis
  
• Combination Therapy to Prevent Kidney Transplant Rejection
  ClinicalTrials.gov Identifier: NCT00078559 - Active, not recruiting
  Kidney Transplantation
  
• Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, and Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma.
  ClinicalTrials.gov Identifier: NCT00277017 - Completed
  Kidney; Cancer
  
• Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
  Multiple Sclerosis
  
• Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00183989 - Recruiting
  Mantle Cell Lymphoma
  
• Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
  ClinicalTrials.gov Identifier: NCT00548002 - Completed
  Staphylococcus Aureus; Bacteremia; Endocarditis; Sepsis
  
• Combination Therapy with IL-2 Plus Antiretroviral Drugs to Treat HIV Infection
  ClinicalTrials.gov Identifier: NCT00004737 - No longer recruiting
  HIV Infection
  
• Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
  ClinicalTrials.gov Identifier: NCT00004985 - Completed
  HIV Infections
  
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
  ClinicalTrials.gov Identifier: NCT00017719 - Completed
  HIV Infections; Pregnancy
  
• Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome
  ClinicalTrials.gov Identifier: NCT00303004 - Active, not recruiting
  Eisenmenger Syndrome
  
• Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX
  ClinicalTrials.gov Identifier: NCT00479583 - Recruiting
  Cancer